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Abstract 
The rx/Rax gene is a conserved homeobox transcription factor that is known to 
play an important role in the development of the eye. Mutations in rxjRax gene 
manifest in the congenital loss of eyes known as anophthlamia or the development 
of small-eyes; microphthlamia. Despite numerous literatures describing the 
expression of Rx/Rax in the anterior hypothalamus of several model organisms, its 
function there is still hugely unknown and remains to be investigated. In order to 
gain insight into the role of rx, I have performed experiments aimed at 
understanding the signalling events governing the expression and function of rx3, a 
homologue of rxl Rax, in the anterior hypothalamus ofthe embryonic zebrafish 
model system. 
Several studies have shown the reduction of pomc expressing neurons in the 
arcuate nucleus ofthe hypothalamus when the function of rx3/Rax is 
compromised. Here I have shown that rx3 may, together with the signalling 
molecule sonic hedgehog (Shh), act to specify and promote the differentiation of 
progenitor cells to the Pomc cell fate. The functional loss of either rx3 or Shh leads 
to a decrease in the number of pomc expressing neurons in the arcuate nucleus; 
located adjacent to the rx3 and shh expressing domains at the anterior 
hypothalamus. Further analyses reveal that rx3 and Shh may mutually activate 
each other's expression during the early establishment ofthe anterior dorsal 
hypothalamus. Experiments also show that Fgf may operate upstream of rx3 to 
regulate its expression; as well as the number of pomc positive cells in the arcuate 
nucleus. These studies show for the first time, a role for rx3 in the development of 
the anterior hypothalamus and the differentiation of pomc positive progenitors in 
the arcuate nucleus through its interaction with Shh. 
Additionally, I have found the signalling factors Shh and Fgf3 to be maintained in 
the adult zebrafish hypothalamus. Furthermore, I have evidence to suggest a role 
for Shh in governing the proliferation of neural progenitor cells in the medial 
hypothalamus of the adult zebrafish. This study is the first to investigate neural 
stem/progenitor cells in the hypothalamus of the adult zebrafish. 
1 
Introduction 
Introduction 
1. The hypothalamus: embryo and adult 
The hypothalamus is situated within the ventral forebrain and links the nervous 
and the endocrine systems. It is primarily responsible for regulating physical 
homeostasis, circadian rhythms and behavioural responses and co-operates with 
other regions of the brain to govern emotions such as fear and anger. Anatomically, 
the hypothalamus is comprised ofretrochiasmatic, medial and mamillary regions, 
which occupy, respectively, the anterior, medial and posterior hypothalamus. 
Together these regions form a major portion of the ventral diencephalon and are 
bounded anteriorly by the optic chiasm and posteriorly by the hypothalamic 
/thalamic boundary. 
Although the hypothalamus is undoubtedly one of the most important tissues of 
the nervous system, the mechanisms that underlie its development are still rather 
poorly understood - perhaps not surprising given its complexity. Only of late has 
research begun to indicate the role of intricate molecular pathways in its induction 
and patterning. 
1.1 Functional overview ofthe hypothalamo-neuroendocrine axis 
In amniotes, the hypothalamus connects to the pituitary or hypophysis via the 
infundibulum, an outgrowth ofthe ventral diencephalic floor commonly known as 
the pituitary stalk. The hypothalamus regulates the function of the pituitary 
through the release of neurohormones and neurotransmitters from two major 
groups of neurosecretory neurons: parvocelIular neurons, which control the 
anterior pituitary (adenohypophysis) and magnocellular neurons, which innervate 
the posterior pituitary (neurohypophysis). Magnocellular neurons consist oflarge-
sized cells, mainly in the supraoptic nucleus and periventricular nuclei. 
Parvocellular neurons are comprised of small neurons, largely found within the 
paraventricular nuclei ofthe hypothalamus (see Table 1 for full list of 
hypothalamic nuclei). 
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• Temperature regulation -
cooling of the body 
• Reproduction and parental 
behaviour 
• Control ofthe autonomic 
nervous system 
Supraoptic nucleus • Control of water balance via 
Paraventricular nucleus kidney 
• Control of reproductive organs 
during ovulation and 
copulation 
• Control of milk flow in 
mammals 
• Contraction of uterus in 
mammals 
• Social and parental behaviour 
• Control of the autonomic 
nervous 
Posterior nucleus • Temperature regulation-
Mammillary body warming of the body 
• Control of autonomic nervous 
Suprachiasmatic nucleus • Pacemaker for the biological 
ms 
Arcuate nucleus • Control of synthesis and 
release of anterior pituitary 
hormones 
Ventromedial nucleus • Feeding behaviour 
Dorsomedial nucleus • Aggression 
• Control of autonomic nervous 
Table 1: The major nuclei in the hypothalamus of vertebrates and their main 
functions. (Source: Comparative Vertebrate Neuroanatomy,200S1) 
Magnocellular neurons connect directly with the neurohypophysis, whereas, at 
least in amniotes, the connection ofparvocellular neurons to the adenohypophysis 
is indirect (Figure 1). Magnocellular neurons project their axons through the 
infundibulum into the neurohypophysis, where their secretions of oxytocin and 
vasopressin are released directly into the blood stream for general circulation, 
hence 'direct connection'. In contrast, parvocellular neurons terminate their 
projections in the anterior-dorsal infundibulum, at a point that will form the future 
3 
B 
Parvocellular 
a 
Hypophyseal 
porta I system 
• Capillary 
Intermediate lobe 
of pituitary 
(par.lnt. rmtdia) 
Magnocellular 
b 
halamus 
circulation 
........--..( Neurosecretory cell 
Figure 1: (A) Schematic representation of the major nuclei in the adult mammalian hypothalamus. 
Abbreviations: Ac, arcuate nuclues; AN, anterior nucleus; DM, dorsomedial nucleus; MB, mammillary 
body; MPo, medial preoptic nucleus; PN, posterior nucleus; Pv, paraventricular nucleus; Se, supra-
chiasmatic nucleus; So" supraoptic nucleus; VM, ventromedial nucleus. Anterior to the left. 
(B) Schematic diagram of the hypothalamic hypophyseal portal system. Panel a, indirect link (parvo-
cellular neurons); panel b; direct link (magnocellular neurons). Both figures are adapted from [1]. 
median eminence - a plexus of nerve terminals and portal capillary vessels (Figure 
1). Parvocellular neurons release two main classes of hormones: releasing 
hormones and inhibiting hormones, which are picked up by the network of 
capillaries in the median eminence. This network forms part of the hypophyseal 
portal system, which then transports the hormones into the adenohypophysis, 
hence 'indirect connection'. Depending on which of the two classes are released, a 
variety of hormones are then either suppressed or released into the general 
circulation by the adenohypophysis. The full list of hormones from the 
hypothalamus and the target adenohypophyseal hormones can be found in Table 
2. 
l..iJ!T!!i1i i'F.1 ~ l.i{IiTTl~:lInl ll l [~ 'tlUi.!,{:,l iU:r.r. flU 11 (~ 
- ...... 
-
..::. 
ltrnl~t-'1I11:-1iL'I'" I IL~ 01rmTil 
Gonadotropic releasing • Follicle stimulating • Testis 
hormone (GnRH) hormone (FSH) • Ovary 
• Luteinizing 
hormone (LH) 
Corticotropin releasing • Adrenocorticotropic • Adrenal cortex 
hormone hormone (ACTH) 
Thyrotropin releasing • Thyroid stimulating • Thyroid 
hormone (TRH) hormone 
Prolactin releasing factor • Prolactin (PRL) • Ovary 
(PRF) and Prolactin • Mammary gland 
release-inhibiting 
hormone (PIH) 
Melanocyte stimulating • Melanocyte • Pigment cells 
hormone releasing stimulating 
factor (MRF) and hormone (MSH) 
Melanocyte stimulating 
hormone release-
inhibitinK factor (MIF) 
Growth hormone • Growth hormone • Skeleton 
releasing hormone (GH) 
(GHRH) and 
Somatostatin (SOM) 
Hormones produced in • Oxytocin (isotocin in • Uterus 
the hypothalamus and fish) • Mammary gland 
transported to the • Social behaviour 
posterior pituitary • Vasopressin • Kidney, blood 
(neurohypophysis) where pressure 
theyare secreted. • Social behaviour 
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Table 2: Some ofthe major hypothalamic and pituitary hormones that are 
released into the general circulation and their target non-endocrine glands and 
organs (Source: Comparative Vertebrate Neuroanatomy, 20051) 
The zebrafish similarly possesses both magnocellular and parvocellular axons. As 
in amniotes, magnocellular axons project directly to the neurohypophysis, 
releasing hormones directly into the portal vasculature. However, in contrast to 
the amniote, the fish does not appear to have an extended infundibulum, nor a 
median eminence. Instead, parvocellular axons are believed to project directly to 
the adenohyphysis, the releasing hormones acting directly on adenohypophyseal 
cells, without an intermediate transport via a portal capillary network. 
Despite these intrinsic differences, the core mechanisms for establishing the 
hypothalamic-hypophyseal system appear to be conserved in fish and chick. In 
both species, FGF ligands secreted by the medial ventral midline or forming 
pituitary stalk of the zebrafish/chick hypothalamus play a critical role in axon and 
vasculature guidance. In vitro analyses in the chick, and in vivo analyses in the 
zebrafish show that FGFs exert long-range chemoattractive effects on both 
hypothalamic neurosecretory axons and the endothelial vasculature, attracting 
them to the medial ventral midline/pituitary stalk. Thus, in both fish and chick, the 
mechanisms underlying the functional hypothalamic-hypophyseal-pituitary axis 
appear to be conserved2• 
1.2 Development and patterning of the eNS 
The formation of the central nervous system (CNS) including the hypothalamus is a 
complex event that occurs in several intricate steps. It begins with the formation of 
the neural plate through cell-cell interactions between the dorsal mesendoderm 
with the overlying ectoderm during late gastrulation; a process whereby the three 
distinct germ-layers (i.e. ectoderm, mesoderm and endoderm) are formed. In 
higher vertebrates, the neural plate folds into the neural tube through the process 
of neurulation (Figure 2). The future CNS including the brain and spinal cord are 
derived from the neural tube. These steps are described in detail below. 
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Figure 2: Formation ofthe neural tube. (A,B) The neural plate invaginates ventrally to form 
the U-shaped fold. (B,C) The neural folds come into contact at the midline and fuse before 
fully invaginating ventrally to form the neural tube. (B') Electron microscopy scanned 
image of the invaginating neural tube. 
Image sources: 
i) Images A-C are obtained from [149]. 
ii) Image 8' is obtained from [150] . 
1.2.1 Induction of the neural plate from ectoderm 
Studies performed in a variety of species, most notably, Xenopus, demonstrate a 
key role for the mesodermal layer in inducing neural plate from ectoderm. 
Experiments conducted by Hans Spemann and Hilde Mangold in 1924 point to the 
existence of a group of mesoderm cells that function as 'organizers' for the 
overlying ectoderm to adopt the neural fate. This group of cells is now known as 
the 'Spemann organizer' in the Xenopus3; its functional counterpart in amniotes is 
known as the Node or Hensen's node4 (Figure 3). The Spemann organizer 
functions to inhibit the signalling molecule BMP4 by secreting BMP antagonists 
such as chordin and noggin. Upon inhibition of BMP4, the ectoderm thickens and 
forms the neural plate. The indirect induction of the dorsal ectoderm to a neural 
fate (neurectoderm) by the Spemann organizer via inhibitory mechanism suggests 
that the ectoderm would adopt a neural fate by default if not induced by BMP. The 
default neural fate ofthe ectoderm potentially underscores the importance of the 
nervous system as an evolutionary conserved 'master structure' without which 
control over other parts of the body would be impossible to achieve. 
1.2.2 Neural plate to neural tube 
The neural plate is organized along the principle rostrocaudal (anteroposterior) 
and mediolateral axes. The former is also termed the neuraxis, and corresponds to 
the main body axis. As outlined above, in many vertebrates, the neural plate 
subsequently folds to form the neural tube. Folding of the neural plate is made 
possible when cells throughout the neurectoderm lose their cuboidal shape typical 
of embryonic epithelia and take on a tall columnar, pseudostratified arrangement. 
The shape change causes the elevation of the margins on either side of the now U-
shaped neural plate (Figure 2). The ends of these margins are known as the neural 
folds. These ends eventually meet at the dorsal midline margin and coalesce 
through the process of neurulation to form the rod-like neural tube. There are two 
distinct forms of neurulation that takes place in different parts ofthe neural tubes 
a) primary and b) secondary neurulation. 
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Figure 3: The organisers of neural induction in the frog and chick. (A) The Spemann's 
organiser in the frog's neural induction process. Grafting experiments performed 
by Spemann and Mangold showed an induction of a secondary eNS neuroaxis by the 
donor notochord derived from the grafted dorsal blastopore in the host embryo. (B) 
Similar experiments performed in the chick led to the finding that the Hensen's node is 
the functional equivalent of the organiser. 
Image sources: 
i) Image A was obtained from [151] 
i/)lmage B was obtained from [152J 
In primary neurulation the neural folds come into contact and fuse to form the 
neural tube, as described above. In contrast, secondary neurulation occurs when a 
coalescence of multiple cavities appears in a preformed solid cord of posterior-
most neural cells, which resembles a rudiment form of the neural tube. Thus both 
processes occur in the embryo but are spatially segregated: primary neurulation 
occurs in the anterior neural tube and secondary neurulation in the posterior 
neural tube. The tubes from both primary and secondary neurulation form the 
complete neural tube. 
In the zebrafish however, as in all teleosts, the neural tube forms through a 
different neurulation process. The neural tube of the zebrafish forms through 
convergence-extension movements that cause ectodermal cells to accumulate 
along the midline and protrude ventrally. This give rise to a structure called the 
neural keel, which later produces a rod-like structure called the neural rod. A 
cavity then forms along the centre of the neural rod to produce the neural tube 
(Figure 4). This process is somewhat similar to the secondary neurulation process 
described above. 
1.2.3 Regionalisation ofthe neural tube 
The CNS in vertebrates is organized along two main axes, AP and DV, that underlie 
future distinct anatomical and functional structures. Signals operate early in 
embryogenesis to pattern the neural tube along the AP and DV axes, so that the 
anterior neural tube forms the brain and the posterior neural tube gives rise to the 
future spinal cord. Regionalisation along the D-V axis occurs through signals that 
derive, dorsally from the ectoderm, and ventrally from the notochord and 
prechordal mesoderm, specialized structures that differentiate from the organiser. 
Regionalisation of the neural tube, along both the A-P and D-Vaxes, occurs through 
the action of long-range signalling molecules that can transmit signals from one 
cell to another and can trigger a response in the recipient cell. Cells that primarily 
produce these signals serve as the 'signalling source' or the 'signalling center' for a 
particular tissue. Well- characterized signalling molecules in embryonic 
development include Shh, BMP, Nodal, Fgf and Retinoic Acid. These molecules 
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Figure 4: Schematic representation of neural tube development in the zebrafish. 
(A) Cells accumulate and pile up at the midline of the surface ectoderm through 
convergence-extension movements. (6) The cells bulge ventrally creating a rod-like 
structure called the neural keel. (C) The neural keel later cavitates to form the 
neural tube. (0) Confocal micrographs of transverse sections through rhodamine-
phalloidin-stained zebrafish embryo showing the formation of neural tube. 
Image source: 
i) Image 0 is obtained from [154]. 
execute their function by regulating transcription factors in responding cells. A 
number of lines of evidence show that signalling molecules, especially Shh, 
function as morphogensS, molecules that govern the patterning of a tissue by 
establishing a concentration gradient across the tissue. This gradient elicits 
different responses in recipient cells in the tissue, according to the threshold 
concentration. In other words, initially similar cells are differentially patterned 
based on the amount of morphogens they received. The morphogen concept is best 
described using the 'French flag' model first suggested by Lewis Wolpert in the 
1960s. The signalling molecules-transcription factor interaction gives rise to a 
highly organised topology ofthe neural tube where disctinct neuronal subtypes 
are generated in a characteristic order (see Figure 5 for example ofthis in the D-V 
axis ofthe neural tube)6. Recently emerging evidence suggests that signalling 
molecules (i.e. Shh)-transcription factors operate in a dynamic feedback loop to 
establish compartmentalised response within the ventral neural tube during early 
patterning7• 
As a result of these patterning events, distinct domains are established in the early 
neural tube. Additionally, cross-talk between early regions establishes further 
subdivions, particularly well-characterised along the A-P axis. Thus, in the early 
embryo the rudimentary brain can be separated into three distinct anatomical 
compartments, the prosencephalon (forebrain), mesencephalon (midbrain) and 
rhombencephalon (hindbrain). Further subdivisions arise from these: the 
telencephalon and diencephalon forming from the prosencephalon and the 
metencephalon and myelencephalon from the rhombencephalon. The 
diencephalon occupies relatively ventral regions of the brain, and gives rise to a 
variety of ventral forebrain structures, including the epithalamus, dorsal thalamus, 
ventral thalamus and the hypothalamus. The orders of these structures are 
evolutionarily conserved throughout vertebrates. 
1.3 Development and patterning of the hypothalamus 
The integrated patterning and development of A-P and D-V regions of the neural 
tube means that anterior-most floor plate cells extend into the forming 
diencephalon. A number of recent studies, in fact, show that anterior-most floor 
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Figure 5: Graded SHH concentration along the D-V axis ofthe posterior neural tube 
(spinal cord anlage) and the responsive trancription factors (TFs). Different 
progenitor cell domains (pO-p3) form in response to the graded SHH (blue) emanating 
from the floor plate (FP). The graded signal elicits different responsive transcription 
factor that give rise to the specific and compartmentalised progenitor domains. 
Image source: 
Images were obtained from [7]. 
plate cells give rise to ventral-most regions of the forming hypothalamus, through 
a series of signalling event orchestrated by secreted molecules emanating from the 
adjacent prechordal mesoderm (PM). 
1.3.1 Formation of the floor plate 
The notochord and prechordal mesoderm underlie the neural tube and signal to it 
along the entire A-P axis. Ventral midline regions ofthe neural tube that lie 
immediately adjacent to the notochord and floor plate will ultimately form a 
specialised group of ceJls, termed floor plate ceJls (Figure 6). The floor plate is a 
highly conserved morphological structure in vertebrates, and serves as a signalling 
source for adjacent cells in the neural tube. Thus the floor plate, along with the 
notochord/prechordal mesoderm, and its complementary dorsal organizer, the 
roof plate, plays a key role in the determination and specification of cell fate along 
the neural tube. 
The mechanisms underlying floor plate determination have been fiercely-debated 
and as a result, two models were proposed: a) inductive model and b) allocation 
models. The first model suggests that underlying mesoderm (notochord or 
prechordal mesoderm) induce ventral midline neural tube cells to differentiate 
into floor plate fate via secretion of Shh from the notochord, or Nodal (or, in the 
chick, a combination of Nodal and Shh) from the prechordal mesoderm9• Support 
for this interpretation derives from experiments showing that naive and 
uninduced epiblast precursor cells isolated from the ectoderm immediately 
anterior to the Hensen's node, or lateral neural plate cells, differentiate to floor 
plate cells when exposed to recombinant Shh. In the presence of re comb in ant 
Nodal, a lower concentration of Shh is required to achieve a similar induction of 
floor plate. Conversely, removal of the notochord, or genetic ablation ofShh, 
prevents floor plate formation in the posterior neuraxis; similarly, removal of the 
prechordal mesoderm, or genetic ablation of Nodal or Nodal signalling, prevent 
floor plate formation in the anterior neuroaxis9• 
The second model proposes a common origin of precursor floor plate cells with 
axial mesoderm. Fate mapping experiments in the chick and quail hypothesize that 
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Figure 6 : Development of the hypothalamus. (A) SHH is expressed in the 
floor plate at the ventral neural tube of the early developing embryo. The floor plate 
spans the entire anterior-posterior neuraxis. (8) The hypothalamus is specified 
when SHH is induced in the anterior basal plate. Simultaneously, signals (BMPIWNT) 
from the underlying prechordal mesoderm activate the expression ofTBX2 in the 
anterior floor plate. TBX2 inhibits the expression of SHH in the anterior floor plate. 
The TBX2 positive domain subsequently undergoes further patterning into different 
discrete domains along the anterior-posterior axis of the hypothalamus. (A,B) SHH is 
represented in red; TBX2 in blue. Anterior to the left; dorsal to the top. 
the floor plate and notochord are derived from a common cell pool located in the 
Hensen's node4• Mutant analysis in the zebrafish support this idea10. These 
findings led to the proposal that Shh is required as a trophic factor for the survival 
and maintenance of the floor plate cells rather than an inducing factor. The two 
models are not mutually exclusive, and recent evidence suggest that the two 
models operate at different positions of the floor plate, induction required for 
anterior-most floor plate cells, and maintained trophic support for more 
posteriorly-located floor plate cells8. 
1.3.2 Hypothalamus identity: induction ofthe anterior floor plate 
As outlined above, Shh and Nodal are secreted from prechordal mesoderm and 
induce anterior-most Shh positive floor plate cells. As in posterior regions of the 
neuraxis, such Shh positive floor plate cells have been proposed to then 
homeogenetically induce Shh in the ventro-lateral forebrain ll-13, resulting in Shh 
expression in cells of the basal plate. Together, the anterior floor plate cells and 
Shh positive basal plate cells comprise the anlage of much ofthe future 
hypothalamus (Figure 6). Almost immediately, anterior-most floor plate cells 
undergo a further differentiation to 'hypothalamic floor plate-like' cells, losing Shh 
expression and instead expressing hypothalamic markers. Shh expression is 
downregulated through the action of BMP (Bone Morphogenetic Protein) secreted 
from the PM. Analyses in the chick demonstrate that BMP mediated expression of 
the T-box transcriptional repressor, TBX2, is sufficient to repress SHH expression 
and promote hypothalamic floor differentiation, and suggest that BMP promotes 
the upregulation ofTBX2 by reducing the levels ofWNT activity in anterior floor 
plate cells14• This mechanism is likely to operate in other species: in the mouse, 
deletion of a TBX binding site upstream of the Shh gene results in prolonged 
expression of SHH in the hypothalamic floor15• In the zebrafish, Tbx2b is expressed 
in a similar fashion to that shown in the chick16, and Axin, a Wnt antagonist, is 
required for the differentiation of floor plate cells into hypothalamic cells17• The 
red uction in Shh expression in anterior floor plate cells leads also to a loss of Shh 
signalling components. Experimentally prolonging Shh signalling in anterior floor 
plate cells prevents their differentiation towards a hypothalamic floor fate. 
Normally, the homeodomain transcription factor, Emx2 is upregulated in the 
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posterior hypothalamic floor, and the signalling Iigands, FGF10 and FGF3 are 
upregulated in and adjacent to the medial hypothalamic floor. When Shh signalling 
is prolonged, such markers fail to be upregulated14. However, expression of both 
Shh and Shh signalling components are maintained in the immediately adjacent 
basal plate through late stages of embryogenesis (Figure 6). 
In the published literature, a different nomenclature has been used to define 
regions of the forming hypothalamus in the chick and the zebrafish. In the 
zebrafish, no study has examined early stages of zebra fish development (10-15 
hpf), when Shh might be expressed in the anterior floor plate. However, 
examination of 26-30 hpf embryos reveals a similar profile in gene expression: 
cells in a midline region defined as the 'posterior ventral hypothalamus' (PVH) 
express FGF3, FGF8, Tbx2b and Emx2. This suggests they are the homologous cells 
to chick 'hypothalamic floor'. In support ofthis interpretation, Nodal signalling has 
been shown to be required for the specification ofthe PVH. In the 26-30 hpf 
embryo, PVH cells are surrounded, anteriorly and dorsally, by Shh positive 
'anterior dorsal hypothalamic' (ADH) cells13• These appear to be homologous to the 
Shh positive basal plate cells that are in a similar position in the chick embryo (see 
Figure 1.9 in result chapter 1). In the zebrafish, hypothalamic cells at the ADH 
express the transcription factor rx3 (retinal homeobox transcription factor 3). In 
this thesis, I retain the use of the term PVH; however, I refer to the ADH and the 
basal plate as distinct structures. 
The conservation of signalling molecules and transcription factors in both 
amniotes and anamniotes suggests a conserved mechanism for formation and 
patterning ofthe hypothalamus. Some ofthese mechanisms in which transcription 
factors operate in the hypothalamus are even found to be conserved in 
invertebrates18• Despite this, little is known about the function of such highly 
conserved transcription factors. In this thesis, I am going to focus on one such 
factor, the rx3 or rx/ Rax gene. 
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2. The retinal prol:enitor homeobox 3 (rx3) 
The retinal progenitor homeobox gene (rx) or its mammalian homologue the 
'retina and anterior neural fold homeobox' gene (RAX) belong to the homeobox 
gene family of transcription factors and play a pivotal role in the development of 
the optic vesicles and the eyes. In the early mouse embryo, RAXis expressed in the 
anterior neural fold, a group of cells at the anterior pole ofthe neural plate that 
constitute a secondary signalling centre, responsible for the localised patterning of 
the anterior forebrain including areas that will give rise to the forebrain and optic 
vesicles19. An early study19, demonstrated Rax expression in the anterior neural 
fold of embryonic day 7.5 (E7.5) mouse embryos, a restricted expression in the 
optic vesicles, optic stalk and ventral diencephalon at E9.5, and maintained 
expression in the retina. These observations suggested a function for the Rax gene 
in development of the optic vesicles/eyes, and led to further investigations into the 
function of Rax/rx gene, the majority which describe how mutations in the Rax/rx 
gene result in severe eye malformations as discussed in the following sections. 
2.1 Conservation of rx/Rax gene and protein sequences 
The rx/ Rax gene is highly conserved amongst vertebrates and Drosophila as well. 
The rx gene belongs the family of homeobox genes and has, in its sequence, 
conserved octapeptide and Rx homeobox domains as well as a conserved OAR 
domain at the C- and N-terminals of the peptide respectively. The homeobox 
domain is approximately 180 base pairs long and encodes a protein that binds to 
DNA, thus allowing the gene to perform its role as a developmental transcription 
factor in all eukaryotes20• 
The Rax gene shares a high nucleotide sequence similarity with a range of 93-99% 
sequence identity within primates including humans and 65-91% within mammals 
compared to humans. The zebrafish orthologue rx3 gene shares a 57% sequence 
similarity to the human RAX gene, whilst rxl shares 54% and rx2 shares 53% 
respectively. According to gene annotations in EnsembJ21, the zebrafish rx3 gene is 
the true orthologue ofthe human RAX gene. It is also syntenically homologous to 
the human RAX gene on chromosome 18 compared to rxl and rx2, although in the 
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zebrafish, rx3 gene is located on chromosome 21. This is consistent with its 
similarity in both expressions and functions attributed to the mouse Rax gene as 
previously described. 
2.2 Phylogeny of the Rax/rx genes 
The phylogenetic tree in Box1 describes the evolution of the RAX/Rx gene across 
selected vertebrates. The tree is generated through Clusta1X2.022 and TreeView X23 
based on the mUltiple sequence alignment (MSA) of the RAX/Rx proteins of the 
respective organisms, analysed using ClustalX2.0 as well (Figure 7). The tree in 
Box1 shows a high similarity of the RAX proteins in higher vertebrates with the 
mouse (Mus musculus) and the rat (Rattus norvegicus) sharing the closest 
similarity. Although the zebrafish Rx3 does not share the same c1ade or branch as 
the human, mouse and rat, it does share a high protein sequence similarity with 
the RAX proteins of human, mouse and rat (see Figure 7). The OAR and homeobox 
domains are highly conserved as shown in the MSA data. 
2.3 rx (Rax) in vertebrate eye development 
As mentioned above, the rx gene has been shown to be critical in vertebrate eye 
development. Mutations in the RAX gene in human cause anophthalmia, a 
condition where either both eyes (or one eye) are missing24. Micropthalmia, a less 
severe form of anopthalmia, where eyes are formed smaller than the usual size, 
also arises from mutations in the RAX gene. These defects can also be observed in 
the mouse, xenopus and zebrafish where perturbation of the rx/ Rax gene function 
results in the development of small or absent eyes25-27• The genomes of the teleosts 
(including the zebrafish) and amphibians contain three rx genes of which rx3 gene 
is expressed the earliest in the presumptive eye field. The rx3 gene in the zebrafish 
is 1260 base pairs (bp) in length or 292 amino acids (aa). In the zebrafish, 
mutation in the rx3 gene (chokh mutant) disrupts the formation of the presumptive 
eye field and subsequently prevents the morphogenesis of the optic vesicles, which 
fail to evaginate from the presumptive forebrain region26• In this mutant, only the 
surface ectoderm-derived eye lenses remain. This consequently leads to the failure 
of eye formation. The mechanism by which rx3 specifies the eyes is partly 
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BOX 1 
Mus musculus 
Rattus norvegicus 
Homo sapiens 
Danio rerio 
Phylogenetic tree representing the degree of similarities between the RAX 
proteins of the mouse (Mus musculus), rat (Rattus norvegicus) and human 
(Homo sapiens), with the Rx3 protein of the zebrafish (Danio rerio). The 
mouse and rat share the same clade indicating the closest similarities of the 
protein among all four vertebrates. 
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zebrafish (O.rerio). Conserved sequences are indicated. 
t •• 
1'9 
150 
H9 
119 
understood: in the chokh mutants, retinal progenitor cells are specified, but 
remained trapped in the lateral wall of the diencephalon, failing to undergo 
morphogenesis to form the optic vesicles 26.28.29. 
2.4 Rx/Rax expression in the bypothalamus 
In contrast to the many studies that have analysed the role of Rax/rx gene in eye 
development, fewer studies have analysed its function in the hypothalamus. The 
Rax null mice exhibit defects, not only in the eyes, but also patterning defects in the 
hypothalamus3o• In early embryonic development, the optic cup (the outer layer of 
the optic vesicles) maps to an adjacent region to the hypothalamus in the anterior 
neural plate. Together, these observations have led to the proposal that the two 
tissues may have common origins that require rx gene for specification. An 
additional study has demonstrated that Rx function is cell autonomously required 
for the formation of the neurohypophysis (posterior pituitary) in the mouse31• 
Of all three rx genes in the zebrafish, only rx3 is expressed in the hypothalamus: 
expression is first detected in embryogenesis, but maintained in the hypothalamus 
of adult zebrafish32. However, our current knowledge and understanding of the 
role of Rax/rx3 gene in the development of the hypothalamus is still in its infancy. 
Previous studies have begun to analyse the function of Rx3 in the hypothalamus, 
and have demonstrated a reduction in the number of propiomelanocorticotropin 
(pomc)33 and vasotocin-neurophysin (vtn)18 hypothalamic neurosecretory 
neurons, in both chokh (rx3) mutants and rx3 morphants, indicating a requirement 
for rx3 in the formation and (or) differentiation of these neurons. However, the 
mechanism by which rx3 governs the formation for these neurosecretory neurons 
are unclear. In result chapters 1 to 4 of this thesis, I will focus and investigate the 
mechanism that underlies the role of rx3 for the formation of the Pomc neurons in 
the arcuate nucleus ofthe hypothalamus of the embryonic zebrafish. 
In this thesis, I have also investigated the maintenance of signalling factors in the 
adult zebrafish hypothalamus independently from investigating the function of rx3 
in the embryonic hypothalamus. As will be seen and discussed through result 
chapter 5, the signalling molecules are hypothesized to govern the behaviour of 
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neural progenitor cells in the medial hypothalamic region of the adult zebrafish. 
Section 3 below hence serves as the overall Introduction to result chapter S. 
3. Adult neural stem cells and neurol:enesis 
3.1 Overview of stem cells 
Studies in invertebrates and vertebrates, including humans, have shown the 
existence of stem cells that have the capability to self-renew and give rise to cells of 
different fates through the process of differentiation. They are the origin of all cells 
in an organism. The great pathologist Rudolph Virchow (1821-1902) once stated, 
"All cells come from cells" reflecting the nature of stem cells which were yet to be 
discovered at that pOint in time. Stem cells are pluripotent or multi potent and have 
the ability to self-renew and repopulate the niche in which they reside. 
Pluripotency refers to the ability of stem cells to repopulate each and every cell 
type in an organism, a key property that is attributed to embryonic stem cells34• 
Multipotency refers to the ability to differentiate and give rise to cells within an 
organ or tissue and it is used, for instance, to characterise tissue-specific, or adult 
stem cells, including neural stem cells (Figure 8). Recent research indicates the 
maintenance of stem cell niches in many areas of the adult, including the brain. 
These findings demonstrate the persistent nature of stem cell maintenance in the 
adult through self-renewal, and suggest they could serve as potential sources for 
new cell birth to replenish dead or damaged cells. 
However, the adult stem cell field, though advancing rapidly, is still clouded with 
scientific altercation on a proper guideline that can be used to identify and classify 
a 'stem cell'. The general opinion of what a stem cell should constitute in the adult 
system mainly stems from researches into adult haematopoietic stem cells, since it 
was in this system that adult stem cells were first identified35• Thus a rigorous 
definition: adult stem cells, like embryonic stem cells, must demonstrate the 
capacity to self-renew either in vivo or in vitro in artificial culture conditions and 
must also demonstrate multipotency i.e. retaining the ability to differentiate to 
different (albeit limited) cell lineages. A number of cellular markers are used to 
define both the stem cell and the niche, but none is strictly specific. Another 
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Figure 8: Schematic representation of neural stem cell differentiation process. Neural stem 
cells are multi potent and can undergo neurogenesis and gliogenesis to produce all neural 
cell types in the eNS. Gliogenesis generally takes place after neurogenesis and both of these 
processes mutually inhibit each other. Neural stem cells are also capable of undergoing 
self-renewal. 
Image source: 
Modified from [154]. 
emerging opinion but not yet a requirement for defining a stem cell is the 
observation of asymmetric cell division to produce a 'stem' daughter cell and a 
lineage-determined daughter cell. 
3.2 The stem cell niche concept 
Stem cells are believed to exist in niches where they are maintained as a group of 
cells or population instead of randomly distributed individual cells. A stem cell 
niche can be defined as a specialized microenvironment in which stem cells 
reside36• The stem cell niche concept originated from studies in the mouse 
haematopoetic system and mouse gonads36• Their molecular control has been 
particularly well-studied through analyses of the gonadal niches in invertebrates37• 
The precise nature of stem cells has been a fiercely-debated topic, and will be 
discussed further in the context of the adult brain in the proceeding sub-chapters. 
3.3 Adult neural stem cells in the mammalian and non-mammalian central 
nervous system 
3.3.1 Neural stem cells and neural pro&enitor cell identification 
In the developing central nervous system (CNS) ofthe vertebrate embryo, a myriad 
of neuronal, glial and ependymal cells are produced in a spatio-temporally defined 
order 38. These cells originate from neural stem cells (NSCs), which are the 
multipotent stem cells, found in the nervous system. NSCs appear to be maintained 
in the adult CNS as well, where they can continue to serve as multipotent stem cells 
with the capability of producing new neurons and glia cells via intermediary neural 
progenitor cells (NPCs). Despite our relatively advanced understanding of the 
biology and function of adult stem cells, the detection ofNSCs in the adult CNS has 
been extremely difficult. This is mainly due to the intricacies of identifying a bona 
fide NSC, as distinct from a neural progenitor cell. Molecular markers, such as those 
listed in Table 3, cannot easily distinguish between NSCs and NPCs. Proliferation is 
frequently used in attempts to distinguish NSCs from NPCs: the latter can be 
readily detected using cell proliferation markers, since they are actively dividing. 
PCNA, which marks for S-phase, MCMS, which marks for cells in G1, and BrdU, 
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which marks S-phase cells, are frequently used to assess the presence of NPCs and 
potential NSCs. 
SoxB1 (including sox2 and sox3) Transcription factor 
Nestin Structural protein 
GFAP Structural protein 
BLBP Lipid binding protein 
Vimentin Structural protein 
S100- beta Calcium binding protein 
Table 3: Established neural stem cell/progenitor markers in the CNS and their 
functional effects. 
3.3.2 NSC niches in the adult vertebrate brain 
In the CNS of adult mammals, dividing NPCs are most commonly detected in the 
subventricular zone (SVZ) of the lateral ventricles and subgranular zone (SGZ) of 
the dentate gyrus, both in the telencephalon, with some detected additionally in 
the central canal of the spinal cord39•40. The seminal works of Jose ph Altman 
(1965, 1969) showed that cells near the site of a induced-lesion rat brain could 
form new neurons, glias and neuroblasts (precursor neuronal cells) to repair and 
replenish the damaged site. We now know that the NSCs that contribute to these 
cells in the adult rat or mouse brain mainly reside in the SVZ and SGZ. In the 
mouse, NSCs from the SVZ of the lateral ventricles undergo neurogenesis under 
normal conditions, migrating tangentially to the olfactory bulb where they 
reconstitute the neuronal component of the olfactory epithelium. This migratory 
route is referred to as the rostral migratory stream. There is no evidence as yet to 
suggest a similar migratory event in humans and other higher primates, although 
proliferation and neurogenesis have been detected within the olfactory bulb of 
adult humans41. This may be attributed to the fact that the sense of smell in 
humans is underused, relative to rodents that are highly dependent on their sense 
of smell to navigate for food and escape from predators. Multipotent NSCs can also 
be found in the innermost subgranular cell layer of the adult hippocampus. Newly 
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hippocampus. Newly born neuroblasts migrate to the dentate gyrus where they 
become incorporated as granule neurons in the granular cell layer. These cells are 
thought to contribute to the formation of new memories in adult vertebrates. 
Apart from the well-defined niches of the SVZ and sez, NSC niches have also been 
detected in several other brain regions, including the neocortex42, 43, substantia 
nigra in the midbrain44, cerebellum45 and hypothalamus46 (Figure 9). Active 
research is currently being carried out to further validate the extent of 
neurogenicity of the NSCs at these sites. 
Whilst the mammalian system, especially the mouse, has been at the forefront of 
neural stem cell research in adults, non-mammalian systems (teleosts) such as the 
zebrafish are fast gaining popularity as an alternative model for stem cell research. 
(The zebrafish as a model system for my work will be discussed further in the 
proceeding section). It has been reported in many studies that areas of active 
proliferation can be detected throughout the rostro-caudal brain axis ofteleosts, 
including the zebrafish. Unlike mammals, in the zebrafish, neurogenesis (Le. the 
birth of neurons) naturally occurs at an active rate to replenish the neuronal 
network in the adult zebrafish central nervous system. This makes the zebrafish 
attractive as a model for the study of adult neural stem cells and neurogenesis 
especially since neurogenesis occurs at a much less-frequent rate in the 
mammalian system including humans. It is thought that the neurogenic niches in 
the zebrafish may suggest a function that has been 'lost' in higher vertebrates. 
Progenitor cells from several so-called 'non-neurogenic' mammalian NSC niches 
regions have been isolated and successfully differentiated in vitro into neurons47, 
suggesting that they are normally 'suppressed' in their ability to regenerate in vivo. 
Research by Michael Brand's group in 2006 showed the existence of constitutively 
proliferating cells in 16 different positions along the rostro-caudal axis ofthe 
ventricles in the adult zebrafish brain48, Cells from these areas undergo 
neurogenesis to give rise to new-born functional neurons in the adult zebrafish 
brain48. 
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Figure 9: Neurogenic regions identified in different regions of the vertebrate brain. (A) Comparative regions of different areas acting as 
neurogenic niche and regions of constitutive proliferation as identified in the brains of the zebrafish, mouse and songbird. Regions with 
constitutive proliferation are shown in red and neurogenic regions are shown in orange. (8) Regions in the adult mouse brain where 
existing (red) and emerging (pink) neural stem cell niches can be found. 
Image source: 
i) Image A is obtained from [47]. 
ii) Image 8 is obtained from [155]. 
3.3.3 Neural stem cells and neurogenesis in the adult hypothalamus 
Neurogenesis in the adult mammalian hypothalamus was first reported XU et. al. 
(2005) in the rat model system. It was shown through this work that a specialized 
subset of radial glial-like ependymal cells termed tanycytes, which line the third 
ventricle in the hypothalamus, may function as neural progenitor cells. Lineage 
tracing experiments showed that tanycytes give rise to neurons that migrate along 
tanycyte processes, into the parenchymal region of the hypothalamus, where they 
integrate into the neuronal network and form functional synapses. In 2005, 
research in Jeffery Flier's lab showed that ciliary neurotrophic brain factor (CNTF) 
can induce neurogenesis in the arcuate nucleus of the adult mouse 
hypothalamus49. CNTF-induced differentiated cells partake in the regulation of 
energy balance through the generation of cells involved in feeding behaviour (Le. 
propiomelanocorticotropin or pomc; neuropeptide Y or NPY)49. In another study 
by the same group, proliferating NPCs detected and labelled via BrdU co-
expressed Hu or doublecortin, both of which are prominent markers for immature 
or early born neuronsso• BrdU labeling is a basic yet very powerful technique to 
fate map proliferating cells since BrdU (a synthetic nucleotide) is incorporated into 
the replicating DNA strand during cell division. BrdU is retained in the cells even 
after the cessation of proliferation and hence cells that are BrdU and Hu or 
doublecortin positive provide evidence that the immature neurons originate from 
proliferating neural progenitor cells. Actively dividing cells which are BrdU 
positive were localized mainly to ventricular regions of the ventricle supporting 
the idea that NPCs are generated from a NSC population in these regions. More 
recently in 2010, research by Pierce et. al. demonstrated the potential plasticity of 
neurons in the arcuate nucleus in the hypothalamus of the adult mouseS1• They 
show that de novo neurogenesis in the arcuate nucleus can occur without any 
induction when functional agouti-related peptide (AgRP) neurons (similar to the 
NPY neurons) are loss through progressive neuro-degeneration. These newly born 
AgRP positive cells replace the lost cells and integrate into the feeding regulatory 
networkS1• These findings provide evidence for functionally-important de novo 
neurogenesis, and suggest that a local neural stem cell niche may be present in the 
adult vertebrate hypothalamus. 
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Evidence from our labs2 provides substantial new support for this idea. 
Unpublished data from our lab, showed that Nestin and Vimentin double positive 
tanycytes largely occupy the medial portion ofthe hypothalamus, and are found 
lining the median eminence, and the ventral third of the 3rd ventricle suggesting 
that they may function as neural stem or progenitor cell. Intriguingly, the analyses 
of the adult mouse hypothalamus suggest that endogenous FGFs may govern 
hypothalamic tanycytes NSC/NPC proliferation. FgI-10 and Fgf18 are expressed 
specifically within tanycyte subpopulations and FGF signalling elements are 
detected in tanycytes. 
The combination of all the above works arguably provides ample evidence for the 
existence of a NSC niche in the adult hypothalamus. However, two main factors 
mean it is difficult to analyse the behaviour of NSCs/NPCs in the adult mouse 
hypothalamus. First, although there is evidence that hypothalamic NSCs/NPCs 
undergo proliferation, this appears to occur at extremely low levels. Thus, it has 
proved difficult to detect the proliferation of NSCs/NPCs, far more so than in the 
SVZ of the lateral ventricles or the subgranular zone (SVZ) of the dentate gyrus. 
Such low-level proliferation can be attributed to the usually quiescent nature of the 
NSCs in the hypothalamus of adult rodents. Second, the in vivo manipulation of 
factors that may be involved in governing the behaviour ofthe NSCs/NPCs is 
technically challenging. Given the difficulties involved in having to study the NSCs 
of the adult rodent hypothalamus in vivo, there is a real need for a complementary 
model system. It is now widely accepted that NSCs exist in the adult zebrafish 
hypothalamus as well and that they are more actively re-entering the cell cycle to 
proliferate compared to their rodent counterparts48• Hence investigating NSCs in 
the hypothalamus of the adult zebrafish will provide valuable insights into the 
regulation and behaviour of the NSCs, complementing analyses of rodent models. 
4. The zebrafish as a model system to study development and adult 
neuro(:enesis 
The zebrafish (Danio rerio) originates from the tropical fresh waters of India and is 
a well-established vertebrate model for scientific research especially in 
developmental biology. Although the rodent models (i.e. rat and mouse) are for 
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many, the ideal vertebrate model to study human development, given their closer 
evolutionary relationship with humans, the zebrafish has proved to be a powerful 
system for genetic manipulations, embryology studies and in vivo imaging, all of 
which are indispensable tools for the study of developmental biology. Moreover, 
the zebrafish has certain advantages over the rodent models that make it a more 
viable model system for many experiments. Its embryos are transparent and large 
enough for their development to be easily observed under a dissecting light 
microscope. During the first 24 hours of development, the embryos are pigment-
free and completely transparent. These features allow for a clear visualization of 
developing organs and tissues, including the hypothalamic anlage. There are also 
pigmentation-free mutant lines that prevent pigments from forming throughout 
the Iifespan of the embryos. Pigment-free lines that remain pigmentless in the 
adults have also been developed and made available to researchers (Le.golden S3 
and casper IinesS4). Zebrafish embryos develop at a very fast rate and most of the 
anlage can be easily identified after two days of fertilization, including a 
compartmentalized brainss. Also, the high fecundity ofthe zebrafish allows for a 
high number of embryos to be collected for experiments. This is especially useful 
for studies involving mutant or transgenic line screening, sorting and analysis. 
Adult zebrafish have also proved to be a useful tool for wide-ranging studies, from 
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cell regeneration to environment toxicology. The adult zebrafish can be maintained 
in large numbers that require less space compared to a housing facility for rodent 
models. They are easier and less-costly to maintain compared to rodent models. In 
the study of NSCs and neurogenesis, the adult zebrafish provides an extremely 
crucial and exciting link to study the factor / s that allow NSCs in the adult brain to 
naturally replenish the neuronal circuitry with new neurons, a feature that is thus 
far limiting in higher vertebrates including rodents. It is thought that neurogenic 
niches in the higher vertebrates have been 'suppressed' in their ability to 
regenerate in vivo since progenitor cells from several so-called non-neurogenic 
regions have been isolated and successfully differentiated in vitro into neurons47• 
Like the mouse, the availability of adult viable mutant and transgenic lines allows 
for gene functional studies to be performed in the adult zebrafish. Research 
studies, including mine, are actively seeking out the gene or genes that regulate the 
active cell cycle of the NSCs and NPCs in the adult zebrafish brain. This knowledge 
31 
active cell cycle of the NSCs and NPCs in the adult zebrafish brain. This knowledge 
can then be transferred to the mouse model to investigate if the same genes can be 
manipulated to increase the re-entry of the NSCs into active cell cycle in the adult 
mouse brain. 
5. Thesis hypotheses 
In this thesis, I aimed to complement ongoing studies in the lab, by investigating 
some outstanding and pertinent questions in both early hypothalamic 
development and the adult hypothalamus, using zebrafish as the preferred model 
system, as follows: 
A) Role for rx3 in the embryonic hypothalamus (Chapters 1 to 4) 
As described in section 2, the highly-conserved rx/ Rax gene is required for the 
development of the eyes, and many studies have focused on the role of rx/Rax in 
vertebrate eye development. However, rX/Rax is expressed in the anterior 
hypothalamus. The effects of rx3 gene knockdown in the hypothalamus have been 
only very briefly described in the literature, where brief studies have suggested a 
role in the differentiation of pomc positive neurons. No study has yet examined the 
mechanisms by which rx3 may mediate these effects. I therefore set out to 
investigate the expression, role and function of rx3 in the hypothalamus of the 
zebrafish embryos by investigating: 
i. Region/s in which rx3 is expressed in the embryonic hypothalamus. 
ii. Effect of rx3loss of function on hypothalamic markers, including signalling 
ligands and pomc. In particular, I wished to test the hypothesis that rx3 
functions cell-autonomously to govern pomc neuronal differentiation. 
iii. The regulation of rx3 expression in the hypothalamus 
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B) Maintenance of signalling factors and the regulation of NSCs in the adult 
zebrafish hypothalamus (Chapter 5) 
The existence of NSCs/NPCs at the ventricular layer of the 3rd ventricle in the adult 
vertebrate hypothalamus, including the zebrafish, has been described in many 
studies. Nevertheless, the NSC niche in the adult hypothalamus has yet to gain 
acceptance as an established and functional NSC niche since most of the studies 
involved either introduction of inductive/mitogenic factors, unnatural ablation of 
existing cells or artificial in vitro cultures; all of which were performed in adult 
rodent models. Moreover, little is understood of the molecular control of 
NSCs/NPCs in the hypothalamic niche. As discussed in section 3, there are 
limitations to the study of hypo thalamic NSCs/NPCs in the adult rodent models. 
These limitations can be complemented through the use of the zebrafish model 
system. I therefore set out to address the existence of NSCs/NPCs in the adult 
zebrafish hypothalamus and investigate their potential regulation by signalling 
factors that are expressed within the same region (Le. the ventricular zone of the 
3rd ventricle) of the NSCs. The adult zebrafish is ideal based on the reasons I have 
described in sections 3 and 4. In particular, I investigated the following 
questions/hypotheses: 
i. Can I find evidence for a NSC niche in the adult zebrafish hypothalamus that 
harbours cells similar to those detected in the mouse hypothalamic NSC 
niche 
ii. Is the NSC niche located in a similar region to that described in adult rodent 
models (Le. the medial hypothalamus) 
iii. Do local signalling ligands regulate NSC/NPC cell proliferation in the adult 
zebrafish hypothalamic niche. 
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Materials & Methods 
Materials and Methods 
1) Zebrafish stora&:e and housekeepin&: 
All wildtype zebrafish used in this thesis are LWT (London wild type) strain. The 
nestin::GFP transgenic embryos were kindly provided by Dr. Uwe Strahle 
(Karlsruhe Institute of Technology, Germany). The chokh mutant embryo used in 
chapter 2 was kindly provided by Dr. Breandan Kennedy (University College 
Dublin, Ireland). All zebrafish lines are kept in a controlled and regulated 
environment at the Aquaria Facility, University of Sheffield. The zebrafish were 
kept at constant water temperature of 28.SoC with a daily light-dark cycle of 14 
hours light and 10 hours dark. All lines are maintained and embryos obtained 
through natural mating. Embryos for experiments were obtained through 
'marbling' technique where marbles are placed in an inner container with a wire-
grid base that holds the fish and an outer container where the eggs will collect. 
Embryos collected for experiments are kept in E3 medium prepared according to 
the Zebrafish handbookss and are maintained at 28.5°C throughout experimental 
procedures. 
2) Zebrafish sta&:in&: 
All embryonic zebrafish were staged according to Kimmel's staging guides6. All 
adult fish used in this thesis were of one year of staged through birthdates record. 
3) Plasmid donin&: 
All of the in situ hybridisation probe constructs (plasmids) used in this thesis were 
either obtained directly from the source (i.e. maker) or through secondary sources, 
except for pomc, which I have made and produced. Please see probe list for details. 
In this section, I will first describe how the pomc probe construct was made and 
then proceed to outline the general steps that are involved in the processing of the 
constructs for probe synthesis. 
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i) PCR (polymerase chain reaction) primer design 
PCR Primers targeting the 3' region excluding the 3' UTR (untranslated region) 
from nucleotide number 699 to 1216 ofthe pomc gene (sequence obtained from 
ENSEMBL Genome Browser21) were designed using Invitrogen Primer Design 
programme57, which is available online. Following is the pomc gene region as 
described above, which was used as the input (Box1) for the primer design 
programme and the corresponding primers designed to target this region (Box2): 
Box1 
>pomc 3' region (excl. 3' UTR) (BLAST confirmed) 
CGCTTCCGGCAGAGATGAGACGCGAGCTGGCAAATAACGAGGTCGACTATCCGCAAGAAG 
AGATGCCTTTAAACCCACTGGGGAAGAAGGACCCCCCCTACAAAATGACCCATTTCCGCT 
GGAGCGTCCCGCCGGCTAGCAAGCGCTATGGAGGCTTCATGAAGTCCTGGGACGAGCGTG 
CTCAGAAACCACTGCTCACACTCTTCAAAAACGTAATGCATAAAGACCAACCGAGGAAGG 
ATGAGTGAGTGGCTTTAAGGGGGAGAGGTTGTTATAGGGGGATGTTTTGAATATACTTTC 
TTCCCAGCAAACTTCTGGATGAGAGGTTCTTATCATGCATAGAAACGAAGGTGGGCAATG 
TTAACAATAGCACTTAAATCTTGATGAGTTTATTCACACTGTATTCAACAATAAATTCTG 
AATTCTGTATATAGAAATGCTGTGGTGATTAAATACCAGCTTAGAGGCTAAAACAGCATT 
TTTAGAATATTTATTGAACATGTATTATACTGTACATTTTGAAAATGTGACATAAAATGA 
TGTTTCAAGCAGAAGAGAACACAA 
Box 2 
Primers: 
Forward (5'-3') 
Reverse (5'-3') 
AGGTCGACTATCCGCAAGAA 
TTGTGTTCTCTTCTGCTTGAAA 
ii) RNA extraction and cDNA library synthesis 
RNA was extracted from a clutch of 40-50 embryos at stage 40 hpf collected in a 
2.5 ml microcentrifuge (Eppendort) tube. The embryos were first anaesthetized 
using Tricaine according to the prescribed procedure and was culled by freezing in 
dry ice minus E3 buffer for 15 minutes. Trizol solution was then added into the 
tube and the embryos were then passaged through 25G needles attached onto 
syringe multiple times until fully sheared to homogeneity. Chloroform was then 
added to the tube, mixed and centrifuged at 4°C. The aqueous phase was then 
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aliquoted into a new and clean tube, isopropanol added and mixed. The mix was 
then centrifuged at 4°C. The supernatant was aliquoted and disposed, and the RNA 
pellet was left to air dry before resuspending in DEPC water. cDNA synthesis was 
performed using the Superscript First-Strand Synthesis System (Invitrogen). 
iii) PCR parameters and validation 
PCR for the pomc gene fragment (as in Box 1) from the cDNA library was 
performed using the following protocol and parameters: 
PCR reaction volume = 50 !!l; reaction components as follows: 
• cDNA template 
• Forward primer 
• Reverse primer 
• Taq polymerase 
• Taq polymerase buffer 
• dH20 
The PCR reaction was performed on the MJ Thermocycler using the following cycle 
parameters: 
I. Denaturation 
H. Annealing 
Ill. Elongation 
92°C (for 30 seconds) 
50°C (for 30 seconds) 
72°C (for 45 seconds) 
The above steps were repeated for 30 cycles. The size of the resulting PCR product 
was then verified using agarose gel electrophoresis to match the expected pomc 
gene fragment band size of 564 base pairs (bp) or roughly at 500 bp measured 
against the 1000 bp DNA ladder (Promega). 
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iv) TOPO-TA cloning 
The pomc PCR product (gene insert) was cloned into the TOPO-TA cloning vector 
(Invitrogen), following the instructions provided by the manufacturer. 
v) Bacteria subcloning and Plasmid Extraction 
The resulting pomc (TOPO) was subcloned into the bacteria E.coIi (DH5 alpha 
strain) through standard transformation protocol and the bacteria was propagated 
in Luria Bertani (LB) culture medium (lnvitrogen) as described in Molecular 
Cloning: A laboratory manualSB• The amplified pomc (TOPO) plasmid was extracted 
from the bacteria culture, purified and concentrated using the Maxi-prep Plasmid 
Extraction Kit (Qiagen). 
vi) DNA seguencing and seguence verification 
A minute amount of the purified pomc (TO PO) concentrated stock was sent to the 
DNA Sequencing Facility (University of Sheffield) to validate ifthe gene insert 
matches that of pomc as well as to investigate the gene insert direction 
(orientation) in the MUltiple Cloning Site ofthe TOPO vector. The DNA Sequencing 
Facility employs the use of BigDye Terminator (ABI) and the ABI Sequencer. The 
sequencing was performed only in one direction using the T7 primer. The 
sequence was verified against the genome database using BLAST (NCBl)s9 to 
ascertain if the pomc identity of the insert gene and its sequence direction or 
orientation within the TO PO vector. The BLAST result showed a strong match of 
the gene insert with the zebrafish pomc gene in the database (Le. 99% identity) 
and orientation is in the sense direction (5'-3') in tandem with the vector. The map 
of the pomc (TOPO) construct is provided in Box 3. 
vii) Determination of RNA polymerases and the corresponding restriction sites 
Based on the map provided in Box3, the SP6 RNA polymerase site would serve to 
synthesize the anti-sense probe (true probe) and the T7 RNA polymerase site for 
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Box3 
Map of pomc-TOPO construct. 
5' ----. 3 ' 
pomc 
pCRII-TOPO-pomc 
the synthesis of the sense probe (control probe). Their corresponding restriction 
digestion sites for the construct linearisation (as discussed in the following 
section), was determined based on the map as well. The RNA polymerase / 
restriction site combination is as follows: 
• sense probe 
Polymerase: T7; Compatible restriction sites: HindIl!, Kpnl, BamHl 
• antisense probe 
Polymerase: SP6; Compatible restriction sites: Notl, Xhol, Xbal 
To ensure that these restriction sites do not cut or digest the pomc gene insert 
internally, I used the NEBcutter (by New England Biolabs)60 programme which is 
available online. The result shows that all six ofthe above restriction enzymes do 
not have restriction sites within the pomc gene insert. 
viii) Linearisation of construct 
The pomc (TOPO) construct was Iinearised at both directions to make the sense 
and antisense probes. The restriction enzymes used were HindIl! for sense 
direction and Not! for anti sense direction. The Iinearisation protocol follows the 
standard single restriction digestion protocol as provided by the enzymes 
manufacturer (Promega). 
N.B. Processing steps of all other constructs obtained from contributed sources 
were performed similar to steps v, vi and viii described above. Step vii was not 
necessary since the contributed constructs came with full instructions on the 
polymerases and their corresponding restriction sites for linearisation. The full list 
of probe constructs can be found in Table 1. 
",~: " Probe Restriction site Polymerase Source 
shh HindU! 
[gp Sail 
T7 
T3 
Ingham Lab (CDBG, 
Sheffield) 
Dr. William Norton 
(CNRS, Paris) 
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fgf8 Notl T7 Roehl Lab (CDBG, 
Sheffield) 
fgflO HindIIl T7 Roehl Lab (CDBG, 
Sheffield) 
sox2 EeoRl T7 Cunliffe Lab (CDBG, 
Sheffield) 
sox3 EeoRl SP6 Dr. Richard Dorsky 
(Utah, U.S.A) 
pea3 Notl T7 Roehl Lab (CDBG, 
Sheffield) 
ptel Xbal T7 Whitfield Lab (CDBG, 
Sheffield) 
pte2 EeoRl T7 Whitfield Lab (CDBG, 
Sheffield) 
rx3 Xbal T7 Dr. William Norton 
(CNRS, Paris) 
emx2 Xhol T7 Dr. William Norton 
(CNRS, Paris) 
pome Not/, Xho/, Xbal SP6 Self made 
tbx2a BamHl T7 Whitfield Lab (CDBG, 
Sheffield) 
tbx2b BamHl T7 Whitfield Lab (CDBG, 
Sheffield) 
gli2 BamHl T7 Whitfield Lab (CDBG, 
Sheffield) 
pax6 Smal T7 Cunliffe Lab (CDBG, 
Sheffield) 
isl1 Xbal T3 Dr. Richard Dorsky 
(Utah, U.S.A) 
th Xhol T7 Cunliffe Lab (CDBG, 
Sheffield) 
zie2a EeoRl SP6 Dr. Yevgenya 
Grinblat (Wisconsin, 
U.S.A) 
zashla EeoRl T7 Cunliffe Lab (CDBG, 
Sheffield) 
Table 1: Restriction enzyme site used for construct linearization in the process of 
making anti sense probes for in situ hybridisation experiments. 
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4) ISH probe synthesis (DIG and FIr labelled) 
The in situ hybridisation probes were synthesised using either DIG labelled or 
Flourescein labelled haptens with the following protocol: 
The following reaction was prepared: 
• Linearised vector 
• RNA polymerase (Le. SP6, T7 or T3 from Promega) 
• 5x transcription buffer (Promega) 
• DIG - or Flourescein -labelled haptens (Roche) 
• RNase inhibitor (Promega) 
• dHzO 
and incubated at 37°C for 2 hours. DNase (RNase free) (Promega) was added to the 
reaction above and was incubated at 370 C for an additional 15 minutes. This step is 
vital to digest the linearised vector. Lithium chloride (4M) and ice-cold ethanol was 
then added to the reaction and gently mixed by tapping on tube. This was kept at-
25 0 C overnight to allow the precipitation ofthe synthesised RNA probe. On the 
following day, the reaction was centrifuged at 13,000 rpm in 4°C. The RNA probe 
pellet was identified through eyes. The supernatant was aspirated and replaced 
with 70% ethanol. The tube was gently tapped to allow rinsing of the pellet. The 
tube was the centrifuged again at 13,000 rpm in 4°C. The supernatant was 
aspirated and the RNA (probe) pellet was allowed to air dry at room temperature. 
Finally, the pellet was resuspended in a formamide and dHzO solution (1:1 volume 
ratio). The formamide is important to maintain the probe in RNase free 
environment. The probe is then examined on agarose gel electrophoresis to 
validate their expected band size and was stored in -25°C. 
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5) Embryonic zebrafish protocols 
i) Embryonic zebrafish processing for experiment 
A) Eradicating pigmentation on embryos 
Like all other model organism, the zebrafish has it own processing procedure to 
mainly to facilitate visualization and image acquisition. All embryos analysed in 
this thesis are processed either before or after fixation with chemicals that are able 
to eradicate their pigmentation. The development of pigmentation in the zebrafish 
embryos begins to take place at around 32 hpf and can be a major hindrance 
during image acquisition. Its dark shade prevents viewing accessibility to the 
signals during microscopy defeating the translucent feature of the embryo. There 
are two ways of circumventing this problem; a) using PTU, b) bleaching. PTU (1-
phenyl-2-thiourea) is specialised chemical that targets the development of 
melanophores/cytes in the embryo that are responsible for the pigmentation. It 
works by addition into the embryo-containing E3 medium directly before 24 hpf of 
development. It is recognisably a pre-fixation method, which would normally have 
no side effect on the embryos although the development of oedema in the heart 
have been reported in PTU treated embryos at late stage of embryonic 
development. Nevertheless, very few or no pigmentation exists in the embryos 
after PTU treatment making it still widely used technique in most labs. Another 
technique is the use of bleach solution, which is made up of Formamide (%), and 
Hydrogen peroxide (%) in dH20. This is a post-fixation as well as a post-
hybridisation technique aimed eradicating the pigments once the in situ 
hybridisation signals have been fully developed. Since this technique is performed 
post-fixation, there is no effect at all to the development of the embryos. The only 
disadvantage of this technique is the appearance of remnant pigments that 
although less darker in shade, can still sometimes hinder the full and proper 
visualization of signals. The protocols used for both above are follows: 
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al PTU 
Stock solution of PTU was made up to 100x concentration and stored in toxic 
cabinet at room temperature. Solution was warmed-up to 700 C before use to 
dissolve crystals that might form. The PTU solution was added directly into the 
embryo-containing E3 medium to 1x concentration. This was done at 
approximately 90% epiboly or early tail-bud stage and left to incubate at 28.5oC 
overnight (approximately 12-15 hours). The E3 medium was replaced after this 
time period and embryos were allowed to develop to the desired stages before 
fixation. 
bl Bleachin~ procedure 
Bleaching solution was made fresh before use as described above. Solution was 
added directly onto post-hyridisation fixed embryos in 4-well dishes and allowed 
to mix on orbital shaker at low speed. The embryos were monitored consistently 
every 5-10 minutes to gauge levels of pigment dissipation. The reaction was 
stopped as soon as pigmentation dissipates to satisfaction, by replacing the 
bleaching solution with PTW. The embryos were rinsed 3x in PTW before placing 
in glycerol solution as described below. 
Bl Glycerol mountin~ 
After fixation, the embryos were rinsed 3x with PTW. They were then transferred 
through a series of glycerol solution at different concentration starting from the 
lowest (Le. 30%) followed with 50%, 70%, and finally, 90% solution. Embryos 
were visualised and imaged in 90% glycerol solution. Embryos were also kept in 
the same solution at 4°C for long-term storage. 
ii) In situ hybridisation 
In situ hybridisation was performed on fixed embryos using desired probes based 
on the protocol as follows: 
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Embryos kept in 100% methanol, were rehydrated following a series of diluted 
methanol solution (Le 75%, 50% and 25%) before fully rehydrated in PTW 
solution in which the embryos were rinsed for 3x; 5 minutes each time. The 
embryos were then treated with Proteinase Kin PTW solution for 10 minutes for 
younger staged embryos (10 - 30 hpf) and 20 minutes for older staged embryos 
(55 hpf), both at room temperature. After Prot K treatment, the embryos were then 
briefly rinsed once with PTW and re-fixed with 4% PFA for 20 minutes at room 
temperature. This step is vital to fix and kill the activity of any left over Prot K since 
these can degrade the antibodies that will be used at a later step in this protocol. 
After the re-fixation step, the embryos were rinsed in PTW for 3x, at 5 minutes 
each time. The embryos were then incubated with hybridisation solution (minus 
probe) for 1 to 2 hours at 68°C. The probes were diluted in the hybridisation 
solution according to their optimised concentration and were pre-warmed at 680 C 
before adding to the embryos for the hybridisation to take place for an overnight 
period. 
On day 2 of the protocol, the embryos were succumbed to a series of68oC and 
room temperature washes. All washing steps were either performed in incubator-
shakers or on orbital shakers. All washing buffers used at 680 C were pre-warmed 
to this temperature before use. The probe solution was aspirated off the embryos 
and replaced with a buffer comprising the hybridisation solution and 2xSSC at 1:1 
ratio. The embryos were incubated in this buffer for 20 minutes at 68°C. This 
buffer is then replaced with 2xSSC buffer and continued incubating at for 20 
minutes at 68oC. The 2xSSC buffer was then replaced with 0.2xSSC buffer and the 
incubation continued at 680 C for 30 minutes. This step was repeated twice. The 
embryos were then allowed to cool down to room temperature before replacing 
the 0.2xSSC buffer with a buffer comprising a mix of PTW and 0.2xSSC (1:1 ratio). 
The embryos were washed in this buffer on an orbital shaker for 20 minutes at 
room temperature. The embryos were then washed with PTW for 3x; 5 minutes 
each time before being placed into Blocking Buffer for 1 to 2 hours at room 
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temperature. The blocking buffer is then replaced with the same buffer that 
contains either an anti-DIG (4000x dilution) or anti-Flourescein antibody (3000x 
dilution) and allowed to incubate overnight at 4°C. 
The antibody-containing buffer was aspirated and the embryos were washed in 
PTW for 3 to 4 hours. The PTW solution was replaced every half-hour within this 
time frame. The embryos then rinsed 3x with alkaline phosphate buffer and 
allowed to stand in this for 1 hour at room temperature. The developing solution 
according was prepared as described and the embryos were transferred into this 
to allow the signal development to take place. The development ofthe signal was 
monitored and stopped by post-fixation with 4% PFA for 1 hour at room 
temperature. The embryos were rinsed with PTW for 3x and were processed for 
pigmentation eradication and stored in glycerol as described in sections lA and 18. 
iii) Double in situ hybridisation 
This protocol describes the steps that were performed to achieve double in situ 
labelling to simultaneously detect two different gene expression using two 
different probes. Steps on Day 1 are the same as described above except both 
probes were added Simultaneously at the overnight incubation step. The steps on 
Day 2 and Day 3 are generally the same as above. However, the secondary 
antibodies were added and detected sequentially. The choice for which should be 
detected first is arbitrary but the one which shows the stronger signal among the 
two would usually be detected first. Also the stronger signal would be detected 
using Fast Red and the weaker one is detected using NBT/BCIP. Ifboth signals 
have similar intensities, then the gene with a wider area of expression would be 
detected using NBT /BCIP for the reason that Fast Red would quite often produce 
background staining more easily compared to NBT /BCIP. 
45 
iv) Immunohistochemistry 
Immunohistochemistry was performed on whole mount embryos as described in 
this thesis. Similar to the in situ hybridisation protocol, embryos kept in 100% 
methanol were rehydrated to PTW. The embryos were then permeabilised with 
Trypsin (0.025%) at 37 0 C for 20 minutes. After permeabilisation, the embryos 
were rinsed 3x with PTW; 5 minutes each time. The embryos were then incubated 
in Blocking Buffer at room temperature for at least 1 hour. The blocking buffer is 
then replaced with the primary antibody (diluted in Blocking Buffer) and 
incubated at 4 0 C overnight on an orbital shaker. On the following day, the embryos 
were washed with PTW for 2 hours with PTW changes every half hour. After 
washing, the embryos were incubated in blocking buffer that contains the 
secondary antibody to detect and label the corresponding primary antibody. This 
step was done for 45 minutes to 1 hour at room temperature on an orbital shaker. 
This and all the following steps were performed in the dark. The embryos were 
then washed in PTW for 1 hour with PTW changes every 15 minutes. The embryos 
were then very quickly visualised under a fluorescence-equipped 
stereo microscope to check if the labelling worked before actual imaging. 
~::, ( ..'. Primary antibody Concentration Source 
... , .. 
~. , " .. 
Abcam BrdU 
MCM5 
Vimentin 
1:200 
1:1000 
1:100 
1:1000 
1:500 
Kind gift from Dr. Soojin 
Ryu (MPI, Heidelberg) 
Milipore 
HuC/D 
GFP 
Milipore 
Abcam 
Table 2 : List of primary antibodies used in this thesis and their corresponding 
concentration and sources. 
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FITC 1:200 Jackson Immunolabs 
Cy3 1:200 Sigma 
Alexa Flour-488 1:500 Invitrogen 
Alexa Flour-563 1:500 Invitrogen 
Table 3 : List of secondary antibodies used in this thesis. 
v) Chemical treatment of zebra fish embryo 
The section describes the chemical treatment used in the attenuation of shh andfgf 
signalling pathways that forms the core of result chapters 3 and 4 of this thesis. 
Details pertaining to the nature of the chemicals used are described in the above 
two chapters. 
A) Cyclopamine 
Cyclopamine (Merck) was prepared in ethanol according to instructions to make 5 
mM stock concentration and stored in dark at - 25 0 (' The preparation was 
performed in the dark as instructed in the datasheet and all safety procedures 
including personal safety procedure were strictly obeyed. CycIopamine is added 
directly onto the embryos in E3 medium to the desired working concentration (in 
this thesis, the concentration is optimised at 100 uM), in the dark. Prior to this, the 
30 hpf embryos were dechorionated and placed in 6-well plates; approximately 
15-20 embryos per well. Dechorionation was not necessary for the younger stage 
embryos and was not performed. The plates were kept in the dark by wrapping 
with aluminium foil and incubated at 28.5oC for the duration of time as described 
in the result chapter 3. CycIopamine medium was disposed according to 
regulations. 
B)SU5402 
SU5402 (Merck) was prepared in DMSO to make 20 mM stock concentration 
according to instructions and was stored in dark at -25oC. The preparation was 
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performed in the dark as instructed in the datasheet and all safety procedures 
including personal safety procedure were strictly obeyed. Treatment of embryos 
with 5U5402 was performed in the same way as the cyclopamine treatment 
according to the duration oftime as described result chapter 4, except that as IlM 
concentration was used. Disposal of 5U5402 was performed in accordance to the 
regulations. 
vi) Morpholino 
Morpholinos were used in this thesis as detailed in result chapter 2 to investigate 
the loss of rx3 gene function. There were two morpholinos used against the rx3 
mRNA; i) rx3MO ATG which is designed to inhibit the translation start site and 
preventing the translation process of the rx3 mRNA from occurring, ii) rx3MO 
splice that targets specific splice sites within the rx3 mRNA preventing the 
functional processed form of rx3 mRNA from being produced. Both morpholinos 
were purchased from Gene Tools, LLC. The sequences ofthe morpholinos are as 
follows (5'-3'): 
i) rx3ATG MO 
5equence:GAGATCCAACAAGCCTCATTGAACG 
ii) rx3E212 MO splice 
Sequence:GTGTCTCTCACCTGTACTCGGACTT 
iii) Control morpholino 
Sequence:CCTCTTACCTCAgTTACAATTTATA 
In this thesis, a cocktail of both rx3 morpholinos was used as described in result 
chapter 2. The working concentrations; rx3 MOATG: 0.25 mM and rx3MO splice: 
0.15 mM. The morpholinos were prepared according to the instructions supplied 
by Genetools Inc. The morpholinos were prepared the night before their use and 
diluted up to the respective working concentrations as above using dH20. A small 
amount of phenol red was added to the solution. This works as a marker-indicator 
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during the microinjection process. The prepared morpholinos were kept in 4°C 
overnight until ready for use the next morning. 
vii) Microinjection 
Microinjection needles (Harvard apparatus) were prepared through the needle-
puller. The microinjection process was conducted using the microinjector 
(Nirashige) and the morpholino injection was performed on embryos atthe 1-cell 
stage using standard procedures55• The morpholinos were injected into the yolk 
close to the cell. The injected embryos were then collected and kept in 28.soC to 
resume normal growth up to the desired stages. The microinjection efficacy was 
validated through the loss-of-eyes and enlarged telencephalon phenotypes that 
characterized the rx3 morphant embryos as described in result chapter 2. The 
morphant embryos were segregrated based on the strength of their phenotype i.e. 
absent (complete loss of both eyes), reduced (reduction in the size of both eyes) 
and normal (normal eyes observed). Only the absent phenotype was used for this 
thesis as it mimics the phenotype seen in rx3 mutant or chokh as described in 
result chapter 2. 
viii) Heat shock procedure 
This procedure was used in result chapter 5 to upregulatefgf3 expression in the 
heat-shock promoter-drivenfgf3 gene expression (hsp:fgf3) mutant embryos. This 
mutant line also contains a cardiac specific GFP expression cassette in the same 
heat-shock construct that allows for the segregation of the mutant embryos (GFP 
expressed in the heart anlage) from the normal siblings (no GFP expression). To 
upregulate fgf3 signalling, the mutant embryos (GFP positive) and normal siblings 
(GFP negative) were first segregated as described above and put in different SO ml 
test tubes (Falcon) filled with E3 buffer up to 30 ml. The tubes were then kept in 
water bath at 38°C for 45 minutes before cooling down to 28.s°C. The E3 buffer 
was replaced and the embryos were maintained in 28.soC for at least 2 hours prior 
to the desired stage of interest. 
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6) Adult zebrafish protocols 
i) Culling and Fixing 
All adult zebrafish analysed in this thesis are males at 1 year of age. The adult fish 
were culled according to Schedule 1 of the UK Home Office regulations. The brains 
were dissected out in the fix solution and were placed in fresh fix solution 
overnight at 4°C for fixation. The brains were washed with PTW 3x; 5 minutes each 
time on the next day before storing them in 100% MeOH at -25°C similar to that 
performed for the embryos. 
ii) Sectioning through cryostat or vibratome 
A) Cryostat 
The brains were rehydrated to PTW as described for the embryos and were kept 
submerged in 30% sucrose solution overnight at 4°C. The brains were then 
embedded in O.C.T (VWR) on a plastic mould for cryostat sectioning. Prior to the 
embedding process, the brains were first put into a series of 30% sucrose:O.C.T 
solution at ascending concentrations ofO.C.T (v/v) (Le. 2:1, 1:1 and 1:2) and 
finally into 100% O.C.T. Once the brains are put into the mould and orientated to 
the right position, the mould is quickly placed in dry ice for snap freezing. The 
block of O.C.T that contains the brain is removed from the mould and place onto 
specialised cryostat holders or 'chuck'. The chuck is then placed into the cryostat 
(Bright) for sectioning. The sections in this thesis were cut at 30 ~m in thickness 
and collected on Superfrost slides (Thermo Scientific). The sections were then 
allowed to airdry for 1-2 hours before processing for experiments. 
B) Vibratome 
For thicker hypothalamic sections, the vibratome was used instead of the cryostat. 
The brains were similarly rehydrated to PTW after storage in 100% methanol. The 
brains were then embedded in 4% agarose. The agarose is then carefully trimmed 
to the right orientation of the embedded brain and glued onto the vibratome 
so 
holder. The holder is then placed in the vibratome (V-vibrato me) and the brains 
were sectioned at 50 Jlm. 
iii) Intraperitoneal injection of adult 
In this section, I will describe the intraperitoneal injection (IP) technique that I 
have used to introduce cycIopamine and BrdU into the adult zebrafish system 
including the hypothalamus. Whilst IP injection of BrdU has been done before, IP 
injection of cycIopamine and its regime is novel and was innovated through this 
thesis. 
A) General techniQue 
One-year-old adult zebrafish (wild type) were kept separately and individually into 
smaller tanks a day before the procedure to enable accustomization to isolation. 
On the day of procedure, the fish were anaesthesised in tricaine through 
submerging and was immediately placed into the groove of the specially prepared 
agar plate in a ventrally-upwards position. The fish were then very quickly injected 
intraperitoneaIIy (JP) through the stomach and placed back into the tanks for 
recovery (see Figure 1). A tiny amount (2 Jll) of methylene blue was added into the 
injected solution to serve as an indicator to ensure the solution was injected 
properly. 
B) IP injection of cyclopamine 
Using the above procedure, cycIopamine was injected into the adult zebrafish as 
discussed in chapter 5. The cycIopamine stock was prepared similar to that 
described for the embryos, but was used at a working concentration of 1 mg/ml or 
2.4 mM. The zebrafish were injected at 1 Jlg/O.l g of body weight. The fish were 
injected with cycIopamine once everyday for seven consecutive days and were 
injected with BrdU (3.3 mg/ml) on the eight day. The zebrafish were BrdU-chased 
for 4 hours before culling according to Schedule 1 of Home Office procedure and 
fixed as described previously. 
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Figure 1: Illustration of the IP injection technique performed on the adult zebrafish 
7) Image acguisition 
Standard DIC images were obtained using an Olympus BX60 with SPOT 
Programme (Diagnostic Instruments Inc). Wholemount fluorescence images of 
embryos were acquired using a Zeiss Confocal microscope. Optically sectioned DIC 
and fluorescent images were obtained using a Zeiss Axioimager equipped with 
Apotome and Axiovision Programme (Zeiss). Processing of data images were 
performed using Adobe Photoshop CS3. Models and illustrative images were 
constructed using either Adobe Illustrator CS or Microsoft Powerpoint 2004. 
8) Statistical method 
All statistical analyses in this thesis were performed using Prism 5 (for Mac OS X) 
software. Unpaired t test were performed to determine ifmean differences were 
statistically significant. SEM (standard error of mean) were analysed and plotted 
in the columns of each graphs. Each data value sampled, were tested for Gaussian 
distribution prior to t test by performing baseline subtraction of the two data sets 
and analysed through D' Agostino and Pearson omnibus normality test as 
recommended by the programme. 
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Results 
Chapter 1 
Chapter 1: Molecular profile ofthe embryonic zebrafish hypothalamus 
1.1 Introduction 
As outlined in the Introduction, a number of studies suggest that the early 
developmental signalling processes and patterning events that establish the 
embryonic hypothalamus appear to be largely conserved between the zebrafish 
and higher vertebrates. However, to confirm this and to seek a clear understanding 
of the anatomical division of the zebrafish hypothalamus, as well as examine 
differences between the zebrafish and chick embryonic hypothalamus, I first set 
out to identify the different divisions of the embryonic zebrafish hypothalamus 
using defined published molecular markers. These studies act as the basis for my 
investigations into the role, and potential mechanism of action, of the transcription 
factor rx3 in the embryonic hypothalamus (Chapters 2-4). I focused on the markers 
shh,fgfs and the transcription factors rx3, emx2 and tbx2a/b. Additionally, to test if 
the signalling pathways of shh andfgfs operate in the embryonic zebrafish 
hypothalamus, I examined well-characterised molecular read-outs for both these 
pathways. These include ptc1/ptc2 as molecular read-outs for Shh signalling and 
pea3 as a molecular read-out for the Fgf signalling pathway. I also provide reasons 
for studying these molecules in the context of the transcription factor, rx3. 
1.2 Results 
Expression analyses in the embryonic zebrafish hypothalamus 
1.2.1 Expression of shh and ptc1/2 
Shh is a secreted ligand that signals through the transmembrane protein 
Smoothened (Smo) and the GIi family of transcription factors (known as Cubitus 
interuptus in the Drosophila). In the absence of Shh ligand, Smo is inhibited by the 
Hh transmembrane receptor protein Patched (Ptc). The pathway is activated 
when Shh binds to Ptc and releases Smo from the inhibitory process of Ptc. Upon 
activation, Smo signals to the Gli transcription factors (see Box 1.1 for details on 
the Shh signalling pathway). The inhibition ofSmo by Ptc is still an area of active 
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SHH signalling is activated when SHH ligand binds to PATCHED (PTC) and prevents it from inhibiting SMOOTHENED (SMO). 
SMO is a transmembrane protein whose function is inhibited through the action of PTC in the absence of SHH ligand. SMO 
is found mainly in the cytoplasm of the cell when the pathway is inactive. The signalling cascade is activated when SHH 
ligand binds to PTC. This binding results in the abrogation of the inhibitory function of PTC. SMO is then released from its 
inhibition by PTC and becomes hyperphosphorylated. It then accumulates in the plasma membrane in D. melanogaster. 
In vertebrate cells however, SMO accumulates in the cilia following exposure to SHH ligand or the HH ligands, SMO is then 
activated and functions as the modulator for the GlI transcription factor family (Glioma-associated oncogene homologue) 
which undergo further processing before activating the transcription machinery. 
research, recent evidence suggesting an important role for vitamin D361• The Shh 
ligand itself undergoes processing before binding to Ptc. The Shh protein is 
comprised of a C-terminal autoprocessing domain and an N-terminal signalling 
domain. Processing ofthe protein produces an N-terminal fully-processed form of 
the secreted Shh ligand with palmitate and cholesterol moieties attached at its 
ends (see Box 1.2 for details). 
I first examined the expression of shh as a marker of the presumptive 
hypothalamus. Figure 1.1 shows that shh is expressed over an extensive period in 
the diencephalic basal plate, and an adjacent anterior region, termed the anterior-
dorsal hypothalamus (ADH). The precise origin of shh positive ADH cells in 
zebrafish, and their relationship to the shh positive basal plate is unclear. However, 
fate-mapping studies in the chick suggest that, in that species, cells that occupy the 
equivalent region of the ADH are a mixed population of anterior-most floor plate 
and basal plate cells (Manning et al 2006). A shh negative domain is found ventral 
to the Shh positive territory; as outlined in the Introduction, in keeping with 
previous literature13, I term this region the posterior ventral hypothalamus (PVH). 
In the chick, this region derives from anterior floor plate cells that are intitially 
induced by NodalfShh, and then downregulate Shh6• The literature suggests that a 
parallel mechanism may operate in zebrafish (see Introduction), but as yet, no 
study has examined whether, in the earliest stages of neurulation, Shh is expressed 
in the prospective diencephalon. I therefore examined Shh expression in the 10 hpf 
embryo. My results show faint, but clear shh expression in the anterior 
(diencephalic) floor plate. As in other species14• 15, this expression is transient, and 
is downregulated at approximately 25-27 hpf. In contrast, shh expression in the 
basal plate/ ADH persists at least until lOO hpf (the latest stage examined),. At 28-
30 hpf, shh is prominently expressed in the ADH. However, by 55 hpf, and later 
stages, only weak expression is detected in the ADH (red arrow, Figure l.lC,D). shh 
is now expressed more strongly at the ventricular region just posterior-ventral to 
the ADH (white arrow Figure l.lC,D). It is unclear whether this is a new domain of 
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SHH protein undergoes multiple processing events before attaining its fully 
processed form (SHH-N) through which signalling is initiated. The full size 
SHH protein is 45 kDa and consists of an N-terminal signal sequence, N-
terminal signalling domain and a C-terminal autoprocessing domain. The 
full size SHH protein is also referred to as the preproprotein. During 
translocation into the endoplasmic reticulum (ER), the N-terminal signal 
sequence is recognized by the signal recognition particle (SRP), which 
targets the preproprotein to the ER. Upon translocation, the signal sequence 
is then cleaved by signal peptidase found in the ER. The C-terminal ofSHH 
protein is then removed through autoprocessing. The autoprocessing of 
SHH protein produces the N-terminal signalling domain or SHH-N (20 kDa). 
This cleavage is catalysed by a protease located within the C-terminal 
domain. A cholesterol molecule is added to the C-terminal of the SHH-N 
during the process. At the N-terminal, palmitate is added, an absolute 
necessity for efficient signalling. The fullv processed and signalling form of 
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Figure 1.1 : Temporal expression of shh in the zebrafish. A-E , In situ hybridization analysis for the expression of shh in the zebrafish 
embryo at various stages of embryonic development. (A) shh expression can be detected at the floor plate of a1 0 hpf embryo 
(arrowheads; green demarcate expression in anterior). All images are of lateral view of the embryos except (A) which is a ventral view 
of the embryo. Anterior is to the left for A. Orientation is as described in F for 8-E. Abbreviations: ADH (anterior dorsal hypothalamus), 
PVH (posterior ventral hypothalamus), FP (floor plate), Tel (telencephalon), ZLI (zona limitans intrathalamica), OT (optic tectum) 
and A,P,D,V (anterior, posterior, dorsal, ventral). Scale bars represents 50 !-lm. 
expression, or whether shh is maintained at high levels in posterior-most ADH 
cells. 
As described in the Introduction, SHH expression in the hypothalamic floor plate of 
the chick is downregulated via a molecular cascade, which involves the 
transcription factor TBX214. The loss of shh expression in the zebrafish 
hypothalamic floor/prospective PVH suggests the possibility for a similar role of 
the zebrafish tbx2 gene. To begin to analyze if a similar cascade is likely to operate 
in the early zebrafish embryonic hypothalamus, I analyzed the expression of tbx 
genes. In zebrafish, two orthologs of TBX2 have been described, tbx2a and tbx2b, In 
situ hybridisation shows that of these, tbx2b is confined to the hypothalamic floor 
(Figure 1.2A,B). Double ISH with shh (Figure 1.2B) reveals that tbx2b is detected in 
the hypothalamic floor adjacent to the shh expressing basal plate. This expression 
pattern is remarkably similar to that in the chick, and strongly supports the idea 
that the region termed the hypothalamic floor in the chick is the homologous 
region to the PVH of the zebrafish62• Further, this finding strongly suggests that the 
mechanism of regulation of Shh in the hypothalamic floor plate is conserved 
throughout vertebrates. 
Two aspects of Shh expression in the basal plate/ ADH, however, suggest that these 
domains may be differentially regulated in zebrafish, compared to chick. First, the 
expression of shh is especially prominent in the ADH, taking the shape of a bulge 
instead of a more defined rod-like expression observed in the chick. Another 
observable difference is the lower expression level of shh in the basal plate region 
posterior to the ADH that is not easily observed in the chick (arrowhead in Figure 
1.lB and Figure1.2B,E). 
As there is no antibody available to detect Shh protein expression in the zebrafish, 
it is impossible to observe the diffusion of Shh away from the ADH and basal plate, 
and determine which cells are likely to receive Shh ligand. However, cells that are 
in receipt of Shh ligand may be active in its pathway. One of the easier and most 
straightforward ways to identify these cells is to analyse mRNA 
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Figure 1.2: Expression analysis of tbx2a and tbx2b. A-D, All embryos were analysed at 
30 hpf stage of embryonic development. (A) tbx2b is expressed at the PVH. It is expressed 
in a complementary pattern to that of shh (8) and together these expression patterns 
outline much of the hypothalamus. The diencephalic-telencephalic boundary/junction 
(DTJ) is labelled by the blue arrowhead. ((,D) tbx2a is expressed in the Rathke's pouch: the 
ectodermal component of the pituitary. (E) SHHITBX2 expression in the chick [14]. 
Arrowhead labels the basal plate. Scale bars represents 50 \-tm. 
expression of molecular read-outs for the Hedgehog pathway. Positive expression 
suggests an active pathway. Cells located some distance away from shh positive 
cells that express molecular read-outs reflect non-cell autonomous activation of 
the pathway through diffusion of Shh protein. The Hedgehog pathway inhibitor ptc 
is commonly used as the molecular read-out of the signalling pathway as it 
operates in a negative feedback loop to regulate shh signalling. To test if shh 
signalling is operating in areas in and around the basal plate and ADH, I performed 
ptc1 ISH and found that it is expressed most prominently just dorsal to the ADH 
and the Shh positive basal plate at 30-55 hpf (Figure 1.3). ptel appears to be 
expressed in a strip of expression above the shh expressing region at the ADH 
instead of a bulge as described for shh expression. At SS hpf, ptc1 is detected 
additionally in the ventricular region, similar to expression of shh (Figure Lie). 
pte2 is expressed similarly to ptcl at SS hpf but at a much lower level (Figure 1.3). I 
also analysed the expression of the transcription factor gli2a but found no positive 
expression around the ADH. However, strong expression was detected in cells at 
the anterior ventral region (arrowhead in Figure 1.3D'). 
1.2.2 Expression of &fsignalling components 
Fibroblast growth factors (Fgfs) belong to a family of growth factors that are 
involved in a variety of developmental processes in the embryo. In total, 22 FGF 
ligands have been described in human and 24 in the zebrafish. Fgfs signal through 
Fgf receptors 1-4 (fgfrl-4), found consistently throughout vertebrates, although 
EST (expressed sequence tags) studies in murine lymph node stromal cells have 
identified a fifth variant, fgfrS63. Each of these receptor variants responds 
specifically to different sets of Fgf ligands and signal through different pathways 
that include the Ras/MAP kinase and the phospholipase-C gamma pathways (see 
Box 1.3 for outline of Fgf signalling pathways) 
In the zebrafish,fgfs have been shown to be required for the specification of the 
adenohypophysis (anterior pituitary)64.fgj3 signalling is primarily required for the 
transcriptional activation of genes regulating the early speCification of 
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Figure 1.3 : Expression analysis of ptc1, ptc2 and gli2a. (A,A') ptc1 expression at 55 hpf 
embryos around the ADH and PVH; arrowhead in (A) shows expression in the posterior 
basal plate region. Arrowhead in (A') is the expression of ptcl in the 3rd ventricle. 
(B) ptc1 is expressed prominently dorsal to the basal plate and ADH of 
30 hpf embryos and very weakly in cells ventral to the basal plate and ADH (arrowhead). 
(C) ptc2 expression in a 55 hpf embryo shows similar but much weaker expression to ptc 1. 
Arrowhead shows expression in the 3rd ventricle. (D,D') No gli2a expression is detected 
in the ADH of embryos at 55 hpf, but is expressed in cells at the ventral hypothalamus 
(arrowhead in D'). Scale bars represents 50 !-lm. 
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FGF signalling pathway. FGF ligands binds to FGF receptors (FGFR). The 
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Cartoon is adapted from [93]. 
adenohypophyseal progenitor cells64• However, no study has yet described a role 
for Fgfs in the embryonic hypothalamus. To begin to investigate a potential role of 
fgfs in the embryonic zebrafish hypothalamus, I examined the expression offg13, 
fgf8 andfgf10, since these have been described in the hypothalamus of the 
zebrafish and other vertebrates64-66• As described in Figure 1.4,fgj3 is expressed 
in a pattern broadly similar to that oftbx2b (compare Figure 1.4A and 1.2A), 
although expression appears to be slightly broader. Thus, at 26-30 hpf,fgj3largely 
marks the PVH (white arrowheads Figure 1.4A, B). Expression rapidly diminishes, 
and is markedly less intense at 30 hpfthan at 26 hpf. A streak offgj3 is also 
detected in the medio-Iateral hypothalamic region (red arrowhead in Figure l.4B). 
At 55 hpf,fgj3 expression can only be detected in posterior-ventral most cells of 
the PVH (white arrowhead in Figure 1.4C). fgf8 is expressed only in posterior-
ventral-most cells of the PVH at 26 hpfand this expression in maintained to 30 hpf 
although its expression is only prominent in the ventral most cells at this stage. 
fgf8 expression is not observed in the hypothalamus or anywhere else in the 
diencephalon at 55 hpf; at this stage, expression is detected only at midbrain-
hindbrain boundary (MHB) (arrowhead in Figure 1.4F). Analysis offgf10 reveals 
no clear positive expression in the ventral diencephalon including the 
hypothalamus at all the above stages, although strong expression is detected in the 
otic-vesicle and the fin-bud (Figure l.4G'). 
To test iffgfsignalling is operating in the hypothalamus, I examined expression of 
the ETS-domain transcription factor pea3 (pea3), which acts downstream of Fgf and 
is widely used as a molecular readout for fgfsignalling. Examination of pea3 at 30 
hpf shows its expression both throughout the PVH, and additionally, some 
expression in the ADH (Figure 1.5). However, no pea3 expression is detected in the 
hypothalamus of aSS hpf embryo. 
1.2.3 Expression of rx3. tbx2alb and emx2 
In addition to analysing the expression of signalling molecules, I also studied the 
expression of several transcription factors that are known to be expressed in 
specific domains of the embryonic hypothalamus. As described in section 1.2.1, 
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Figure 1.4 : Analysis of fgf expression in the zebrafish embryonic hypothalamus. 
(A-I) In situ hybridisation of fgf3, fgf8 and fgf70. (A) Strong fgf3 is observed in the 
PVH at 26 hpf indicated by arrowheads. This expression diminishes by 30 hpf (B) 
and by SS hpf is confined to posterior-ventral most regions (C), white arrowhead. 
(g(3 is also expressed prominently at the midbrain-hindbrain boundary (MHB) 
(red arrowhead) at SS hpf. (D-E) (g(8 is expressed in PVH at 26 hpf and 30 hpf, but 
no expression could be detected in the hypothalamus at SS hpf (E), arrowhead 
in (F) indicate expression in the MHB. (G-I) (g(70 expression is not detected in the 
hypothalamus at all three developmental stages. (G') (g(10 expression in the otic 
vesicles and fin-buds of the 26 hpf embryo. Scale bars represent SO ~m. 
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Figure 1.5 : Analysis of pea3 expression in the embryonic hypothalamus. (A,A') pea3 is 
expressed in the ADH and PVH at 30 hpf.lt is also strongly expressed in the MHB as well 
as in the preoptic area (POA). (B) At 55 hpf, pea3 is not easily detected in the 
hypothalamus. 
tbx2b (homolog ofthe TBX2 gene in higher vertebrates) is expressed similarly to 
chick and mouse tbx2. However, its paralog tbx2a is not found in the neural tube 
but is expressed in what appears to be the ectodermal component of the 
adenohypophysis (arrowhead in Figure 1.2D). 
In the chick hypothalamus, the homeobox transcription factor EMX2 is expressed 
in posterior-most regions of the PVH14, and studies in zebrafish suggest a similar 
profile13. To confirm that a similar expression pattern is found in the zebrafish 
embryo, I studied the expression of emx2 through ISH. My data reveal that in the 
hypothalamus, emx2 is expressed exclusively in the posterior PVH at 30 hpf 
(Figure 1.6D). At 55 hpfhowever, the expression of emx2 becomes restricted to 
only a few cells within the posterior-most boundary of the PVH (arrowhead in 
Figure 1.6E). It is expressed robustly in the optic tectum (OT) at this stage. 
Together, these analyses confirm that the zebrafish PVH is likely to be the 
functional equivalent of the chick hypothalamic floor. 
The transcription factor rx3 is expressed in the ADH of the embryonic zebra fish 
and has been used as a molecular marker to demarcate the ADH17. In order to 
confirm this, I examined expression of rx3 at 10 hpf, 30 hpf and 55 hpf. In 
accordance with previous findings, rx3 does demarcate the ADH at 30 hpf. At 10 
hpf, rx3 expression can be observed at the precursor optic vesicles (white arrows 
in Figure 1.6A) and the presumptive hypothalamic field (boxed region in Figure 
1.6A). The presumptive hypothalamic field clearly includes midline expression, 
raising the possibility that, as in chick, early ADH cells may derive in part from 
anterior-most midline floor plate cells (Manning et al 2006). Examination of rx3 at 
55 hpfhowever, suggests that rx3 does not continue to define the ADH. Instead, 
expression is detected in a group of cells lining and situated adjacent to the 
presum ptive diencephalic ventricle or the 3rd ventricle (3V) of the hypothalamus, 
reminiscent of the strong shh expressing cells detected in this area at 55 hpf 
(Figure 1.lC white arrow; Figure 1.7C-E). To corroborate this, and examine how 
expression of rx3 compares to that of shh, I analysed the expressions of rx3 and shh 
in 30 hpf embryos through double ISH. Both expression domains significantly 
overlap at the ADH (Figure 1.7 A), although a 
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Figure 1.6: Analysis of hypothalamic regional markers. (A-E), In situ hybridisation 
detection of the transcription factors rx3 and emx2. (A) rx3 is expressed in the presumptive 
hypothalamic field (red box) and the precursor optic vesicles (arrows). (B) rx3 is expressed in 
the AOH at 30 hpf. However by 55 hpf, a distinct pattern of expression is detected in the 
areas adjacent to the AOH including the 3rd ventricle (C). (0) emx2 is expressed in the PVH 
at 30 hpf and is restricted to posterior-most strip of the PVH cells at 55 hpf (E). Orientation 
for (A); anterior to the left; embryo viewed dorsally. Scale bars represent 50 ~m. 
Figure 1.7 : Analysis of shh and rx3 expression at ADH. (A,S) Double in situ hybridisation of 
rx3 and shh in 30 hpf embryo shows a significant overlap of rx3 and shh signals in the ADH. 
A small area (arrowhead) of the rx3 expressing region does not express shh. (C,E) The 
expression of rx3 and shh appears to overlap significantly in the 3rd ventricle (white arrows) 
with a small non-overlapping region at 55 hpf similar to that in 30 hpf. (D) Cartoon depicting 
the predicted overlapping expression and non-overlapping expression between rx3 and shh. 
Scale bars represent SO ~m. 
small region ofthe rx3 expression domain can be seen slightly ventral/posterior to 
the shh positive ADH (arrowhead in Figure 1.7 A). Similarly, at 55 hpf, a significant 
overlap in expression is detected in cells around the 3rd ventricle (Figure 1.8C). The 
expression of rx3 also partially overlaps pea3 expression in the ADH of 30 hpf 
embryo suggesting that Fgf signalling is operating in these cells (Figure l.8D). 
1.3 Discussion 
1.3.1 Conservation of hypo thalamic territories in vertebrates 
The data in this chapter clearly demonstrate similarities in the molecular profiles 
that demarcate the developing hypothalamus in zebrafish to those of the chick and 
mouse. The downregulation of shh expression in the anterior floor plate of the 
hypothalamus is one of the hallmarks of early hypothalamic patterning event and 
is observed in all three organisms above, indicating a conserved vertebral feature. 
Similarly, the division of the hypothalamus into distinct AP domains is also 
conserved among the three organisms. In the zebrafish, these domains include the 
anterior hypothalamus or the ADH demarcated by rx3 and the posterior or PVH 
that is recognised through its expression of emx2. However, in the zebrafish the 
homologous structure of the medial hypothalamic domain that expresses FGF10 
and is responsible for the morphogenesis of the infundibulum in the chick and 
mouse does not appear to exist (see Figure 1.9). This is consistent with the non-
existence of the infundibulum and median eminence structures in the wider teleost 
group that includes the zebrafish. Nevertheless the possibility that a differentfgfis 
expressed in the medial hypothalamic domain of the zebrafish is potentially worth 
investigating. 
1.3.2 Maintenance of shh expression in the ADH 
As described in the Introduction, shh plays a vital role in the patterning and 
proliferation of cells in the neural tube. After its downregulation from much of the 
anterior floor plate, shh continues to be expressed in the ADH and basal plate 
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A 
55 hpf 
C 
30 hpf 
Figure 1.8: Analysis of rx3 expression with shh and pea3. A-D, Double in situ 
hybridisation of rx3 with shh and pea3 respectively. (A) rx3 expression around the 
3rd ventricle detected by BCIP/NBT and (8) shh expression detected by Fast Red. 
Merge of both images (C) shows overlapping expressions of rx3 and shh in cells at 
the 3rd ventricle (arrowhead). (D) overlapping expressions of rx3 and pea3 at the 
ADH of a 30 hpf embryo. (D') pea3 expression as inset. White arrowhead marks the 
corresponding ADH region shown in D. Scale bars represent 50 ~m . 
B 
A 
Anterior 
TBX2+ 
Chick embr 0 
3rd ventricle 
ADH shh+ 
shh+ (weak ptcl12+ Ventral hypothalamlc cells 
expression; in pink) g1i2+ (gf3 + 
Posterior 
EMX2+ 
Medial 
TBX2+ 
FGF10+ 
FGF3+ 
rx3+ 
c 
OH 
shh+ 
rx3+ 
pea3+ 
PVH 
(gf3+ 
(g(8+ 
tbx2b+ (dark blue) 
emx2+ 
pea3+ 
Zebrafish embr 0 (26-30 h f) 
Figure 1.9: Cartoon summarizing the distribution of signalling factors and transcription 
factors in the different domains of the developing hypothalamus.(B and C) Comparison 
of expression profiles between the chick embryo and the zebrafish embryo. The medial 
hypothalamic domain seen in the chick is non-existent in the zebrafish embryo. 
Source: Image B is adapted from [65]. 
of the hypothalamus. Previous observations in the zebrafish suggest a role for shh 
in the formation of ADH/basal plate, and suggest that Shh from the ADH/basal 
plate may be required to inhibit Nodal signalling from the PVH13. However, no 
study has yet investigated whether Shh from the ADH/basal plate might play a 
wider role. My expression analysis shows thatshh continues to be maintained in 
the ADH at least through 100 hpf, although beyond SS hpf, expression is far less 
prominent than in the 30 hpf embryo .. 
Whilst a downregulation of shh is required for the anterior floor plate of the 
neural tube to establish the PVH region, the maintenance of shh in the basal plate 
and ADH up to the late stages of embryonic development remains intriguing. This 
maintenance of expression raises the possibility that shh, in the ADH, plays a role 
in the further development of these regions. It has been reported that shh in the 
ADH is required for the development of the anterior region of the 
adenohypophysis between 24 and 35 hpf of zebrafish embryonic development67. 
SHH expression in the basal plate has also been linked to the maintenance of the 
diencephalic-telencephalic junction (DTJ) in the mouse embryo, exerting an effect 
indirectly through the proper development of the hypothalamus and thalamus68. 
Hence it will be interesting to study the function ofthe maintained expression of 
shh in the basal plate and ADH in the zebrafish embryo. A notable and interesting 
feature observed in the data above (Figure 1.1) is the bulge-like appearance of shh 
expression at the ADH of the embryonic zebrafish hypothalamus, which is not 
observed in the chick and the mouse embryo. This may suggest that the ADH 
region in the embryonic zebrafish is relatively large, compared to the chick and 
mouse embryo. In the basal plate, immediately posterior to the ADH, shh 
expression is detected at a lower level compared to its expression in the ADH 
(arrowhead in Figure LlB). This seems to be the similar case for the mouse as well 
based on a study of molecular markers in the mouse embryo69, but not the chick. 
In the SS hpf embryo, I detects expression of shh in the diencephalic ventricle or 
the 3rd ventricle of the embryo. Given the wealth of studies that show that neural 
stem/progenitor cells are located in the ventricular region of the neural tube 
(eNS), and the reports that Shh can govern the proliferation of neural 
stem/progenitor cells70, these observations raise the possibility that shh in the 3rd 
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ventricle may play a role in the maintenance and function of neural stem or 
progenitor cells found in the 3rd ventricle of the hypothalamus. Cells lining the 3rd 
ventricle appear to be responding to shh signalling, gauged through the expression 
of ptc in these cells (Figure 1.3). As yet, the relationship between the weakly shh 
positive ADH and prominently-expression shh in the 3rd ventricle is unclear. It is 
possible that the expression of shh in the ADH and the 3rd ventricle are 
interdependent or even that the two domains might share a common origin. A site-
specific knock-down of shh signalling at the ADH or lineage tracing studies would 
be good experiments to investigate the above. 
1.3.3 Potential function of fo.l3 in the ADH 
Fgfs play a vital role in the development of the CNS. Addition of basic FGF (bFGF) 
to ectodermal cells derived from Xenopus gastrula leads to the differentiation of 
neuronal cell fates71.ln the zebrafishfg18 mutant, the parapineal nucleus fails to 
migrate from its midline position to the left side the brain72. However, the role of 
Fgfs in the development of the hypothalamus has not been fully described. Studies 
in the chick suggest a requirement for FGF10 and FGF3 in the medial hypothalamic 
floor plate, driving formation ofthe infundibulum and suggest a role for FGFs in 
promoting cell proliferation in the PVH65. In examining the expression offgfs in the 
zebrafish embryonic hypothalamus, I could not detect any expression offgflO, 
which is inconsistent with reports in the chick and mouse infundibulum73 • 
However, this is not unexpected since the infundibulum is non-existent in teleosts, 
including the zebrafish. Also, previous studies suggest that the functions offgP and 
fgf10 have partly interchanged in the zebrafish64, Hence, although FGFIO does still 
play a fundamental role in pectoral fin/limb bud development in the zebrafish and 
mouse, it does not appear to have any developmental role in the zebrafish 
hypothalamus64• 
In contrast to fg[1 O,fgf3 and fg18 are expressed in the zebrafish embryonic 
hypothalamus. Close examination reveals thatfgf3 is strongly expressed 
throughout the nascent PVH at 26 hpfwhereas[gftJ is confined to posterior-ventral 
most parts of the PVH. Whilst the expression of [gf3 can still be observed at 55 hpf 
at the ventral hypothalamus,fg18 is no longer being expressed at 55 hpf suggesting 
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a role for fgf8 in the early but not the later stages of hypo thalamus development. 
My data indicates that fgj3 is expressed in the region immediately ventrally-
adjacent to the ADH at 26 hpf (Figure 1.4A). Hence,fgj3 may act non cell-
autonomously on cells at the ADH, as double ISH detection of pea3 and rx3 shows a 
slight overlap in expression (Figure 1.8). At this same stage,fgf8 expression is only 
observed in posterior-most PVH cells, making it unlikely that pea3 expression in 
ADH cells is triggered by the expression offgf8. 
1.3.4 Investigating the roles of shh. (g,f3 and rx3 in the ADHl3rd ventricle 
As I have shown and discussed, shh andfgj3 are expressed in and adjacent to cells 
of the ADH and 3rd ventricle. Moreover, downstream components of Shh and FGF 
signalling pathways are expressed in cells in and around the ADH/3rd ventricle 
over the period 30-55 hpf, suggesting active signalling. The roles of Shh and FGFs 
in the ADH/3 rd ventricle have not been directly described in any studies thus far. 
Similarly, the role of the transcription factor rx3, a marker for the ADH, remains to 
be elucidated in the hypothalamus. The overlapping expressions ofrx3 and shh at 
the ADH in 30 hpf embryos hints strongly at a possible interaction between the 
two (Figure 1.7 A). Similarly, investigation into the expression of rx3 and shh at 55 
hpf shows a maintained co-expression in cells along the presumptive 3rd ventricle. 
There is also potentially an interaction between rx3 andfgf(fgj3) based on the 
overlapping expression of rx3 with pea3 in the ADH at 30 hpf. 
To investigate these potential interactions, I therefore set out to test in the next 
chapter if the loss of rx3 function would have an effect on the development of the 
ADH and monitor the changes in shh andfgf expression and their downstream 
signalling readouts. 
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Chapter 2 
Chapter 2: Loss of rx3 in the anterior hypotbalamus of the embryonic 
zebrafish 
2.1 Introduction 
As outlined in the Introduction, rx3 is an evolutionarily-conserved transcription 
factor, whose function in the hypothalamus remains poorly addressed. Previous 
studies have noted expression of rx3 in the ADH of the hypothalamus, and have 
demonstrated a reduction in the number of pr opiomela no corticotropin (pomc)18 
and vasotocin-neurophysin (vtn)18 hypothalamic neurosecretory neurons, in rx3-
null (termed chokh) mutants and rx3 morphants, indicating a requirement for rx3 
in the formation and/or differentiation of these neurons. Pomc is produced in the 
arcuate nucleus and plays a vital role in the regulation of feeding behaviour. It is a 
precursor polypeptide that undergoes a variety of post-translational modification 
through enzymatic cleavage to give rise to different derivatives that execute 
different functions. These peptides include the melanocyte-stimulating hormone 
(MSH) and adrenocorticotropic hormone (ACTH). Loss of pomc gene function has 
been implicated with obesity problems. Vtn and its mammalian homolog arginine 
vasopressin have a wide role in controlling physiological and behavioural 
responses, for example osmoregulation, stress response and sexual behaviour. In 
this thesis, I focused on pomc positive cells given the successful synthesis (see 
Materials and Methods) and workability of its probe. 
While previous studies show that, under rx310ss-of-function conditions, there is a 
reduction in pomc positive neurons in the arcuate nucleus, these studies did not 
provide any mechanistic details that could explain the loss ofthese neurons. The 
arcuate nucleus in which pomc neurons are found, is located antero-ventral to the 
ADH/3 rd ventricle region of the 30 hpf embryo. My observations in the last chapter 
show that rx3 in expressed in both of these domains, and raise the possibility that 
expression in both or either domain could normally govern Pomc neuronal 
differentiation. However, my observations of overlap in expression ofrx3 with shh, 
and pea3 raises the additional possibility that rx3 may operate indirectly to govern 
Pomc neuronal differentiation, through an interaction with either of these 
signalling pathways. To begin to investigate these possible mechanisms underlying 
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the regulation of the neurosecretory neurons by rx3, I examined pomc expression, 
relative to rx3 expression in the hypothalamus, and relative to the expression of 
the signalling factors shh and/gf3, and their downstream signalling components in 
wild type embryos and after rx3 manipulation. 
To manipulate rx3 and examine its regulatory role, I performed rx3 morpholino 
injections on one-cell stage zebrafish embryos to produce rx3Ioss-of-function 
embryos or rx3 morphants (see Materials and Methods for details on the 
morpholino technique). At the time of writing this thesis, I was able to perform a 
single first comparative analysis of morphants with chokh mutants (kind gift from 
Dr. Brandean Kennedy, UCD), but have just received written permission from the 
UK Home Office to import the chokh mutant from University College Dublin, 
Ireland, and so have not yet had the opportunity to use the chokh mutant embryos 
extensively for the studies described in this thesis. In this chapter, I therefore: 
a) test the hypothesis that rx3 morphant embryos exhibit a similar phenotype to 
chokh mutants, and are a viable loss of function model 
b) examine expression of rx3 relative to pomc 
c) test the hypothesis that rx3 may govern progenitor cell proliferation in the 
hypothalamus 
d) test the hypothesis that rx3 exerts its effects, by regulating expression of shh 
and/gf3 
2.2 Results 
2.2.1 The rx3 morphant display similar phenotypes to the chokh mutant 
To confirm that rx3 morphants produce embryos of similar phenotype to the 
mutant chokh embryos, I analysed and compared several obvious morphological 
features attributed to the loss of rx3 function in chokh embryos. The most obvious 
phenotype observable is the loss of both eyes (Figure 2.1). This phenotype is 
commonly referred to as the absent eyes phenotype. This is the main phenotype 
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Figure 2.1 : Phenotypic comparison between the chokh mutant and rx3 morphant at 55 hpf. (A) Whole embryo comparison 
of the chokh and rx3 morphant shows similarity in the overall morphological appearances. In both types of embryos, the eyes 
failed to develop. (B,D) The non-functional eye lens as observed in the embryos (arrowheads). (A,B,D) Lateral view of the embryos. 
((,E) Dorsal view of the embryos. Scale bars represent 50 I-lm. 
observed in a majority of rx3 morpholino-injected embryos. There are also 
embryos that display an intermediate, or reduced-eye phenotype. This is 
consistent with findings reported in a previous study in which both rx3 morphants 
and chokh embryos were used 18. In testing the efficacy of the morpholino 
injection, I found that injecting with a combination of both splice and ATG 
morpholinos produces a bigger number of embryos with the absent eyes 
phenotype without any observable non-specific effects in the overall phenotype of 
the embryo. Hence, all the data in this chapter are produced using rx3 morphants 
generated from a cocktail of both morpholinos. This is similar to the method used 
in the above literature, in which a mixture of both forms ofrx3 morpholinos were 
used to generate rx3 morphant embryos18. Another noticeable phenotype, which I 
have used in addition to the absent-eyes phenotype to recognize rx3 loss-of-
function em bryos within the pool of rx3 morphants is the appearance of an 
enlarged telencephalon (prominent if embryos are viewed dorsally) as reported in 
Stigloher et.a!. (2006)29 at 30 hpf, although this is not easily observed at 55 hpf. I 
also performed an overall anatomical survey on the rx3 morphant embryos, but 
did not detect noticeable and obvious phenotypic changes apart from those 
described above. 
2.2.2 Reduction of [Jome cells concomitant with increase in proliferating progenitor 
cells and early born neurons 
Given that the rx3 morphant embryos appear to mirror ehokh embryos, I used 
them to further elucidate the role of rx3 in the either the formation or maintenance 
of pome neurons in the arcuate nucleus of the zebrafish embryos. Initially, I 
determined the temporal and expression profile of pome, relative to rx3, to ask 
whether there is ever an overlap in expression, indicative of an autonomous effect 
of rx3 in governing Pomc cell differentiation. My results reveal that I cannot detect 
an overlap. The earliest pomc-expressing cells are found just antero-ventral to the 
ADH, presumably in the prospective arcuate nucleus, at 30 hpf (Figure 2.2). Soon 
after, an additional zone of pomc-expressing cells is detected in the hypophysis 
(pituitary). By 55 hpf, pomc positive cells are clearly detected in both the arcuate 
nucleus and hypophysis. The distribution of these cells in the zebrafish is therefore 
79 
D 
Figure 2.2 : pomc (blue) expressing cells are found ventral to the shh (red) ADH. 
(A) Earliest pomc expressing cells are seen in a 30 hpf embryo in the prospective arcuate 
nucleus. (C) pomc positive cells persist in this region at 55 hpf (arrows). In addition, 
pomc positive cells are now seen in the hypophysis as well (arrowheads). 
(B,D) Cartoon representing A and C respectively. All embryos are viewed laterally. 
Scale bar represents 50 urn. 
similar to that described in the mouse69, which suggests similarities in the 
formation of pomc cells in the arcuate nucleus. 
The late onset of pomc expression relative to rx3, and non-overlapping expression, 
makes it difficult to establish how rx3 may govern pomc cell differentiation. Rx3 
may operate autonomously on rx3 positive progenitor cells, or via a non-
autonomous effect. Nonetheless, in an attempt to begin to elucidate the role ofrx3 
in the development of pomc expressing cells, I first investigated if the number of 
pomc positive cells in the arcuate nucleus of the rx3 morphant is reduced similarly 
to the reported reduction in chokh mutant embryos. Figure 2.3 shows a clear 
reduction of pomc positive cells in the arcuate nucleus of 55 hpf rx3 morphant 
embryos compared to control injected embryos. By contrast, pomc positive cells in 
the hypophysis appear unaffected in the rx3 morphant embryos at this stage 
(Figure 2.3B). Quantitative analysis and comparison of the number ofpomc 
positive arcuate cells in both control and morphant embryos shows that the 
reduction is statistically significant (p value of 0.008) (Figure 2.3C). Examination of 
30 hpf rx3 morphant embryos reveals, similarly, that pomc positive cells are absent 
from the arcuate nucleus, (p value of 0.0029) (Figure 2.3F). At this time point, 
pomc expressing cells are not seen in the hypophysis of the rx3 morphants, 
although they appear to expressed and distributed normally at 55 hpf (black 
arrowheads in Figure 2.3A,B). 
To begin to assess whether rx3 affects the specification of pomc positive cells 
through an effect on hypothalamic neural progenitor cells, I examined expression 
of phospho-histone 3 (ph os-H3) as a marker for actively-dividing cells, through 
immunolabelling. Phos-H3 is upregulated in cells undergoing the mitotic phase (M-
phase) ofthe cell cycle and hence labels progenitor cells undergoing cell division in 
the hypothalamus. A combination of rx3 ISH and phos-H3 immunolabelIing on 55 
hpf embryos reveals a close correlation in rx3 expression and actively dividing 
cells; many positively labelled phos-H3 cells in the domain of rx3 expressing cells 
(Figure 2.4A). To test if rx3 governs progenitor cell division, I analysed the 
hypothalamus of rx3 morphant embryos for the expression ofphos-H3 alongside 
the control-injected morphant embryos at 55 hpf. I detected a significant increase 
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Figure 2.3 : Analysis of pomc expression in the arcuate 
nucleus. (A-C) pomc expressing cells are significantly 
reduced in the arcuate nucleus of the rx3 morphants (MO) at 
55 hpf (red arrowheads), but appear normal in the 
hypophysis (black arrowheads in A and 8). (D-F) A similar 
observation at 30 hpf except that pomc is not seen in the 
hypophysis as well. (A-E) Lateral view (A'-F ) Anterior view. 
Table represents the average number of pomc positive 
cells in the arcuate nucleus. 
Figure 2.4: Examination of proliferation and rx3 expression in the rx3 morphant embryos. 
(A) rx3 in situ hybridisation combined with phos-H3 immunohistochemistry shows the distribution 
of phos-H3 cells in the rx3 expressing region of the ADH. (C-F) An increase in phos-H3 
positive cells is observed in the rx3 morphants at 55 hpf. (B) graph representing this 
increase. (G,H) rx3 is still expressed in the ventricular region of the rx3 morphant embryos 
albeit at a higher level. (G'H') Anterior view of the embryos. All images are lateral view of embryos. 
fir, flourescence; DIC, differential interphase contrast. Scale bars represent 50 J.!m. 
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in phos-H3labelled cells in the ADH domain/3 rd ventricle of rx3 morphant 
embryos compared to control-injected morphants (Figure 2.4 B,D,F). The increase 
in phos-H3labelled cells was mainly distributed along the ventricle ofthe rx3 
morphant at 55 hpf. 
To test whether the increase in phos-H3 positive cells affected cells around the 3rd 
ventricle, I examined rx3 expression as a marker for the 3rd ventricle at 55 hpf. 
Unlike antibody staining, mRNA products can still be detected through ISH after 
morpholino knock down since the morpholinos would only bind to and inhibit the 
target mRNA (Le. rx3 in this case) from being translated and not degrade them 
(refer to Materials and Methods for details on morpholinos). I performed rx3 ISH 
on the rx3 morphants to examine that the 3rd ventricle is normal. The resulting 
data show that rx3 is expressed in the 3rd ventricle, and if anything, appears 
relatively stronger to controls (Figure 2.4G, H). This, together with the phos-H3 
data, raises the possibility that progenitor cells in the 3rd ventricle, including rx3 
positive progenitor cells, are increased in number after rx3 knockdown. 
Together this suggests that rx3 may act specifically as a negative regulator of 
hypothalamic progenitor cell proliferation. To examine whether the increase in 
ventricular progenitors and decrease in pomc neurons reflected a general decrease 
in hypothalamic neurons, I next examined the expression of isl1, a 
LIM/homeodomain transcription factor widely expressed in early developing 
hypothalamic neuronsll. In rx3 morphant embryos, isl1 expression was generally 
upregulated around sites of endogenous expression (arrowheads Figure 2.5B). 
Thus depletion of rx3 does not lead to a general decrease in neurogenesis. To 
examine if the loss of rx3 function affects other regions apart from the 
hypothalamus, I analysed the expression of pax6 (homeobox gene) that shows a 
general upregulation around sites of endogenous expression albeit its absence in 
the hypothalamus (Figure 2.5D). 
Since these effects are non-autonomous to rx3 expression, this raises the likelihood 
that reduction in rx3 may lead to a change in a signalling ligand or signalling 
pathway, and so cause a widespread change in the patterning of the hypothalamus 
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Figure 2.5 : pax6 and isl1 expression analyses in rx3 morphant. (A,B) isl1 expression is upregulated in the 
ventricular region (red arrowhead) as well as in the PVH (white arrowhead). It is also vastly upregulated in 
the dorsal tissue (black arrowhead) as well as in the general CNS. (A;B') Anterior view of the embryos. (C,D) 
pax6 is not detected in the hypothalamus of rx3 morphant as in the control embryo. It is however upregu-
lated in the dorsal tissue similar to isl1 and is generally upregulated in the CNS of the morphant embryo. 
Scale bars represent 50 ~tm. 
and its surrounding regions. Based on my observations in result chapter 1 that rx3 
expression overlaps with that of shh and pea3, I therefore next examined 
expression of shh and/9/s in rx3 morphants. 
2.2.3 Changes in shh expression domains in rx3 morphants 
The expression of shh overlaps with that of rx3 in the ADH at 26-30 hpf, and in the 
3rd ventricle at 55 hpf as detailed in section 1.2.3. To study a possible effect of rx3 
on Shh, I investigated shh expression in rx3 morphant embryos. I detected a 
dramatic change in shh expression in 55 hpf rx3 morphant embryos. shh 
expression around the 3rd ventricle is not diminished upon reduction of rx3 (red 
arrowhead, Figure 2.6B). Indeed, shh appears to be expressed at higher levels, 
supporting the idea that there are increased progenitor cells in this region in 
morphant embryos. By contrast, expression of shh in both the ADH and the basal 
plate (white and green arrowheads in Figure 2.6 A,B) is completely diminished in 
the morphants. Similarly, expression of shh in the telencephalon (in other species, 
secondarily induced from Shh in the anterior dorsal hypothalamus12) is lacking 
(black arrow, Figure 2.6B). The reduced shh expression in the basal plate may be 
due to a complete loss of this territory. The apparent loss of territory is clearly 
visible in ventral views (Figure 2.6A', B'), which show a compressed extent of shh 
expression along the dorso-ventral axis. As a result, expression of shh around the 
3rd ventricle now appears to abut expression in the ZLI. 
Together these results show that a loss of rx3 function through morpholino leads 
to a loss of shh expression in the ADH, and support the notion that a loss of rx3 
function leads to an increase in number progenitor cells in the 3rd ventricle. Thus, I 
hypothesise that rx3 exerts two temporally distinct effects on the hypothalamus, 
the first, an early action mediated through Shh-signalling from the ADH, and the 
second, a later action, mediated via the control of progenitor cells in the 3rd 
ventricle. 
To test how changes in shh signalling in the morphant embryos affect Shh 
signalling, I examined both ptcl and ptc2 as molecular readouts. Both are 
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Figure 2.6: Loss of shh expression in the rx3 morphant embryos. (A,B) shh expression is 
not detected in the ADH region (white arrowheads), the basal plate (green arrowheads) 
and the telencephalon, but is still expressed in the ventricular region (red arrow-heads). 
(C,D) Increase in ptcl expression is seen generally throughout the embryo including the 
hypothalamus. (E,F) ptc2 expression appears to be generally upregulated in the morphant 
embryos, with the exception of the ADH. (A-H) Embryos are view laterally. (G~H ') Embryos 
are viewed ventrally. Arc; arcuate nucleus. Scale bars represent 50 flm. 
dramatically upregulated in morphant embryos in regions that include the arcuate 
nucleus (Figure 2.40 and F) or its remnant structure. The one exception seems to 
be ptc2 expression in the AOH, which does not show a general upregulation; 
increase in expression is quite specific to the hypothalamus. However, these 
results together suggest that reduction of rx31eads to widespread and general 
changes in shh signalling throughout the hypothalamus and ventral forebrain. 
2.2.4 Changes in mfsignalling in rx3 morphants 
In section 1.3.3, I described the overlapping expression of pea3 and rx3 in the AOH 
at 30 hpf. I therefore next investigated if rx3 exerts any influence on the expression 
offgfligands, or FGF signalling (as assessed by pea3) in the hypothalamus. ISH 
reveals no change in the territory in whichfgf3 is expressed in rx3 morphant 
compared to control embryos. In both cases,fgf3 is expressed in PVH cells 
(arrowheads in Figure 2.7 A and B). The levels of expression of fgf3 in the PVH, 
moreover, appear similar in control and morphant embryos (by contrast,fgf3 
expression is markedly upregulated in the MBH of morphant embryos). Similarly, 
the Fgf signalling pathway readout, pea3 shows no change in expression in the 
hypothalamus (Figure 2.7F), although expression is diminished in the 
telencephalon and epiphysis of morph ants (Figure 2.7F). Althoughfgj8 does not 
overlap with rx3 in its expression (section 1.3.3), I examined the expression offgj8 
in the rx3 morphants and found no change in expression in the hypothalamus, 
although ectopic expression offgj8was now clearly detected in pseudo-optic 
tissue (Figure 2.70). In summary, in rx3 morphant embryos, shh and the Shh 
signalling pathway show dramatic alterations in cells in and around the 
hypothalamus, including the AOH, 3rd ventricle, and the region in which pomc 
positive cells differentiate, but Fgfs andfgfsignalling appear unaffected. 
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Figure 2.7 : Expressions of fgfs show no change in rx3 morph ant embryos. (A-B) fgf3 
expression is maintained in the morphant embryo; expressed at the ventral floor plate 
region (arrowhead). (C -O) fgfB is expressed in the pseudo-optic tissue (boxed) of the 
morphant embryo; outlined in O~ (E-F) pea3 remains unexpressed at the AOH and 
shows no change in expression in the hypothalamus.lt is however downregulated in 
the telencephalon (white arrowhead) and the epiphysis (red arrowhead). 
Scale bar represents 50 um. 
2.3 Discussion 
2.3.1 Requirement for rx3 in the specification and differentiation of pomc positive 
cells in the arcuate nucleus 
The neuropeptide Pomc is the key determinant for the 'starvation' response during 
active feeding. Hypomorphic mutation in this gene leads to obesity74. 75. In the 
zebrafish embryo as with all other vertebrates, pomc expressing neurons are found 
in the arcuate nucleus of the hypothalamus and the pars distalis and the pars 
intermedia of the adenohypophysis. As reported in section 2.2.2, pomc expressing 
cells are significantly reduced in the arcuate nucleus of rx3 morphant embryos. 
However the number of pomc positive cells remains unchanged in the 
adenohypophysis suggesting that rx3 function is specific to pomc positive cells in 
the hypothalamus. It also interestingly suggests that the regulation of pomc 
positive cells is different between two tissues that are adjacent to each other. 
These findings concur with those reported in the rx3 mutant, chokh. Previous study 
analysing the neuronal genetic enhancers of the pomc gene interestingly shows 
two different enhancers, each driving the transcription of pomc gene in the arcuate 
nucleus and the pituitary (adenohypophysis) of the mouse.76 A similar situation 
might be operating in the zebrafish and this may just help explain the specific 
regulation of rx3 on the Pomc neurons found in the arcuate nucleus and not the 
adenohypophysis. However no report thus far provides any information on the 
mechanism by which rx3 may specify pomc expressing cells at the arcuate nucleus. 
I had set out to examine whether there might be a clear cell-autonomous link 
between rx3 and pomc positive cells. Instead, my results suggest a complex mode 
of action of rx3. First, I find that rx3 and pomc are not co-expressed: rx3 is 
restricted to cells of the ADH and 3rd ventricle, whereas pomc positive cells are in 
the arcuate nucleus and do not appear to overlap with these territories. Second, I 
find that rx3 is temporally expressed in two distinct domains, the ADH and the 3rd 
ventricle, either or both of which could affect differentiation of pomc positive cells. 
Third, I find that loss of rx3 function leads to profound changes in shh and Shh 
signalling elements (i.e. ptc1/2) in and around the ADH, as well as affecting cell 
proliferation in the 3rd ventricle. These findings suggest that a reduction in rx3 
could elicit changes in patterning, proliferation and specification of the 
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hypothalamus, including pomc positive cells. In result chapter 3, I perform 
additional experiments to test the hypothesis that Shh signalling governs the 
differentiation pomc positive cells. 
2.3.2 rx3 governs shh in the hypothalamus 
In this chapter, I show that shh expression is downregulated cell-autonomously in 
the ADH in a non-functional rx3 environment (i.e. the rx3 morphant embryos). This 
observation hints strongly towards the requirement of rx3 for the normal 
expression of shh in the ADH. In addition, the loss of rx3 function leads to a loss of 
shh in adjacent regions that do not normally express rx3 as observed in the basal 
plate and the telencephalon. In other species, Shh homeogenetically induces Shh. 
This has been observed both in the posterior floor plate77 and in the telencephalon, 
where Shh expression is induced by Shh from the ADH12. Thus, the most likely 
explanation for the loss of shh in the basal plate and the telencephalon of the rx3 
mophant is a secondary consequence ofthe loss of shh in the ADH. 
Shh is known to induce expression of its own receptor, Ptcl (Patchedl/ptchlF8. 
Thus, the loss of shh expression in the ADH of the rx3 morphants led me to 
hypothesize that I might detect a loss of its downstream signalling; on the contrary 
I saw an increase in both ptel and ptc2 expression. Similarly, although I detected a 
decrease in shh expression in the ADH and basal plate, I detected an increase in shh 
in the 3rd ventricle of rx3 morphants. The increase in shh is concomitant with the 
increase in the number of proliferating neural progenitor cells labelled by phos-H3, 
suggesting that there may be more Shh positive proliferating progenitors in the 3rd 
ventricle of rx3 morphants. The observation that Shh expression persists in the 3rd 
ventricle of rx3 morphants eliminates the possibility that shh expression in the 3rd 
ventricle is induced by its expression in the ADH. 
The Fgf signalling pathway appears unperturbed in the hypothalamus of the rx3 
morphant: fBf3 and fBf8 and the downstream effector, pea3, show similar 
expression profiles between the morphant and control embryos, although 
expression levels of pea3 are diminished in the telencephalon and epiphysis of rx3 
morphant embryos (Figure 2.7 E,F). Neither [gj3 nor [gf8 are expressed in these 
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regions, but possibly, rx3 could govern the Fgf pathway, or a different fgf Since rx3 
is not expressed in the epiphysis, the loss of pea3 in this region is most likely due 
to a loss of a secondary inductive signalling cascade feeding into these regions. The 
possible link between the loss of Fgf signalling in the telencephalon and the loss of 
shh expression in the telencephalon (which is secondarily induced by Shh from the 
ADH) is certainly worth investigating. 
2.3.3 Patterning defects in the forebrain ofrx3 morphants 
rx3 morphants show ectopic expression of pax6 and is/1, markers which are 
normally expressed in the dorsal hypothalamus, telencephalon and optic vesicle 
(Figure 2.7]79.80. Through a previous study in the chokh mutant, we know that the 
telencephalon and optic vesicle share a common pool of progenitor cells and that, 
in the mutant, cells destined for the optic vesicles acquire telencephalic identities 
instead29• The expanded dorsal tissue in Figure 2.7 could therefore be mis-
specified telencephalic tissue, which in turn would suggest that rx3 normally 
functions in hypothalamic specification. Alternatively, the increase in pax6 
expression in the rx3 morphant embryos might be a consequence of the loss of shh 
expression in the ventral telencephalon as described. In the neural tube, Shh from 
the floor plate acts to specify different neuronal fates along the ventro-dorsal axis 
in a concentration-dependent manner, and inhibits Pax6 expression. Conversely, 
Pax6 contributes to distinct ventral progenitor cell populations by functioning cell-
autonomously to oppose Shh signalling along the gradient6. 81. These mechanisms 
may operate additionally in anterior regions of the neural tube, including the 
hypothalamus. An intriguing question that needs to be addressed is whether the 
telencephalon and anterior hypothalamus share the same set of early progenitor 
cells originating from a common domain in the anterior neural plate. 
In summary, my findings demonstrate that rx3 loss of function results in the loss of 
shh expression in the ADH, but not in the 3rd ventricle as well as the loss of pomc 
positive cells in the arcuate nucleus. A previous study has demonstrated that Shh 
signalling can act to indirectly induce the expression of Pomc through the Gli 
activator82• This raises the question of why Shh in the 3rd ventricle does not appear 
to induce pomc positive fate. A number of interpretations can be made. First, in 
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other regions of the eNS, signalling factors operate against the background of 
competence factors. Early Shh signalling from the ADH could normally be required 
to establish the correct competence allowing progenitor cells to respond to later 
Shh signal and acquire pomc cell fate. Alternatively, rx3 itself may provide cell 
autonomous competence to respond to the late Shh signal, in the process of 
differentiation to pomc cell fate. To begin to examine this, I looked at the loss Shh 
signalling and study its effects in the next chapter. 
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Figure 2.8: Summary cartoon highlighting the key changes in the rx3 morphant embryo compared to 
control embryo at the 55 hpf stage. Loss of shh expression in the ADH suggests a loss of this region in 
the rx3 morphant. A reduced number of pomc positive cells and increase in proliferating progenitors 
can be seen in the rx3 morphant embryo as well. 
Chapter 3 
Chapter 3: Shh is required for establishment of the AD" and the formation of 
pomc expressing cells 
3.1 Introduction 
In the preceding chapters, my data demonstrates that rx3 expression overlaps with 
that of shh in the ADH and the 3rd ventricle and describe that loss of function of rx3 
in morphant embryos results in the loss of shh positive cells or downregulation of 
shh in the ADH. At the same time, pomc positive cells fail to differentiate in the 
arcuate nucleus, antero-ventral to the ADH. I therefore set out, in this chapter, to 
test whether there might be a direct effect of Shh on the specification of ADH cells, 
and pomc positive cells. shh continues to be expressed in the ADH, albeit weakly, at 
least until 100 hpf of zebrafish embryonic development, while ptclis similarly 
detected in the ADH and forming arcuate nucleus at 30 hpf, supporting an early 
role for Shh. 
Studying the role of Shh in the zebrafish em bryo would normally require using 
established hypermorphic mutant lines in which shh signalling is abberant and 
non-functional. These mutants include slow-muscle-omitted (smu)83,you-too (yot)84 
and sonic-you (syU)85. However, as Shh is integral for induction and patterning of 
the ventral neural tube, including the prospective hypothalamus, these mutants 
exhibit severe morphological defects in the diencephalic floor plate and as a result, 
a malformed ventral diencephalon and the hypothalamus. The embryonic brain of 
these mutants fails to divide into two lobes and fused optic vesicles can usually be 
observed, resulting in the cyclops (fused eyes) phenotype. This essentially 
precludes their analysis for the study of the ADH, or for later-forming cells, such as 
pomc positive cells. At the time of writing this thesis, efforts have been made 
(including here in the University of Sheffield) to produce mutant lines that would 
allow conditional-attenuation of Shh signalling in the zebrafish embryo but no 
report has been made on its progress and viability. An optional and popular way to 
achieve a similar outcome is to employ the use of a chemical attenuator ofShh 
signalling, for instance cyclopamine. 
94 
The chemical cyclopamine [IUPAC name: (3~, 23R)-17, 23- epoxyveratraman- 3-
01] is a naturally-occurring teratogen found in the corn lily (Veratrum californicum) 
and was first identified through an investigation by the U.S. Department of 
Agriculture into the cause for one-eyed lambs born to sheep that grazed on these 
wild lilies. It was eventually discovered that cyclopamine acts to antagonise the 
Hedgehog signalling pathway86, 87. It inhibits the pathway via direct binding and 
inhibiting the function of the Hh signal transducer, Smoothened88 
3.2 Results 
3.2.1 Loss of shh signalling affects rx3 domains 
As described, shh is expressed in the ADH, and substantially overlaps with 
expression of rx3; moreover, shh appears to be regulated by rx3, although, as 
shown in the previous chapter, it is unclear if this regulation is a direct or indirect 
effect. To investigate if Shh signalling is necessary for development and 
maintenance of the ADH, I used rx3 as a marker of the ADH, and examined its 
expression after exposing embryos to cyclopamine, to effect a temporal inhibition 
of Shh signalling. As expression of shh begins to take shape in the basal plate/ ADH 
from 27-30 hpf, I initially started the inhibition process of the Shh pathway at this 
stage. Cyclopamine (100 uM) was added directly onto embryos, which were then 
incubated in cyclopamine-supplemented E3 for 12 hours (see Materials and 
Methods for more details on the process). The treated embryos (cyc-t embryos) 
were analysed for ptcl expression to test the efficacy of the treatment. As decribed 
in Figure 3.1, the expression of ptcl was markedly downregulated in cycIopamine 
treated embryos compared to control treated embryos (55 hpf). Only a minimal 
remnant of ptcl expression could be observed around cells of the 3rd ventricle. To 
determine whether such ptc1 expression could be entirely eliminated, I exposed 
embryos to cyclopamine at even earlier stages. This appeared to result in the 
complete elimination of ptel at 30hpf (Figure 3.1C). Together these data confirm 
and validate the attenuation of Shh signalling through the use of cyclopamine. 
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Figure 3.1: Shh signalling is attenuated through the use of cyc\opamine, (A,B,D,E) In situ hybridisation analysis of ptcl expression in 
30 hpf embryos and 55 hpf after treating with cyclopamine following stipulated regimes (C,F) to gauge the loss of Shh signalling. 
(C) Cyclopamine is added to the embryos at 30 hpf and embryos are fixed at 55 hpf. (F) Cyclopamine is added to the embryos at 10 hpf 
and embryos are fixed at 30 hpf. (F) All embryos show lateral views. Scale bars represent 50 I-lm. 
To examine if attenuation ofShh signalling would affect the expression of rx3 in 
either the ADH or the 3rd ventricle, I examined expression of rx3 after following 
both treatment regimes as described above. When the embryos were treated with 
cyclopamine following the 10 hpfto 30 hpfregime, the expression ofrx3 in the 
ADH/3 rd ventricle was substantially downregulated (Figure 3.2). This indicates 
that shh is required for the expression of rx3, either directly, or through an effect 
on ADH cell specification 
However when early expression of rx3 was allowed, and Shh signalling only then 
abolished (i.e. by treating embryos following the 30 hpfto 55 hpfregime), a very 
different effect was observed. In this case, reduction in Shh signalling appears to 
result in a marked change in the pattern of expression of rx3 around the 3rd 
ventricle. Lateral-views of treated embryos show that rx3 expression appears to 
extend more anteriorly than in controls, dipping towards the midline. Ventral 
views show that normal midline expression for rx3 is lost (green arrowhead in 
Figure 3.2C,D). Concomitantly, ventro-Iateral expression of rx3, which in wild types 
appears as bilateral diamond-like shapes, appears to be duplicated (compare white 
arrowheads Figure 3.2C,C' with D,D'). 
One possible explanation of these two distinct effects is that loss of Shh signalling 
leads to the loss of anterior hypothalamic tissue, including the ADH, with 
consequent effects on other tissues, for instance, an expansion of 'posterior-
ventral' markers, including the more ventral domain of rx3 expression. To further 
test these ideas, I first studied expression of zic2a, which is expressed by cells 
forming the optic chiasm, the crossing ofthe optic nerves at the junction between 
the telencephalon and diencephalon (i.e. the DTJ). In cyc-t embryos, the optic 
chiasm appears not to form in its entirety and only a remnant of this structure can 
be observed (red arrows in Figure 3.3D). Thus, reduction ofShh signalling may 
generally cause a loss of anterior-most regions of the hypothalamus. To test 
whether the reduction in anterior tissue is accompanied by an expansion in 
posterior hypothalamic tissue, I examined expression of emx2, a marker of the 
PVH. I detected a small but clear upregulation of emx2 in cyclopamine-treated 
embryos (Figure 3.2E, F). Together these results suggest that Shh signalling is 
required at 
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Figure 3.2: Analysis of rx3 and emx2 expression after attenuation of Shh signalling. (A,B) rx3 expressing domain 
is at the AOH is greatly reduced when embryos are treated with cyclopamine from 10 hpf. «(,(:0,0') rx3 expression 
is markedly changed and forms diamond-like shape dorsally when embryos are treated with cyclopamine from 
30 hpf (arrowhead). Lost of rx3 midline expression is observed in the morphant (green arrowhead). Red bracket in 
C' and 0' marks the anterior expansion of the ventro-medial domain of rx3 (E,F) emx2 expression at the PVH 
(red arrowhead in F) is upregulated in cyclopamine treated embryos (30-55 hpf regime). (A,B,C,O) Ventral view of 
embryos. (C:O:E,F) Lateral view of embryos. Scale bar represents 50 ~m. 
cyct/55 hpf 
Figure 3.3: Loss of zic2a expression at the optic chiasm of cyclopamine treated embryos. 
(A,B) Control treated embryos showing the normal formation of the optic chiasm 
(red arrows), whilst only the remnant zic2a expression in the optic chiasm can be seen in 
cyclopamine treated embryos (red arrows). (A and D) Lateral views. (8 and D) Anterior views. 
Scale bars represent 50 ~m. 
both early and late time points for proper patterning of the hypothalamus. Early 
loss of Shh signalling prevents the appearance of anterior territories (Le. the ADH) 
Later, maintained Shh signalling appears to be required to maintain anterior 
territories at the expense of posterior tissue, including regions around the 3rd 
ventricle. 
3.2.2 shh regulates the specification of flame cells 
I next asked the pertinent question of whether maintained Shh signalling is 
required for the expression of pame cells in the arcuate nucleus, by exposing 30 hpf 
embryos to cyclopamine , as described above. The number of pame positive cells 
was significantly reduced in the arcuate nucleus of cyc-t embryos (arrowheads in 
Figure 3.4A,B). This implies a role for shh in regulating the number of pame 
positive cells at the arcuate nucleus. Since cyclopamine treatment allows for 
temporal but not spatial inhibition of shh pathway, I tested the expression of 
tyroxine-hydroxylase (TH), which labels dopaminergic neurons to determine if the 
reduction of pame positive cells is a specific effect. Some of the th positive neurons 
are found at the posterior shh expressing basal plate near the posterior 
tuberculum89• The data obtained (Figure 3.4C,D) show no observable changes in 
the distribution of th positive neurons at this region and no significant changes in 
the number of th positive cells. However a slight decrease in th positive cells is 
detected especially those distributed at the basal plate (arrowhead Figure 3.4D), 
where shh is expressed. The latter serves as positive control to show that th 
positive cells at the basal plate are affected by the inhibition of Shh signalling as 
well. 
3.2.3 shhlShh regulates progenitor cell markers in the hypothalamus 
In the previous chapter, I noted that the reduction in rx3 resulted in an enhanced 
proliferation (phos-H3 cells) and enhanced isl1 expression. However, as suggested 
in chapter 2, these effects could be due to changes in shh expression in the ADH as 
well as the 3rd ventricle, detected in rx3 morphants. To investigate this, I first 
examined whether attenuation of shh signalling affected neural progenitor cells 
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Figure 3.4 : pomc positive cells are reduced in the arcuate nucleus through the loss of 
Shh signalling.(A,B) In situ hybrdization analysis of pomc positive cells shows its reduction 
at the arcuate nucleus (white arrowhead), but not in the hypophysis (red arrowhead). (C,D) 
analysis of th positive cells at the posterior tuberculum shows a slight reduction in the 
number of cells although not statistically significant. (E,F) graphical representation of the 
changes in the number of pomc and th positive cells respectively. All embryos are viewed 
laterally. Scale bar represents 50 !-lm. 
distributed in and around the ADH and 3rd ventricle. To do so, I examined 
expression of sax2 and sax3, which are well-established markers for neural 
progenitor cells. The result interestingly shows increases in labelling of sax3 but 
not, sax2, suggesting that reduction in shh signalling results in an accumulation of 
neural progenitor cells labelled by sax3 (Figure 3.5). Close examination reveals 
that the expression patterns of sax2 differ from that of sax3 although they both 
label neural progenitor cells. In the cyc-t embryos, sax21abelled cells do not show 
much change in expression at the corresponding ADH (cor-AD H) region as well as 
the PVH (red arrowhead Figure 3.5D) whereas sax31abelled cells accumulates at 
the mid-ventral and PVH region (green and white arrowheads respectively in 
Figure 3.58), noticeably at the ventricular region. Only a slight increase in sax3 
expression is observable in the cor-ADH ofthe cyc-t embryos compared to the 
control treated embryos (red arrowhead Figure 3.58). In fact the main 
upregulation of sax3 is observed in the more posterior tissues (Le. the PVH) 
(Figure 3.58) and sax3 being expressed in PVH9o, supports the 'posteriorisation' of 
the hypothalamus (as proposed in section 3.2.1) at the expense of the ADH 
reSUlting from the loss of shh signalling. 
To further examine this, I investigated if newly born neurons are affected through 
the loss of shh signalling at the cor-ADH region of the cyc-t embryo. I detected 
these cells through isl1 ISH, which labels newly born neuronal cells. As shown in 
Figure 3.5, isl1 expression is upregulated in the areas surrounding the cor-ADH 
and ventricle. This data potentially suggest an accumulation of early born neurons 
that would normally give rise to the neurons in areas surrounding the ADH 
including pamc expressing neurons in the arcuate nucleus. The increase in isl1 
expression is also observable in the ventral hypothalamic region (white arrowhead 
in Figure 3.5F), which suggest accumulation of early born neurons in the PVH as 
well. Apart from isl1, I have also tested the expression HuC/D through 
immunohistochemistry, which also labels for early born neurons, to detect if 
similar observation to isll can be made using HuC/D. Unfortunately however, no 
staining can be detected throughout the embryo most probably due to technical 
issues with the immunohistochemistry protocol. 
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Figure 3.5: Analysis of neural progenitor cells (sox2/3) and early neurons (isl1) in the 
ADH of Shh signalling attenuated embryos. (A,B) sox3 expression is slightly increased 
at the corresponding ADH (cor-ADH) (red arrowhead), medial hypothalamic region 
(green arrowhead) at the PVH (white arrowhead). (C.D) sox2 expression shows no 
change in expression (red arrowhead). (E,F) isl1 expression shows a significant amount 
of upregulation at the cor-ADH (red arrowheads) and PVH (white arrowheads) as well 
of cyclopamine treated embryos. All embryos are viewed laterally. Scale bars represent 
50~m. 
3.3 Discussion 
3.3.1 Role of shh in development and establishment of the ADHl3rd ventricle 
The function of shh expression at the ADH is still poorly understood. It was 
demonstrated that Shh at the ADH is required for the patterning and eventually the 
maintenance of Prolactin (PRL)-secreting cells in the adenohypophysis67• The ADH 
also demarcate the border between the prethalamus and hypothalamus of the 
developing embryo 69.91. In result chapter 1 (Figure 1.1), I have demonstrated that 
shh expression is maintained in the ADH at least until 100 hpf in the zebrafish 
embryos. The data in Figure 1.7, shows the co-localized expression of shh and rx3 
at that ADH suggesting that shh might play an important role in the development 
and establishment ofthe ADH along with rx3. Data in the previous chapter shows 
the regulation of shh expression at the ADH by rx3; loss of rx3 function in the ADH 
led to the diminished shh expression in the ADH. As discussed in the same chapter, 
the result suggests that rx3 acts upstream in a cell-autonomous fashion to regulate 
the expression of shh in the ADH. Through this chapter, I tested if Shh can act to 
regulate the expression of rx3. Interestingly early blockade of Shh signalling led to 
a reduced expression of rx3 in the ADH, but a late blockade show a maintained but 
mis-patterned expression of rx3 at the 3rd ventricle. These suggest that Shh and 
rx3 exert regulatory effects on each other through a feedback loop during the 
specification of the ADH. The loop inter-regulation between Shh and transcription 
factors that patterns the eNS has been documented in the neural tube7 and my 
data suggest that a similar mode of regulation between Shh and rx3 in the ADH. 
The early role for Shh in the development of the ADH is consistent with a study13 
that reported a reduced ADH domain identified through rx3 expression in the smu 
mutants analysed at 28 hpf. Interestingly, they also reported an expansion of emx2 
expression suggesting the ventro-posterorisation of the anterior hypothalamic 
region in the absence ofShh signalling. Interestingly, the latter finding is also 
consistent with my data that shows an increase in both expression and domain of 
emx2 in the PVH. Altogether, shh appears to have different temporal roles that 
together are crucial for the proper development and establishment of the ADH. The 
reduction in pomc positive cells after reduction in Shh signalling could, therefore, 
be a consequence of the mis-specification of the ADH and its surrounding tissue 
104 
including the arcuate nucleus However, I cannot exclude the possibility that Shh 
(along with rx3) plays a role in promoting the differentiation of neural progenitor 
cells towards the pame cell fate. 
3.3.2 shh is required for the specification ofNPCs to the !Jame cell fate 
Similar to the loss of rx3 function (Chapter 2), the loss of Shh signalling sees a 
perturb development of functional cells at the region ventral to the ADH (i.e the 
arcuate nucleus) through the failure of cells to be specified and differentiate 
towards the terminal neuronal fates (i.e. pame positive cells). The accumulation of 
sax3 positive cells along in regions along the ventricle as shown in Figure 3.58 
reflects; i) the p~steriorisation ofthe anterior hypothalamus or the expansion of 
the PVH region at the expense of the AD H, and ii) failure of neural progenitor cells 
(NPCs) to be specified to neurons that could include the neurosecretory neurons at 
regions around the ADH including pame positive cells in the arcuate nucleus. It can 
be postulated from evidence presented in this chapter that Shh from the ADH 
might be non-cell autonomously specifying the NPCs to the pame cell fate. 
However, the possibility remains that Shh might be negatively regulating the 
maintenance of the NPC population and not directly involved in the pame cell 
specification. The blockade of Shh signalling led to the increased in the NPC 
number reflected by the increase in sax3 as well as isl1 expressions. 
3.3.3 Loss of anterior hypothalamic domain affects the optic nerve development 
Attenuation of shh signalling at the latter stage also affected the development of 
the optic nerve through the loss of the descussating optic chiasm as reflected in the 
loss of zic2a expression (Figure 3.3). This would normally suggests a loss of 
peripheral vision with the retention of central vision in the affected embryos92. 
This condition is better known as 'tunnel-vision' and it will be exciting to see ifthe 
embryos really do develop this condition and ifupregulating Shh signalling is 
sufficient to rescue this phenotype. The optic chiasm can be found antero-dorsal to 
the hypothalamus and is an evolutionary conserved structure in vertebrates. 
Closer observation shows that the loss of zie2a expression that labels for the optic 
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chiasm may have been caused by the loss of the anterior hypothalamic region. 
Therefore, Shh signalling is also required for the maintenance of the anterior 
domains of the hypothalamus in the forebrain. 
In summary, it was demonstrated through this chapter that the inhibition of Shh 
signalling in the early phase affected the development of the ADH region seen 
through the drastic reduction of rx3 expression, but inhibition at a later stage 
affected the patterning of the ADH and 3rd ventricle as seen through rx3 
expression. As discussed above, these suggest that Shh and rx3 operate in a 
feedback loop to mutually regulate/control the expression of each other. More 
importantly, the inhibition of Shh signalling saw the reduction of pomc expressing 
cells in the arcuate nucleus as hypothesised in the preceding chapter. 
Concomitantly, an accumulation of progenitor cells labelled by sox3 and early born 
neurons by isl1 was also observed. Together these data suggest that Shh and rx3 
acts to specify and promotes the differentiation of the progenitor cells towards the 
pomc cell fate in the arcuate nucleus. 
In the next chapter, I will investigate the interaction between rx3 and Fgf signalling 
based on the data reported in result chapter 1. 
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Figure 3.6 : Summary cartoon highlighting the key changes in the cyc-t embryo compared to the control 
treated embryo. Reduced ADH domain is observed concomitant with the mis-patterned expression of 
rx3 . Concomitantly, an expansion of the PVH marker emx2 is also seen. Similar to the rx3 morphant, a 
reduced number of pomc positive cells is observed in the cyc-t embryos. 
Chapter 4 
Chapter 4: Fgf acts upstream of rx3 to determine the number of pomc positive 
cells 
4.1 Introduction 
My expression analyses in chapter 1 show expression offgf3 in the PVH (Figure 
1.4). The ETS-transcription factor pea3 is also expressed broadly in the PVH, but, 
additionally, shows a partial overlap with rx3 in the AOH (Figure 1.80). As 
described in chapter 2, the loss of rx3 function in rx3 morphants does not result in 
the loss offgf3 nor pea3 indicating that rx3 does not regulate the expression offgf3 
nor thefgfsignalling pathway. Thus, the reduction in rx3, and its potential effects 
mediated through reduction in Shh signalling, appears not to affect Fgf signalling. 
Nonetheless, this does not preclude a role for Fgf signalling in the regulation ofrx3; 
Fgf could operate upstream of rx3. 
Fgfs are key signalling molecules involved in the proliferation and differentiation 
of an array of tissues. They play a key role in early embryonic patterning and in the 
later specification of particular organs93• For instance, Fgfs govern proliferation of 
neural progenitor cells in the embyronic neural tube94, and are key drivers oflimb 
bud development in vertebrates95, and fin development in zebrafish96• In the 
forebrain,fgfsignalling has been implicated in the development of the 
adenohypophysis (the anterior pituitary) through studies performed in the 
zebrafish embryo64. In the hypothalamus however, the role of Fgfs is still very 
poorly understood compared to their role in the development ofthe pituitary. In 
the mouse, Fgfl0 has been implicated in the control of hypo thalamic neural 
progenitor cells66• However, in zebrafish, FgflO is not expressed in the forming 
hypothalamus as see in result chapter 1. 
To begin to examine if Fgf interact with rx3 in the hypothalamus, I tested whether 
Fgf signalling governs rx3 expression and through it, its affect the number of pomc 
positive cells in the arcuate nucleus. To do so I used the chemical SU5402, which is 
an established Fgf signalling pathway inhibitor, to inhibit Fgf signalling in the 
zebrafish embryos. SU5402 works by binding to and inhibiting the tyrosine kinase 
domain of Fgf receptors, thus preventing Fgfs from signalling97• Like cyclopamine 
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(used in the previous chapter) SU5402 allows for the temporal inhibition ofFgf 
signalling in the zebrafish embryos, which bypasses any potential patterning 
defects from mutant embryos such as the lia or [gj3 mutant line98• 
4.2 Results 
4.2.1 Loss of (gfsignalling through SU5402 reduces the expression of rx3 and the 
number of pomc positive cells. 
To inhibit the activity of Fgfs in the hypothalamus, I treated zebrafish embryos 
with SU5402 at stage following the late cyclopamine treatment regime as 
described in result chapter 3 and analysed them at 55 hpf (refer to Materials and 
Methods for more details). To analyze the efficacy of the SU5402 treatment, I 
studied the expression of pea3 in SU5402 treated embryos (SU embryos), which, as 
described previously, is commonly used as the molecular read-out for Fgf 
signalling. My results show a significantly reduced expression of pea3 after SU5402 
treatment (Figure 4.1B). 
I next examined whether the reduction in Fgf signalling governs rx3 expression in 
the 3rd ventricle where rx3 is expressed at 55 hpf. In SU-treated embryos I detected 
much-reduced expression levels of rx3 in the 3rd ventricle, compared to control-
treated embryos (DMSO treated) (Figure 4.1C,D). To examine whether the 
decrease in rx3 expression affected pomc expressing cells, I performed pomc ISH 
on SU-treated embryos. Consistent with the data reported in chapter 2, suggesting 
a requirement for rx3 in differentiation to the pomc cell fate, the number of pomc 
positive cells was reduced in the SU embryos (Figure 4.2A,B) in which the 
expression of rx3 is reduced and its function is compromised. Similar to that 
reported in chapters 2 and 3, the inhibition of Fgf signalling pathway affects the 
pomc positive cells in the arcuate nucleus. However inhibiting Fgf signalling also 
seems to have an effect on the expression of pomc positive cells in the 
adenohypophysis as well. 
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Figure 4.1 : rx3 expression is reduced in SU5402 treated embryo. (A,S) 
Levels of pea3 expression is significantly decreased after SU5402 
treatment. (C,D) Expression of rx3 is reduced in the 3rd ventricle of the 
SU5402 treated embryo. All embryos are viewed laterally with C,D 
showing only the hypothalamus. ctrl, control treated embryo. Scale bars 
represent 50 !J.m. 
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Figure 4.2: The number of pomc and phos-H3 positive cells are reduced 
in SU5402 treated embryos. (A,B) Anterior view of the hypothalamus 
showing the reduction of pomc positive cells in the arcuate nucleus (white 
circle). Graph representing the reduction of pomc positive cells (E). (C,D) 
Lateral view of the hypothalamus showing a reduction in proliferating 
progenitor cells in the hypothalamus (phos-H3 positive) can be seen after 
SU5402 treatment. (F) Graph representing this reduction. Scale bars 
represent 50 !-lm. 
4.2.2 Fgfs controls the number of proliferating cells in the hypothalamus 
Proliferating cells in the embryonic zebrafish hypothalamus are found distributed 
along the ventricular region of the 3rd ventricle and are mainly found within the 
rx3 expression domain in 55 hpf embryos. Since the expression of rx3 is reduced 
when Fgf signalling is inhibited by SU540 2, I investigated if this would affect the 
proliferating cells. To detect these, I used phos-H3 antibody similar to that used in 
chapter 2. The data obtained show a decrease in the number ofphos-H3 labelled 
cells in the hypothalamus including the 3rd ventricle of SU embryos compared to 
the control treated embryos (Figure 4.2C,0). 
4.2.3 Oyerexpression of (gf3 
Temporal inhibition of the Fgf signalling pathway through SU5402 resulted in the 
decreased expression of rx3 as well as pomc in the arcuate nucleus. The number of 
proliferating cells labelled by phos-H3 is significantly reduced as well. As described 
in result chapter 1, the expression offgj3lies in close proximity to the AOH and the 
arcuate nucleus at 30 hpf. To investigate if Fgf3 can induce the expression of pomc 
cells at the arcuate nucleus given its close proximity of expression, I employed the 
use of the inducible fgj3 hypermorphic mutant (kindly shared by Dr. Henry Roehl, 
COBG). This mutant carries the hypermorphicfgj3 gene driven by a heat-shock 
promoter, which will allow a temporal activation of the fgJ3 gene through 
incubation ofthe embryos at 380 C (please see Materials and Methods for more 
details). This method allows for the increase in Fgf3 to be controlled temporally. 
To test if the Fgf3 signalling pathway is overactivated as a result of the increase in 
Fgf3 levels, I analysed the expression of pea3 and the data shows an increase in the 
mutant heat-shock embryos (Figure 4.38). Interestingly, an increasedfgj3 
signalling does not show a significant change in the number of pomc expressing 
cells at the arcuate nucleus (Figure 4.3C,0,E). The number of pomc positive cells is 
similar between the SU embryos and the control treated embryos. 
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Figure 4.3: No change In the number of pomc expressing cells in the arcuate nucleus 
of the hsp::fgf3 mutant embryo. (A,B) pea3 expression level is increased in the hsp::fgf3 
embryo. (C,D) The increase Fgf3 signalling activity did not affect the expression of pomc. 
(E) Graph representation of C,O. Scale bars represent 50 !-lm. 
4.3 Discussion 
4.3.1 Fgfmaintains rx3 expression in the hypothalamus 
The role offgfs at the hypothalamus is still poorly understood and its role in the 
specification ofthe ADH and 3rd ventricle has not been described before. The data 
provided in this chapter clearly suggest an important function for Fgf signalling in 
regulating the expression of rx3 in the hypothalamus. When Fgf signalling is 
attenuated in the embryos through SU5402 following the described regime, rx3 
expression is downregulated in the 3rd ventricle and the effects of this is seen in 
the reduced numbers of pomc positive cells in the arcuate nucleus. This supports 
the hypothesis that rx3 is required for pomc positive cells specification as 
discussed in Chapter 2. It will be interesting to investigate if the reduction of Fgf 
signalling at an earlier stage (Le. 10-30 hpfregime with SU5402) would have an 
effect on rx3 expression in the ADH to address the question if Fgfs regulates the 
expression of rx3 at the ADH. Given the time limitations on completing this thesis, I 
have tested the above regime once and using the same concentration of SU5402 
(Le. 5 gm) but found that the forebrain embryos were deformed to the extent of 
preventing further analysis. To address this, a lower concentration of SU5402 
might be required to inhibit Fgf signalling without much deformity. The reduction 
in rx3 expression suggests that Fgf acts upstream and is required for either the 
transcriptional initiation of rx3 or the maintenance of rx3 expression. However, as 
the embryos were only treated with SU5402 following the 30-55 hpf regime, the 
data above more accurately reflects a role of Fgfs in the maintenance of rx3 
expression at the 3rd ventricle. 
I have showed through chapter 1 thatfgp is expressed in a close proximity to the 
ADH / 3rd ventricle where rx3 is expressed and the arcuate nucleus. Although it 
might be tempting to postulate that Fgf3 is the functional Fgf acting upstream of 
rx3, it cannot be concluded that Fgf3 is the only Fgf responsible for the observed 
loss of rx3 expression in the SU-embryos as above. This is based on the fact that 
there are 25 fg/genes in the zebrafish and the possibility remains that there might 
be other fgfs apart fromfgp (exceptfgf8 andfgflO) that might be expressed at, 
near and influence the expression of rx3. It is hence worth investigating if there are 
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other fgfs that are expressed in the or in regions adjacent to the ADH/3rd ventricle 
that could potentially be regulating the expression of rx3. It will also be interesting 
to see if the overexpression of Fgf3 using the hsp::fgJ3line have an effect on the 
levels of rx3 expression to further substantiate the requirement for Fgf3 in 
regulating the expression of rx3 in the hypothalamus. 
4.3.2 Fgf controls proliferation of progenitor cells 
There are published evidence to suggest a role for Fgfs in promoting the 
proliferation of neural progenitor ceIIs99.100. Evidence provided in this chapter 
suggests a similar role for fgfs in the control of progenitor cells proliferation in the 
hypothalamus as well. The disappearance of phos-H3 positive cells throughout the 
entire hypothalamus suggests that the function of fgfs is not domain restricted 
when control of proliferation is involved. Hence the function of fgfs on the 
proliferation process can be uncoupled from its regulation of rx3 expression 
maintenance in the hypothalamus. 
4.3.3 Fgfs regulates [Jame population in the arcuate nucleus as well as in 
adenohypophysis 
As shown in the results, the downregulation of rx3 expression in the 3rd ventricle of 
SU embryos affected the number of pame positive cells. The data in Figure 4.2 
shows a reduced number of pame positive cells in the SU embryos, corroborating 
.. 
the data and evidences provided in Chapter 2 that highlights the requirement for 
rx3 in the specification of pame positive cells in the arcuate nucleus. This 
observation strongly suggests a requirement of Fgf signalling for rx3 cell 
expression, which in turn is required for the specification of pame positive cells in 
the arcuate nucleus. Intriguingly however, the attenuation of Fgf signalling also. 
affected the pame positive cells in the adenohypophysis of the SU embryos. The 
pame positive cells appear clustered and reduced in overall number at the 
adenohypophysis consistent with a previous study in the zebrafish, which 
demonstrates the reduced population of pame expressing cells at the 
adenohypophysis ofthefgJ3 mutant fia, demonstrating the requirement for fgJ3 in 
establishing pomc positive cells at the adenohypophysis64. They nevertheless 
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reported a normal expression of pomc in the arcuate nucleus but did not provide 
any quantitative evidence (Le. the number ofpomc positive cells), which may 
explain their failure to detect the changes in the number pomc positive cells at the 
arcuate nucleus as shown in Figure 4.2. The effect seen in both the pomc positive 
populations in the arcuate nucleus as well as the adenohypophysis in the lia 
mutant supports the argument for a role of Fgf3 in the regulation of pomc cells. It 
also suggests a wider role for Fgf3 in the regulation of pomc expression in both the 
arcuate nucleus and the adenohypophysis that have not been previously described. 
Of course the possibility remains that Fgfs in particular Fgf3 may be non-
autonomously regulating the pomc positive cells independently from its upstream 
regulation of rx3. To address this question, a rescue experiment is required 
whereby rx3 mRNA can be injected into one-cell stage lia mutant embryos to see if 
the number of pomc positive cells in the arcuate nucleus (apart from the 
adenohypohysis) can be rescued to their normal levels. 
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Figure 4.4: Summary cartoon describing the key differences in SU5402 treated embryo 
compared to the control embryo. Expression of rx3 is significantly reduced. Loss of pomc 
cells and proliferating progenitor cells is also observed in the SU5402 treated embryo. 
Chapter 5 
Chapter 5: Maintenance ofshh andfgfexpression in the adulthypothalamus 
and role in regulating neural stem/progenitor cells 
5.1 Introduction 
In the previous chapters, I have shown the expression of shh andfgfs in the 
embryonic hypothalamus and demonstrated that they play a role in the 
development/patterning of the anterior dorsal hypothalamus and differentiation 
of cells in the arcuate nucleus. I next wished to study if these signalling molecules 
continue to be expressed in the hypothalamus of the adult zebrafish and whether 
they may play roles in the adult. In this final results chapter, I analysed the 
expression profiles of shh andfgf3 in the adult medial hypothalamic region, where 
a recently-characterised population of neural stem/progenitor cells are believed to 
reside in other speciesso• I wished to determine, first and foremost, whether I could 
identify this niche in the medial hypothalamic region of the adult zebrafish 
hypothalamus and second, to assess whether there might be a role for Shh and Fgfs 
in the behaviour of cells within the niche. Since there are no established markers 
that allow for the distinction of neural stem cells from neural progenitor cells in 
the zebrafish, this analysis did not attempt to distinguish between them, and 
throughout, I will use the abbreviation NPCs to represent both cell types. 
In the mouse and the rat, NSCs and NPCs are restricted to the medial hypothalamic 
region, in a region lying just dorsal to the median eminence, a region that forms the 
boundary between the hypothalamus and the anterior pituitary. The zebrafish 
adult hypothalamus shows marked differences to the adult mammalian 
hypothalamus. First, as described in section 1.3.2, the median eminence does not 
exist in the adult zebrafish. Second, two lobes (superior and inferior) are found in 
the adult zebrafish hypothalamus, and it remains unclear how these relate to 
defined structures in the hypothalamus of adult mammals (Figure S.lA). However, 
I wished to determine whether, despite these differences, a NPC niche does exist in 
the medial hypothalamus of the adult zebrafish. Given the fact that neurogenesis 
can occur in the adult fish, I also 
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Figure 5.1: Schematic view of the adult zebrafish brain. (A) Lateral view showing the hypothalamus at the ventral diencephalon 
(a) superior, (b) inferior lobes of the hypothalamus. (8) Anterior view of the medial hypothalamic section obtained through the 
sectioning plane of the adult brain as shown in A. LR; lateral recesses of the 3rd ventricle 
wished to determine whether I could find evidence to suggest the birth of neurons 
from the neural stem cell niche (Le. neurogenesis) in this region. I focused in 
particular on neurons that might give rise to those in the lateral tuberal nucleus 
(LTN), proposed as the homologue of the mammalian arcuate nucleus101.10Z. In the 
zebrafish, the LTN is located at the ventral most region of the medial 
hypothalamus101• This region is the focus of my investigation in this chapter. 
In order to analyse the role of Shh in the behaviour of NPCs, I established a novel 
technique, attenuating Shh signalling in the adult zebrafish using cyclopamine. 
5.2 Results 
5.2.1 Expression of shh and [gf3 
The medial hypothalamic region in the adult zebrafish can be bilaterally divided 
into different domains around the 3rd ventricle, the ventricular zone and the 
periventricular zone; in addition, a dorso-ventral axis can be recognised (Figure 
5.1). The identification and recognition of these domains in my data is based on 
published work describing similar regions in the adult zebra fish brain and 
hypothalamus103, 104. Analysis of shh expression in tissue sections (sectioning plane 
is shown in Figure S.lA) ofthe medial hypothalamus of the adult zebrafish shows a 
highly restricted expression of shh in the ventral domain of the ventricular zone 
(Figure S.2A). shh expression is not detected elsewhere within the medial 
hypothalamus. By contrast expression of /g13 is restricted to the dorsal domain of 
the ventricular zone, and appears to precisely abut the expression of shh (Figure 
5.28). IntriguinglyJg13 appears to be expressed asymmetrically, one side showing 
more/g13 expression dorsally (arrowhead Figure S.2B). 
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Figure 5.2: Distribution of shh and fgf3 expressions in the adult medial hypothalamic section. (A,8) shh is expressed 
at the ventral regions of the medial hypothalamus and (g(3 is expressed dorsally to the expression of shh. (g(3 appears 
to be expressed asymmetrically; its dorsal most tip (arrowhead in 8). (C) Cartoon showing the abutting expressions of 
shh and (g(3 lining the 3rd ventricle (3V) and shh expression adjacent to the NLT. (A-C) Dorsal is up, ventral is down; 
all sections are viewed anteriorly. Scale bar represent 20 ~m. 
5.2.2 Identifying NPCs in the medial hypothalamic region 
As outlined in this chapter's introduction, the medial hypothalamic region of the 
mouse has recently been shown to harbour a NSC/ NPC niche in the ventricular 
zone of the 3rd ventricle49·51• 105. To study whether the shh or [gf3 positive regions 
that I identified in the adult zebrafish may form part of a niche for NPCs, I 
examined the expression of Nest in in the medial hypothalamic region, through the 
analysiS of GFP in a nestin promoter-driven GFP expressing zebrafish106• The result 
shows a very clear and distinct expression of Nest in at the ventricular zone of the 
medial hypothalamus (Figure 5.3C). Interestingly, Nestin appears to be expressed 
in a similar region to that of shh, i.e. in the ventral region ofthe medial 
hypothalamus. A closer observation ofthe Nestin expression reveals basally-
extending projections emanating from the Nestin positive cells at the ventricular 
zone towards the ventral periventricular region (red arrowheads in Figure 5.3C). 
Thus, the Nestin positive cells have the appearance of radial glial-like tanycytes, 
that in the mouse and rat, have been shown to exhibit NSC and NPC 
characteristics46. 52. To investigate if the Nestin positive NPCs in the zebrafish are 
capable of proliferation, I analysed the expression patterns of MC MS and BrdU, 
which label late Gl phase and S-phase ofthe cell cycle, and hence can identify 
proliferating N PCs. These analyses reveal that a population of proliferating N PCs 
labelled by MCM5 and BrdU exist within the Nestin positive and shh positive 
expressing domain (compare Figures 5.2 and 5.4). Some ofthe proliferating cells 
are labelled positive for both BrdU and MCM5 (arrowhead Figure 5.4H'). I 
-. 
simultaneously performed an analysis of the distribution of MC MS and BrdU 
positive cells along the antero-posterior axis of the zebrafish hypothalamus. This 
data shows that the vast majority of these cells are found in the medial 
hypothalamus consistent to what have been described in the mouse and rat. A few 
BrdU and MCM5 positive cells can be found in the posterior hypothalamus, but 
none can be found in the anterior hypothalamus (Figure 5.4). (I was not able to 
able to perform BrdU injections into nestin::GFP line as it was still not permitted 
under Home Office regulations at the time of writing of this thesis.) 
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Figure 5.3 : Identification of neural stem cell niche and early born neurons through Nestin::GFP labelling and Hue/D. (A) DAPI 
labelling of cells showing the ventricular region where Nestin is expressed and not Huc/O (compare white arrowheads in A,B,e 
and E).(C) Nestin expression indicating the presence of neural stem cells in the ventral region. Projections are seen to emanate 
from the Nestin positive cells to the periventricular region suggesting a glial identity of these cells (red arrowheads). (D) 'Early 
born neurons labelled by Huc/O exist at the periventricular region adjacent to the Nestin positive cells and do not exist at all at 
the ventricular zone. (E) No Huc/D positive cells can be seen at the ventricular zone where Nestin positive neural stem cells are 
residing. (A-E) All images are left-side transverse view of the medial hypothalamus as described in F (green box represents 
Nestin ; red triangle represents Huc/O). Scale bar represent 10 J.lm. 
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Figure 5.4 : Distribution of proliferating NPCs in the hypothalamus labelled by MCMS and BrdU. A majority of these cells are 
found in the medial hypothalamic region (E-H). (I-L) Few proliferating cells can be found at the posterior hypothalamus, but 
Ire found at the anterior hypothalamus (A-D). All images are transverse view of the medial hypothalamus. 
)ar represent 50 !Am. 
As outlined above, the Nestin positive cells have long basally-extending processes, 
suggesting they may be tanycytes. To confirm this, I analysed the expression of the 
tanycytic marker, Vimentin. My data reveals that cells positive for Vimentin are 
present in the medial hypothalamic region lining the ventral ventricular zone 
(Figure 5.5C) similar to that shown in the mouse (Figure 5.5]). Comparison of 
vimentin-Iabelling with Nestin-GFP suggests that they are expressed in similar 
domains and might even be expressed by the same cells. Technical difficulties 
currently prevent double labelling ofVimentin and Nestin-GFP as explained in the 
Discussion below. Additionally, double labelling ofvimentin and MCM5 shows the 
distribution of proliferating cells within and dorsal to the vimentin expressing 
domain (Figure 5.5D,D'). Together, these observations show that similar cells are 
found in the zebrafish to those found in the mouse, and suggest the presence of a 
NPC niche in the medial hypothalamus of the zebrafish. 
5.2.3 Neurogenesis at the medial hypothalamic region 
In addition to examining markers that allowed me to identify the NPC niche, I also 
investigated if the NPCs have the potential to undergo neurogenesis. To do this, I 
analysed the expression of the protein HuC/D, which is expressed in newly born 
neurons and immature neurons. I did this by performing double immunolabelling 
of HuC/D along with, first Nestin, then MCM5. The double labelling of HuC/D and 
Nestin (through GFP labelling) clearly shows early born neurons (HuC/D positive) 
at the medial hypothalamus adjacent to but not overlapping with, Nestin positive 
.. 
neural stem cells (Figure 5.3D). Comparison of Figures 5.3 A,8,C and E (white 
arrowheads), shows DAPI/Nestin positive NPCs in the ventricular zone and shows 
that these do not express HuC/D. Early born neurons derived from NPCs would 
eventually lose their capability to proliferate after undergoing neurogenesis. I 
investigated if this is true for the HuC/D cells observed by performing double 
labelling with MCM5. The majority of MCM5 positive cells are found close to the 
VZ, with far fewer in HuC/D positive cells. MCM5 expression in HuC/D cells 
appears to be restricted to those closest to the VZ, that are most likely to be 
proliferating progenitors (Figure 5.5G,H,H'). 
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Figure 5.5 : Tanycytic cells can be found in the medial hypothalamic region. (C) These cells are labelled by Vimentin and 
reside at the ventral most region (boxed); blown up in C (D) Distribution of proliferating cells labelled by MCM5 (B) are observed 
within the same region as the tanycytes (0'). (E-H) Early born neurons labelled by HuC/O do not express the proliferating 
marker MCM5. The cells located closest to the ventricular zone show highest expression of HuC/D (H') whilst cells farthest 
away show the weakest expression and resemble fully-developed neurons showing neurite outgrowth (H':HIII ). Scale bar 
represent 50 f..lm. 
Further away, cells weakest in HuC/D expression are beginning to resemble 
mature neurons, exhibiting neurite outgrowth (Figure 5.5 H",H"'), 
The molecular marker, zashla labels cells undergoing neurogenesis in the CNS of 
the zebrafish. To confirm that NPCs might undergo neurogenesis, I performed 
zashla ISH on the medial hypothalamic section and found thatzashla is expressed 
in cells at the ventricular zone in a 'salt-and-pepper' distribution (Figure 5.51). Its 
expression lines the ventricle and appears to be expressed in cells lining the lateral 
recesses as well (arrowheads Figure 5.51). 
5.2.4 Attenuation of Shh signalling affects proliferation 
As described in the previous sections, shh is expressed in ventral cells lining the 3rd 
ventricle, i.e. in the region where NPCs can undergo proliferation and 
neurogenesis. I therefore wished to examine if shh exerts any control on the 
behaviour of the NPCs at the medial hypothalamic of the adult zebrafish. In the 
embryonic neural tube and adult neural stem cell niches ofthe dentate gyrus and 
subventricular zones, Shh is known to govern cell proliferation. I therefore 
hypothesised that Shh may govern the proliferation of NPCs in the adult zebrafish 
medial hypothalamus. To investigate this, I innovated a novel way to attenuate Shh 
signalling in the adult zebrafish as detailed in the Materials and Methods chapter. I 
employed the use of cyclopamine in the adult zebrafish through intraperitoneal 
injection (IP). As outlined in the chapter introduction, the need for this stems from 
-. 
the fact that there are no inducible mutants that would allow for Shh signalling to 
be genetically attenuated in the adult zebrafish. 
To validate if the method worked and if cyclopamine could attenuate Shh signalling 
in the adult, I analysed expression of ptel in the medial hypothalamus. Excitingly, 
the result shows a robust and consistent reduction of ptel in the hypothalamus of 
adult zebrafish treated with cyclopamine compared to controls that were ethanol 
treated (Figure 5.6) (both n=5). However, this effect might not be specific to the 
hypothalamus since lP-injected cyclopamine is distributed throughout the 
zebrafish via the bloodstreams. I proceeded to study if the 
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Figure 5.6: The levels of ptcl is significantly decreased in the medial hypothalamus of the cyclopamine 
injected zebrafish. (A,B,D,E) Double labelling through ptcl in situ hybridisation and BrdU immunohisto-
chemistry shows the reduction of BrdU labelled cells concomitant with the reduction in ptc1 expression 
levels. (C) Enlarged merged images of A and B. (F) Enlarged merged images of D and E. All sections are 
transverse view of the medial hypothalamus. Scale bar represent 50 ~m. 
proliferation ofthe NPCs is affected by examining markers ofG1 and S phase. 
These results showed that both MCM5 and BrdU showed a significant reduction in 
the medial hypothalamus of cyclopamine-treated fish (Figure 5.6B,E and Figure 
5.7). Statistical analyses reveal a 75% decrease in BrdU+ cells and a 40% decrease 
in G1-phase cells (Figure 5.6D,H). 
5.3 Discussion 
5.3.1 NPCs exist in the medial hypothalamus of the adult zebrafish 
The data detailed in this chapter show that NPCs exist in the adult zebrafish 
hypothalamus, and are largely restricted to the medial hypothalamic region. This is 
the first characterisation of NPCs in the adult zebrafish hypothalamus, although the 
existence of this niche has been proposed before, along with several other 
uncharacterized NPC niches in the adult zebrafish brain47• Almost all of our 
knowledge on NPCs in the adult hypothalamus stems from research in the mouse. 
One of the key issues limiting research on NPCs in the hypothalamus of the adult 
mouse is the difficulty in detecting cell proliferation in situ under endogenous 
conditions. However, emerging evidence (as outlined in the Introduction) is 
beginning to show that there are indeed proliferating stem and progenitor cells in 
the medial hypothalamic region of the adult mouse, but that these proliferate at a 
low rate compared to the adult zebrafish 52• 
In the adult zebrafish, progenitor cell proliferation (Le. MCM5 and BrdU positive 
cells) can be detected without difficulty in the medial hypothalamus, as shown in 
this chapter, suggesting that NPCs in this region do normally proliferate. Clearly, 
more work needs to be performed in order to fully demonstrate the existence of a 
NSC-containing niche: to qualify as a neural stem cell niche, one needs to 
demonstrate the ability of cells to give rise to newly born neurons or glia (Le. 
multipotency). The data in Figures 5.3 and 5.5 indicates the ability ofthe NPCs in 
the medial hypothalamus to give rise to newly born neurons, labelled by HuC/D. 
However, a more elaborate demonstration is required before this niche can be fully 
established as a functional neural stem cell niche in the adult zebrafish 
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Figure 5.7: Reduction of proliferative cells in cyclopamine injected adult 
zebrafish. (A-C) Vehicle (ethanol) injected. (E-F) Cyclopamine injected. (D,H) 
Graph representing the reduction in BrdU and MCM5 labelled cells in Vehicle 
and Cyclopamine injected zebrafish. Both the reductions are statistically 
significant. Scale bar represent 50 !J.m. 
brain. This includes demonstrating that NPCs in the niche are multipotent, and can 
give rise to both newly born glial-cells as well as neurons. Such a demonstration 
could result from detailed lineage tracing experiments, to trace the NPCs from the 
multipotent state through differentiation into fully functional neurons or glia. This 
could be achieved through the genetic labelling of the neural stem cells using a 
neural stem cell marker gene (Le. nestin) driven by a detectable tag (i.e. GFP or 
Kaede). Labelled neural stem cells would ideally retain the expressed tag although 
nestin is no longer expressed, throughout the process of differentiation and 
maturation into functional neurons or glias allowing for the lineage tracing of the 
neural stem cells to its terminal differentiation. The Nestin-GFP line used in this 
thesis is not suitable for lineage tracing since it was designed to produce a fusion 
Nestin-GFP protein product (Le. in-frame exonic fusion of the GFP into the Nestin 
ORP06) that would degrade when Nestin is no longer expressed and functional in 
the cells (Le. early neuronal cells). 
The expression of the pro neural gene zashla close to the ventricular zone of the 
medial hypothalamus provides additional evidence that NPCs undergo 
neurogenesis to differentiate towards neuronal fates. The basic helix-loop-helix 
(bHLH) transcription factor zashla is the homologue ofthe achaete-scute gene of 
D.melanogaster that is required for neurogenesis107 and its expression in the post-
embryonic brain has been demonstrated to exist in similar regions to Mashl (the 
homologue gene) in the mouse108 allowing for direct comparison for the gene 
expression and function between the zebrafish and the mouse. In the mouse, 
Mash1 has been shown to promote the differentiation of committed neural 
progenitors109 and is required for neurogenesis in the adult rat dentate gyrus after 
transient forebrain ischemiallo. Mashl is detected in the adult mouse 
hypothalamus, and a study has shown the role of Mash 1 for neurogenesis and 
specification of functional neurons in the developing mouse hypothalamusll1 . My 
evidence for zashla expression in the medial hypothalamus ofthe adult zebrafish 
is the first demonstration of hypo thalamic expression of this gene in the fish, and 
suggests a role for zashla gene in neurogenesis in the adult vertebrate 
hypothalamus. Further investigation to corroborate the above would require a 
temporal zashla gene knockout that could be achieved through the Cre-Lox 
inducible system112• 
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5.3.2 Tanycytes as the potential neural stem cells in the hypothalamus 
A key and fundamental issue in neural stem cell biology is the ability to pinpoint 
the exact identity of the neural stem cells. In the medial hypothalamus, NPCs or to 
be more specific neural stem cells are regarded to exist at the cell walls in the 
ventricular zone lining the 3rd ventricle. The 3rd ventricle, together with an 
abundant supply of portal capillary vessels in the close vicinity, potentially serve as 
primary sources of signalling and growth factors that might be required for the 
neural stem cells to proliferate, self-renew and maintain their niche. Tanycytes are 
the likely candidates to serve as neural stem cells since they morphologically 
resemble the radial glia cells, which are the neural stem cells in the embryos and 
has been demonstrated in the adult rat to display characteristics of neural 
progenitor cells46. Tanycytes are neurosecretory neurons that have basal 
projections and contact blood vessels in the median eminence, but some ofthese 
are believed to retain multipotency and neurogenecity46. They are thought to be 
the mature and functional version of the radial glia cells in the adult brain. I hence 
investigated ifthe adult zebrafish hypothalamus harbours any tanycytic cells and 
showed that there are indeed tanycytes located at the ventral region of the medial 
hypothalamus. These cells are positive for Vimentin (an intermediate filament 
protein) and appear to be lining the 3rd ventricle with projections into the 
periventricular zone probably making contacts with the blood vessels. These 
features are consistent with the description oftanycytes in the adult mouse and rat 
hypothalamus albeit the non-existence of the median eminence in the zebrafish. 
Although my data is the first to show the existence oftanycytes in the adult 
zebrafish brain, it is definitely not the case for the wider teleosts as the existence of 
tanycytes has been reported before in the teleost Clarias batrachus-like113• 
Suprisingly, the tanycytes were reported to be in the median eminence of the 
Clarias batrachus-like which is atypical of the teleosts. 
In the mouse, tanycytic neural stem cells express both Vimentin and Nestin114.11S• 
In fact, Nestin has been shown to be able to interact and form heteropolymers with 
vimentin116• In this chapter, I have shown that Nestin-expressing cells exist in the 
same domain as the tanycytes (Le. Vimentin positive cells) in the ventro-medial 
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hypothalamus. The Nestin positive cells even exhibit tanycytic-like projections 
towards the ventral periventricular region as well. Although this strongly suggest 
similar identities between the tanycytes and Nestin positive neural stem cells, it 
does not conclusively prove that they are the same cells. Demonstrating this would 
require double immunolabelling of GFP and Vimentin that I have not yet 
performed. Vimentin detection requires an antigen-retrieval technique, where the 
tissue sample is first treated with sodium citrate at 95 0 C prior to labelling. This 
treatment itself degrades the GFP antigen in the tissue making it extremely difficult 
to detect Nestin-expressing cells. Nevertheless I am now currently experimenting 
with different techniques to try and achieve this, 
As shown in Figure 5.4, proliferating cells labelled by MCM5 are found 
interspersed with Vimentin-expressing cells, suggesting the possible derivation of 
MCM5-positive cells from the tanycytes. It is difficult to observe if the tanycytes 
themselves are labelled with MCM5 at this resolution since Vimentin do not label 
the cell nucleus. Nevertheless tanycytes are believed to be quiescent neural stem 
cells that are not actively proliferating117, hence eliminating the possibility to 
detect tanycytic cells that label positive for both MCM5 and Vimentin. It will be 
interesting however to detect if the tanycytes show the expression of GO cell phase 
or growth arrest phase molecular markers like Gas1 (growth arrest-specific 1). 
Gasl is expressed in cells that are cell cycle arrested118• Interestingly, it has also 
been demonstrated that Gasl expression is downregulated when human NPCs are 
induced to differentiate to astrocytes in vitro119• 
5.3.3 shh controls the proliferation of NPCs 
In this chapter, I have described the expression ofthe signalling molecule shh in 
the ventro-medial hypothalamus. This expression is seen in the same region where 
Nestin, Vimentin and the proliferation markers MCM5 and BrdU are expressed, 
although the latter two markers are positive in cells at the dorso-medial 
hypothalamus and at the lateral recesses as well. This suggests the likelihood that 
shh might be regulating a NPC population(s) at the ventro-medial hypothalamus. 
To test this, I attenuated shh signalling in the adult zebrafish. As briefly outlined in 
section 5.2.4, I performed this through intraperitoneal (lP) injection of 
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cyclopamine into the adult 1-year old zebrafish. IP injection has been widely used 
to deliver substances such as BrdU into the zebrafish as well as the mouse. In fact, 
delivery of cyclopamine through IP injection has been performed before in the 
mouse in a study analysing the effects of cyclopamine on medulloblastoma12o. 
However, cycIopamine delivery in the adult fish has never been performed, more 
so through IP injection. After the initial phase of optimization, the method worked 
very well and ptc1 expression was greatly reduced in cyclopamine-injected 
samples, indicating attenuation of the shh signalling pathway. This technique could 
arguably bypass the requirement for a mutant or compliment results obtained 
through future mutant studies. 
As shh has been shown to be a positive regulator ofthe cell cycle and promote cell 
proliferation including neural precursor cells121-123, I tested the markers MCM5 
and BrdU. BrdU is an artificial analogue of thymidine. It works by incorporating 
into newly synthesized DNA strand, substituting for thymidine during cell division 
in the S-phase of the cell cycle124 that can be later detected using BrdU specific 
antibody. MCM5 or mini chromosome maintenance complex is a member of the 
MCM family of chromatin-binding proteins that is upregulated in cells in the late 
G1 phase of the cell cycle reflecting the requirement for MCM5 in active cell 
proliferation 125,126. 
The result shows that both markers are reduced in terms of positive cell numbers 
in the cyclopamine-injected fish. This indicates that the proliferative capacity of 
NPCs in the medial hypothalamic region is governed by shh. Intriguingly however, 
BrdU positive cells show a greater percentage of reduction (75% reduction) 
compared to the MCMS positive cells (40% reduction). An interesting yet logical 
speculation to explain this observation is that the NPCs are arrested at the G1 
phase of the cell cycle when shh signalling is attenuated. It has been described 
before that shh is required for the inhibition of p21, a cyclin-dependent protein 
kinase (CDK) regulator that directly regulates cell proliferation through the 
inhibition of DNA replication127, 128. Hence, when Shh signalling is attenuated, DNA 
replication may fail to occur in the NPCs, preventing the incorporation of BrdU. 
This is consistent with previous findings that show a reduction in BrdU-positive 
cells when p21 is overexpressed in human cell lines (U20S cells)127, and might 
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explain why BrdU positive cells are reduced in far greater numbers compared to 
MCMS positive cells. 
Given the limited time to undertake these studies, I have not yet analysed a 
potential role for fgf3 in the proliferation of the NPCs. It has been demonstrated 
that ICV (intracerebroventricular) FGF infusion in the adult mouse results in an 
increase in BrdU positive cells in tanycytes in the medial hypothalamic region10S• 
Moreover, FGFs play a role in the embryonic neural tube in the maintenance for 
proliferating Sox progenitors129• Fgfs also cooperate with Shh to control cell 
proliferation in the fin-bud of the developing zebrafish130• It will therefore be 
crucial in future studies to assess whether FGFs govern proliferation of the NSCs in 
the hypothalamus ofthe adult zebrafish. 
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Overall Discussion 
Overall Discussion 
Prior to the work outlined in this thesis, the homeobox transcription factor 
rx3/ Rax was mainly studied through its role in eye development. The loss of 
rx3/ Rax function leads to the loss of eye phenotype, which is manifested as 
anophthamia or microphthalmia in humans. Studies on the mechanism underlying 
these phenotypes have characterised a role for rx3 in optic vesicle versus 
telencephalic morphogenesis29 and a role in the specification of retinal pigment 
epithelium fate131 
In this final part of the thesis, I will discuss the overall findings of the first four 
results chapters and outline possible mechanism(s) to describe the role of rx3 in 
embryonic hypothalamic development, through its interaction with the shh andfgf 
pathways. I will discuss modes that might explain the findings in this thesis. I will 
also discuss the importance of studying the maintenance of these signalling 
molecules in the adult hypothalamus and discuss my findings in the fifth result 
chapter in the context of the first four. Additionally, I will also highlight 
experiments that need to be performed to support the existing data as well as 
future work to extend the findings made in this thesis. Limitations of my work and 
data will also be discussed along with a brief critique on the suitability of the 
zebrafish as a model to study hypothalamic development. 
rx3 regulates the expression of shh in the AD" and vice-versa 
In chapter 1, I described the overlapping expression domains of shh and rx3, first in 
the ADH and then in the 3rd ventricle. To investigate the regulatory role of rx3 on 
shh, I analysed the expression of shh in rx3 morphants and found that expression of 
shh is diminished in the ADH. In chapter 3, I showed that inhibition of shh 
signalling resulted in drastically reduced rx3 expression in the ADH during early 
stage inhibition (Figure 3.2), suggesting that shh acts to regulate the expression of 
rx3 during the establishment of the ADH. Together the data show a previously 
undescribed feedback loop between shh and rx3. Feedback loops between shh and 
downstream transcription factors has been described in the posterior neural tube, 
studies supporting the idea that HD proteins induced along the D-Vaxis of the 
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neural tube in response to Shh, themselves contribute to the Shh output. Thus, 
early studies showed that Shh induces Foxal expression in the floor plate, which in 
turn enhances Shh expression in the floor plate132• More recently, studies show 
that the Nkx genes, which are induced lateral to Shh-expressing floor plate cells, 
feed-forward to strengthen Shh signalIing7, 133. My data reveal that a shh-HO 
transcription factor loop is similarly operating during the early establishment of 
the AOH, suggesting that such a strengthening mechanism might operate more 
widely within the eNS, and through HO proteins other than the Nkx genes. In the 
spinal cord, this mechanism has been suggested to be crucial in converting a Shh 
gradient into a step-like gradient, leading to sharp thresholds of Shh signalling, 
each able to specify a distinct response. Future studies, examining expression of 
other HO proteins that are expressed adjacent to the AOH are required to address 
whether a similar mechanism operates in the hypothalamus, but my data begin to 
suggest that it might. 
Shh from the ADH patterns the anterior hypothalamus and telencephalon 
Numerous past studies have shown that Shh is required for development and 
patterning of the hypothalamus68, 69. However, since Shh is expressed in 
prechordal mesoderm, in the hypothalamic floor plate, and then in the basal plate, 
these studies do not address, specifically, whether Shh from the AOH plays any role 
in the normal specification and maintenance of hypo thalamic tissue. Two recent 
studies in the mouse have begun to address this. The selective deletion of Shh from 
the basal plate including the AOH reveals that Shh is essential for anterior 
hypothalamic patterning69• This study reported that loss of shh in that region 
resulted in the loss of Pome positive cells in the arcuate nucleus, but a maintained 
Rax expression which draws remarkable similarity to my data produced in result 
chapter 3 where inhibition of Shh signalling saw a reduced number of pome 
positive cells in the arcuate nucleus and a maintained rx3 expression in the 3rd 
ventricle (Figures 3.2 and 3.4). Similarly, transgenic approaches in the mouse, 
coupled with in vitro experiments show that neural Shh coordinates 
anteroposterior and dorsoventral patterning in the hypothalamus and in the 
diencephalon-telencephalon junction (DTJ)68. These experiments reveal also that 
neural Shh is necessary for the lateral hypothalamus to attain its proper size and is 
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required for the specification of hypo cretin/ orexin cells. My studies in the 
zebrafish support and extend these findings, showing that Shh that derives from 
the ADH is necessary for the proper patterning of the hypothalamus. Reduction of 
Shh expression, either mediated indirectly via rx3 knockdown, or directly through 
early cyclopamine treatment, led to an expansion of posterior and medial markers 
into more anterior regions: thus, SOX, isl1, rx3, emx all extended anteriorly. The 
expansion of posterior markers was accompanied by a loss of anterior markers, 
including the ADH itself (as judged through the mis-patterned expression of rx3) 
and the loss of zic2a, a marker of the optic chiasm. Intriguingly, the loss of function 
of rx3 caused a downregulation of shh in the ADH, but not in the 3rd ventricle. 
Together, these results suggest that Shh in the ADH, but not the 3rd ventricle, 
govern the anterior patterning of the hypothalamus. 
In keeping with results in the mouse68, my studies show that the loss of shh 
expression in the ADH appears to result in the secondary (non cell-autonomous) 
loss of Shh in the telencephalon (Figure 2.6). In other species, Shh from the 
diencephalon appears to induce Shh in the telencephalon12 and my results suggest 
a similar model in zebrafish. Thus, the loss of Shh in the ADH appears to have 
profound effects on the patterning of both the diencephalon and telencephalon. 
Rx3 and Shh govern the specification and differentiation of progenitor cells 
to pomc positive cells in the arcuate nucleus 
.. 
Studies in the mouse show that a reduction in Shh expression in the hypothalamus 
leads to the loss of a specific hypothalamic neuron, the hyprocretin/orexin positive 
neuron. My results similarly reveal that the loss of Shh in the ADH, mediated either 
through loss function of rx3 and through direct inhibition of Shh signalling, leads to 
the reduction of pomc expressing cells in the arcuate nucleus._The loss of pomc 
positive cells in the arcuate nucleus leads me to hypothesise that Shh is required 
for the specification of these cells, and to hypothesise that Shh could operate at a 
number oflevels to govern this specification. 
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i) rx3/Shh may be required for the early patterning of pomc progenitors. 
First, as outlined above, Shh from the ADH appears to pattern the anterior 
hypothalamus. This raises the possibility that Shh may establish an early pomc 
progenitor. Although I have not examined expression of nkx2.1, this gene is a 
potential candidate. In both mouse and chick, Nkx2.1 is a known direct target of 
the Shh signalling pathway134 and sustained Shh signalling is required for 
expression of Nkx2.112. 135. Importantly, elegant lineage-tracing experiments in the 
mouse show that POMC positive cells in the arcuate nucleus arise from Nkx2.1 
positive progenitor cells in the hypothalamus136. Together, this raises the 
possibility that Shh governs Nkx2.1 progenitor cells, which in turn, can give rise to 
pomc positive neurons. In keeping with this model is the observation that although 
nkx2.1b expression appears upregulated in the posterior hypothalamus of chokh 
mutants, its expression appears downregulated in cells immediately adjacent to 
the ADH, including regions likely to harbour arcuate nucleus progenitors29. Clearly, 
further studies are required to test this, and in future, I aim to analyse expression 
ofthe nkx genes more closely. 
ii) rx3/Shh may govern progenitor cell behaviour in the 3 rd ventricle 
A second possibility is that rx3/Shh in the 3rd ventricle plays a role in governing the 
transition of neural progenitor cells to differentiate towards pomc positive fates in 
the arcuate nucleus. In all species, differentiating neurons migrate to 
lateral/mantle layers of the CNS from stem/progenitor cells in the ventricular 
zone, and migration of POMC progenitors from the ventricle towards the arcuate 
nucleus has been described in the mouse137. My data are consistent with the 
possibility that appropriate expression of rx3 and Shh in progenitor cells in the 3rd 
ventricle is a prerequisite for normal differentiation of pomc positive cells. In the 
rx3 morphant embryos, proliferating progenitors increase in the 3rd ventricle, this 
increase accompanied by elevated levels of shh and rx3 expression. My studies 
however do not establish the relationship between the proliferating progenitors, 
the rx3 positive and the shh positive cells. In the mouse, Rax positive progenitors in 
the hypothalamus are also positive for Nestin and Sox1 (SoxB1) expression 
suggesting the idea that rx3 may mark an early 'stem-like' or progenitor cell, and 
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play a cell-intrinsic role in its behaviour138. Similarly, other studies in the mouse 
show that Shh marks early stem/progenitor cells in the subventricular zone, its 
activity governing their behaviour121.139. Thus, imbalance of rx3, or Shh activity, 
could lead to an altered behaviour of progenitor cells, leading, for instance, 
towards elevated levels of self renewal and concomitant decrease in 
differentiation. 
My studies do not preclude other possibilities. For instance, rx3 may function as a 
competence factor for progenitor cells to respond to Shh from the 3rd ventricle. In 
this model, progenitor cells in the 3rd ventricle, destined to assume a pomc positive 
identity, are incompetent to differentiate to the pomc cell fate through the loss of 
rx3 function, hence their accumulation detected through phos-H3 expressions and 
their inability to respond to Shh in the 3rd ventricle of the rx3 morphant. 
Alternatively, rx3 may be cell-autonomously required for the segregation of pomc-
destined progenitor cells from the rest of the progenitor cell pool in the ventricle. 
The potential 'cell sorting' function of rx3 is postulated through a study performed 
in chimeric mouse that demonstrates cell autonomous role of rx in segregating 
wild type cells from rx-/- cells during morphogenesis of the retina/pituitary31. 
Inappropriate segregation might, in turn, lead to an altered capacity to 
differentiate. 
iii) Late effect of ADH-derived Shh on specification ofpomc 
A third possibility is that ADH-derived Shh drives the late specification and 
differentiation of progenitor cell to the pomc expressing fate, once they have 
migrated into the arcuate nucleus. In chapter 1, I showed that ptc1, a downstream 
read-out of Shh signalling is detected in the arcuate nucleus, where hypothalamic 
pomc positive cells are found (white arrowhead Figure 1.38: the arcuate nucleus is 
located just adjacent to the ADH Figure 2.2). Although there is_no evidence that 
Shh operates directly on the pomc gene to enhance its expression, previous work 
has described an indirect activation of pomc expression in the adult pituitary by 
Shh signalling through the Glil transcription factor8z. This raises the possibility 
that Shh may operate at late phases of pomc cell specification. 
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Together, then, my results could suggest that rx3/Shh play a role in establishing 
either pomc progenitor cells, or pomc expression itself. Of course, these 
possibilities are not mutually exclusive. It is possible that pomc progenitors first 
express rx3 to be Shh competent, begin to express nkx2.1 upon activation by shh in 
the ADHj3 rd ventricle, and then require Shh again at a late phase for pomc 
expression. In order to begin to distinguish these possibilities, I now intend to 
perform an analysis of a broader range of markers, incl uding performing lineage-
tracing experiment using caged-dextran method as described in the literature29• 
Such studies will allow me to begin to understand where the pomc progenitor cells 
lie at distinct phases of development, the markers they express as they 
differentiate, and their relationship to rx3 positive and shh positive cells. 
A second issue that I would like to address in future studies is to firmly establish 
whether Shh signalling is important in two phases: a first phase in which Shh is 
required for the induction and establishment ofthe ADH and its adjacent region 
including arcuate nucleus progenitors, and a second phase in which Shh is 
required for the specification and differentiation of pomc positive cells in the 
arcuate nucleus. Such a distinct temporal function of SHH has been reported before 
in the neural tube, where SHH is first required to convert naive neural plate cells 
into a progenitor state, and in which subsequent SHH signalling mediates the 
differentiation to motor neurons140• I intend to now demonstrate whether a similar 
operation of Shh occurs in the generation of pomc positive cells in the arcuate 
nucleus, suggesting a conserved function and mechanism of shh in the generation 
of neurons along the A-P axis of the vertebrate neural tube, for instance, either 
through further conditional experiments using cyclopamine, or through the use of 
light-activated morpholinos. 
Caveats 
An outstanding question is that of why pomc positive cells are still found in the 
arcuate nucleus of the rx3 morphant embryos albeit in significantly lower 
numbers. This occurs despite the apparent loss of the ADHjshh expression in the 
ADH. There are at least three reasons that could account for this: 
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First, it is possible that there are other factors apart from Shh and rx3 governing 
pome cell differentiation. For instance, in the adult mouse hypothalamus, the 
differentiation of neural progenitor cells from the 3rd ventricle to a Pome cell fate in 
the arcuate nucleus requires FGF signalling49. My studies show that i) Inhibition of 
Fgf signalling led to the reduction of pomc positive cells in the arcuate nucleus and 
ii) Fgf signalling appears largely unaffected in the hypothalamus after rx3 or Shh 
signalling reduction in rx3 morphant embryos. Thus, it is possible that Fgf plays 
some role in pome differentiation. 
Second, since the analyses were performed using rx3 morphants, there is a chance 
that the inhibitory effectofthe morpholinos dissipate as the embryos develop and 
mature. The gradual loss of morpholino knockdown effects in the developing 
zebrafish embryo is quite common. Hence, it will be vital to repeat some of these 
experiments using the ehokh mutant embryos. 
Thirdly, as rx3 morphant embryos have lost rx3 function from the one-cell stage, it 
is possible that some of the observed effects are indirect effects resulting from the 
early loss oftelencephalic/diencephalic subdivisions. In future, I would therefore 
like to perform a conditional analysiS ofrx3 function. Although a conditional rx3 
knock-down mutant can be generated, a quicker way would be to attenuate rx3 
function through the use of light-activated morpholinos or photomorph141• This 
new method incorporates the design of mRNA specific targeted morpholino (Le. 
rx3) in the same way as a regular morpholino but embedded within a caging 
molecule that will degrade upon exposure to a 405 nm laser wavelength. Using a 
confocal, this laser can be directed to specifically degrade the cage and release the 
morpholino in a site-specific manner. This technique hence not only allows for 
temporal, but spatial control as well and can almost eliminate non-specific effects. 
Regulation of rx3 expression by Fgfs 
In addition to demonstrating that rx3 is likely to operate in concert with Shh, my 
data reveals a potential role for Fgf as an upstream regulator of rx3 expression. 
This finding supports previous studies, demonstrating that Fgfacts upstream of 
soxBl gene (sox2/3) expression during retinal development142 and that soxBl 
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genes regulate expression ofrx3 during early embryogenesis143 .Together these 
analyses suggest a possible molecular route, in which upstream Fgf signalling 
indirectly regulates the expression of rx3 through soxBl genes. In future 
experiments, I would like to address this by examining soxBl expression in SU-
treated embryos, and examining rx3 expression in soxBl knock-out embryos (Le. 
sox2 or sox3 morpholino knockdown). 
Maintenance of shh and/gp in the adult zebrafish hypothalamus 
The expression of signalling factors in the adult environment is beginning to 
attract active research as these molecules may play pertinent roles in the 
maintenance of adult systems. Mis-regulation of SHH signalling has been 
implicated in the onset of tumours including basal cell carcinoma (BCC)144.145 and 
medulloblastoma146.147 whilst mis-regulated FGF signalling has been implicated in 
the growth of astrocytomas148. These findings clearly suggest that both shh and fgfs 
are important in the adult as 'system maintenance' factors without which disease 
states will begin to manifest. 
In result chapter 5, I have demonstrated the maintenance of shh andfgp in the 
adult zebrafish medial hypothalamus, and demonstrated that, in the adult medial 
zebrafish hypothalamus, shh may be crucial for the proliferation of NPCs. In future, 
I would like to examine if rx3 is still expressed in the adult zebrafish hypothalamus 
and if it is regulating shh expression as in the embryos. Interestingly, rx3 is 
reported to be expressed in the hypothalamus ofthe adult Medaka fish (Oryzias 
/atipes)131 suggesting the strong likelihood of detecting rx3 expression in the 
hypothalamus of the adult zebrafish. 
Additionally, the expression of/Bj3 detected in the adult zebrafish hypothalamus 
warrants a further investigation into the role offgP in the potential regulation of 
NPCs and a potential involvement in rx3 maintenance. Unfortunately, the chokh 
mutant line is juvenile lethal and would not survive until adulthood, making it 
impossible for loss-of-function rx3 study in the adult. Nevertheless, it might still be 
informative to study the above using heterozygous chokh mutant embryos. 
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Suitability of the zebrafish as model for hypotbalamic study 
As outlined in the thesis Introduction, the zebrafish has many unique features, 
which facilitates its use as an emerging model system for developmental biology 
research. However as with any other model system, there are both advantages and 
limitations to the zebrafish model. In this section I will highlight some of the 
advantages and limitations of using the zebrafish to study the hypothalamus from 
my own experimentation experience gained through this thesis. 
i) Advantages 
One of the most useful advantages of using the zebrafish is the relative ease of 
performing whole-mount ISH and immunohistochemistry during embryonic 
development, especially at the early stages. It is not as easy to perform whole-
mount ISH using chick and mouse embryos due to their large size and thick 
ectodermal layers that prevent the easy penetration of ISH probes and antibodies. 
In these model systems, ISH is normally performed on hypothalamic sections or 
semi-wholemounts, where the embryos are cut into half along their neuroaxes. 
However, whole mount visualization of ISH labelling often provides invaluable 
information through an absolute observation of gene expression in the 
hypothalamus. Also, established methods such as PTU and bleaching that allows 
for the removal of melanocytes which cause pigmentation from the mid-staged 
embryos onwards, are available and easily performed in the zebrafish embryos. 
The availability of pigment-less mutants like nacre and golden provides an 
alternative to the above and can be crossed to other mutant lines as well, to 
produce pigment-less embryos. Apart from that, removal of the eyes to allow 
visualization of the hypothalamus is quite a straightforward technique which can 
be done manually using fine needles or chemically through dispase treatment as 
described in Materials and Methods. 
iD Disadyanta~es 
The hypothalamus ofthe zebra fish embryo is extremely small relative to the chick 
and mouse embryos. This makes the characterisation and manipulation of the 
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hypothalamus challenging. Whilst the hypothalamus is anatomically similar to the 
chick and mouse at very early stages of development, it begins to look different 
from late embryonic stage onwards into adult. A clear example of this is the 
existence of two hypothalamic lobes (Le. the superior and inferior lobes) in the 
adult zebrafish, which does not exist in the adult rodent models. Another example 
is the appearance of the lateral recesses of the 3rd ventricle (or diencephalic 
ventricle) in the adult hypothalamus, which is not seen in the rodent models. As 
yet, the function of these recesses is still currently unknown. Also as outlined in the 
result chapters, the zebrafish does not have infundibulum or median eminence 
structures. Nevertheless, despite these anatomical differences, the zebrafish 
hypothalamus is still by and large functionally similar to those of the higher 
vertebrates and shares conserved patterning and development as seen through 
this thesis. 
Conclusion and Application 
The data presented in this thesis is the first to describe the novel role of rx3 in the 
hypothalamus. It is also the first to show rx3 as a regulator of the shh pathway, and 
vice-versa, and the upstream control of rx3 expression by fgf. 
Pame is a key gene involved in feeding behaviour and this suggests that 
anopthalmic patients (where loss offunction Rx/Rax is described) might suffer 
from a dysregulated feeding function, which is worth investigating. The Rx/Rax 
-. 
gene is thus potentially useful as a therapeutic target not only for anopthalmia but 
also for feeding-related problems. 
Apart from that, the data provided in this thesis also show the maintenance of shh 
andfgf3 in the adult hypothalamus. Evidence suggests that shh functions to control 
the proliferation of adult neural progenitor cells. These findings provide further 
support to the importance of studying maintained signalling factors in the adult 
environment. Additionally, the technique to introduce chemicals through IP 
injection as developed through this thesis could be extremely useful to study a 
variety of signalling factors in the adult zebrafish. 
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